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ABSTRACT OF THE DISSERTATION

Genetic and genomic dissections of myelinating glial cell development
by
Breanne L. Harty
Doctor of Philosophy in Biology and Biomedical Sciences
Molecular Genetics and Genomics Program
Washington University in St. Louis, 2017
Associate Professor Kelly R. Monk, advisor
Myelin is a multilamellar sheath made by specialized glial cells that iteratively spiral and
compact their plasma membranes around axon segments. In vertebrate nervous systems,
myelination facilitates rapid action propagation and provides trophic support critical for
neuronal survival. In the central nervous system (CNS), oligodendrocytes (OLs) extend
many processes to simultaneously ensheathe multiple axons, while in the peripheral
nervous system (PNS), myelinating Schwann cells (SCs) pair 1:1 with a single axon
segment. Elaboration of the myelin sheath is one of the most exquisite and complex
examples of massive coordinated cellular shape changes in the nervous system. The
importance of myelinating glia is further highlighted by the fact that disruptions in
myelination result in debilitating symptoms in diseases such as multiple sclerosis, and
Charcot-Marie-Tooth disease. And yet, compared to their neuronal counterparts,
relatively little is known about the molecular machinery governing the development of
myelinating glia. In my thesis work, I used a combination of classic genetics and the
latest genomics approaches in both zebrafish and mouse models to identify novel
regulators of myelinating glial cell development.
xx

Recent work from the Monk lab, and others, has shown that the adhesion family of G
protein-coupled receptors (aGPCRs), particularly Gpr126 and Gpr56, mediate cell-cell
and cell-matrix interactions to regulate SC and OL development. Importantly, the
zebrafish has proven to be a useful model for studying Gpr126, Gpr56 and several other
aGPCRs in various contexts. However, the full repertoire of aGPCRs and their expression
profiles in zebrafish were unknown, limiting the utility of the zebrafish model for the
aGPCR field. Therefore, I mined the zebrafish genome to define the aGPCR repertoire in
zebrafish and used high throughput qPCR to characterize the expression profiles of all
aGPCRs throughout development and in adult tissues. We identified at least 59 aGPCRs
in zebrafish, representing homologs of 24 of the 33 human aGPCRs. Interestingly, we
found that the expression profiles of zebrafish aGPCRs closely match those of their
mammalian orthologs in adult tissues, and our study was the first to describe aGPCR
expression during development in any species. I also profiled the expression of all
zebrafish aGPCRs in the optic nerve, which is enriched for OLs, and the posterior lateral
line nerve (pLLn), which is enriched for SCs. Excitingly, we showed that several other
aGPCRs are highly enriched in myelinating glia-rich tissues, and future work will
determine if these are also important players in myelinating glial cell development.

In a separate, but complementary line of work, I collaborated with members of the Monk
and Solnica-Krezel laboratories to conduct a large-scale forward genetic screen in
zebrafish to identify novel genetic regulators of SC and OL development. In total we
screened nearly 700 genomes and uncovered 31 mutations affecting the distribution
and/or expression levels of myelin basic protein (mbp), which encodes Mbp, a critically

xxi

important component of the myelin sheath. One of the most striking mutants, designated
stl64, displayed dramatic overexpression of mbp. Using whole genome sequencing, I
determined that the stl64 lesion introduces a premature termination codon in the gene
fbxw7. Fbxw7 is an E3 ubiquitin ligase normally responsible for maintaining proper
protein homeostasis by recognizing target proteins and catalyzing their ubiquitination and
subsequent degradation by the proteasome. Previous work showed that Fbxw7 regulates
Notch and mTOR to control OL development and myelination, but a role for Fbxw7 in
SCs has never been described. Using zebrafish and SC-specific knockout models in mice,
I found that Fbxw7 is critical at nearly every stage of SC development and myelination.
Loss of Fbxw7 in SCs results in enhanced SC number, thicker myelin, Remak bundle
defects, and basal lamina abnormalities. We showed that the enhancements in SC
numbers, Remak SC ensheathment, and myelin thickness are all due to elevated levels of
mTOR signaling. When mTOR is deleted from mutant SCs, these phenotypes are
suppressed.

Additionally, I discovered that Fbxw7 also restricts SC-axon ratios. Mutant SCs are
capable of generating myelin around multiple axons simultaneously, in addition to being
able to myelinate large axons while encompassing many small unmyelinated axons at the
same time. This is the first ever in vivo description of multi-axonal myelination by SCs.
Very excitingly, we found that SC myelination capacity is independent of mTOR, as loss
of mTOR in Fbxw7 mutant SCs does not restore proper 1:1 SC-axon ratios. Ongoing
work is focused on discovering the identity of the Fbxw7 target regulating SC-axon ratios
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as well as understanding the consequences and potential utility of multi-axonal
myelination by SCs.

In sum, I have used a combination of classic genetics as well as the latest genomics
techniques to generate several tools for the aGPCR, zebrafish, and myelin research
communities; and most recently I have defined a novel critical regulator of SC
development and myelination, Fbxw7.
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Chapter 1
Introduction
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PREFACE
Portions of this chapter have been reproduced and adapted from the following
manuscripts:
Sigoillot SM, Monk KR, Piao X, Selimi F, Harty BL. Adhesion GPCRs as Novel Actors
in Neural and Glial Cell Functions: From Synaptogenesis to Myelination.
Handbook of Experimental Pharmacology. 2016; 234:275-298.
Mogha A, Harty BL, Carlin D, Joseph J, Sanchez NE, Suter U, Piao X, Cavalli V, Monk
KR. Gpr126/Adgrg6 Has Schwann Cell Autonomous and Nonautonomous
Functions in Peripheral Nerve Injury and Repair. J Neurosci. 2016; 36(49)1235112367.
Please see Appendices A and B for full versions of these manuscripts.

2

1.1

MYELIN IS CRITICAL FOR PROPER NERVOUS SYSTEM FUNCTION

Myelin is a multilamellar sheath made by specialized glial cells that insulates and
protects large caliber axons in the vertebrate nervous system. These myelinating glial
cells are known as Schwann cells (SCs) in the peripheral nervous system (PNS) and
oligodendrocytes (OLs) in the central nervous system (CNS). Oligodendrocytes and
Schwann cells generate the myelin sheath by iteratively wrapping their plasma
membranes and cytoplasm around segments of axons. This process serves to increase the
conduction velocity of action potentials as well as provide trophic support to aid in the
proper functioning and survival of neurons [1]. Myelin is thought to be the last true
innovation in the evolution of the cellular architecture of vertebrate nervous systems,
which occurred in hinged-jawed fish [2]. Simply increasing the diameter of axons will
increase action potential speeds, however this is difficult when those axons are encased in
bone. By myelinating axons, vertebrates were able to achieve more rapid impulse
propagation as well as increased complexity without a corresponding increase in the size
or energy consumption of their nervous systems [3]. Over approximately 300 million
years of parallel evolution, probably beginning with an ancestral glial cell similar to those
found in unmyelinated fish such as lamprey, oligodendrocytes and Schwann cells solved
the same problem using an overlapping, but not identical, set of genes [2]. This led to
some characteristic similarities in function and composition between CNS and PNS
myelin, in addition to some striking differences. For example, oligodendrocytes have
greater myelination capacity than Schwann cells as an oligodendrocyte can
simultaneously myelinate many different axon segments of varying diameters [4], while a
Schwann cell is restricted to myelinating only a single axonal segment.
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1.2 SCHWANN CELL DEVELOPMENT
Schwann cells arise from the neural crest lineage (Figure 1). Neural crest stem cells
differentiate into Schwann cell precursors (SCPs), which migrate along axons during
neuron outgrowth. After SCPs populate axons, they differentiate into immature Schwann
cells. These immature Schwann cells extend cytoplasmic projections into the nerve
bundle and begin to associate with individual axons in a process termed “radial sorting”.
Immature Schwann cells can then mature into either myelinating or non-myelinating
Schwann cells, also known as Remak Schwann cells. This terminal differentiation choice
may be dictated by random chance based on the size of the axons the immature Schwann
cell is associated with at the time of maturation[1, 5]; however the fate decision between
myelinating SC and Remak SC is not well understood. Remak Schwann cells are very
unique in that they can extend many cellular processes to encompass many small caliber
axons simultaneously, but they do not ever proceed with wrapping or myelinating these
axons. Alternately, if an immature Schwann cell becomes a myelinating Schwann cell it
will enter the pro-myelinating stage, in which membrane wrapping begins. Upon
additional cues, such as the transient up-regulation of the transcription factor, Oct6, the
pro-myelinating Schwann cell expresses myelin genes and continues iteratively spiraling
its membrane around the axon segment. In the PNS, Neuregulin I type III appears to be
the key axonal signal that guides Schwann cell proliferation, differentiation, and myelin
thickness[6]. However, the regulation and exact mechanics of the wrapping process,
including how the Schwann cell senses or regulates the number of wraps remain a
mystery. The myelin sheath is then compacted via a process in which nearly all of the
cytoplasm is squeezed into specialized domains, resulting in very tight layers of
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membrane. Although it is clear that compaction requires the proper organization of
several crucial myelin proteins such as Myelin basic protein (Mbp), overall this process is
very poorly understood.

1.3 OLIGODENDROCYTE DEVELOPMENT
Oligodendrocytes undergo a similar developmental program to their PNS counterparts
(Figure 2), although generally less is known about oligodendrocyte development. In brief,
neural stem cells in the subventricular zone of the brain and spinal cord give rise to
oligodendrocyte progenitor cells (OPCs), which proliferate and migrate throughout the
CNS. As the OPCs migrate, they differentiate into a pro-oligodendrocyte that is
characterized by an increased number of cell processes. Pro-oligodendrocytes then
undergo further branching and terminally differentiate into post-mitotic pre-myelinating
immature oligodendrocytes that further mature and myelinate nearby axons upon
appropriate environmental cues, which have not been fully elucidated [7]. Interestingly,
unlike Schwann cells, which have both non-myelinating and myelinating cells in their
fully mature lineage, the oligodendrocyte lineage does not generate a cell type analogous
to the Remak Schwann cell that ensheathes but does not myelinate axons.

1.4 UNANSWERED QUESTIONS ABOUT MYELINATING GLIA
While many strides have been made towards understanding the early development of
myelinating glia, we know considerably less about the requirements for the actual
5

myelination process. For example, while we know the protein and lipid composition of
myelin membranes very well, we do not understand the mechanics of membrane spiraling
or what changes these membrane components might undergo during this process.
Additionally, we do not understand how these cells signal efficiently between membrane
layers, how myelinating glia manage to compartmentalize all of their cytoplasm into
specific domains during compaction, or what is required for the maintenance of this
tightly wrapped state. Further, we know that oligodendrocytes and Schwann cells
perform all of these critical functions using an overlapping, but not identical set of genes;
but we do not fully understand some of the most striking differences between these cells.
For example, what allows an oligodendrocyte to myelinate multiple axons
simultaneously, while a Schwann cell is restricted to a single axon segment? Why do
Schwann cells generate a basal lamina, but oligodendrocytes do not? And do either of
these differences between Schwann cells and oligodendrocytes explain why
remyelination after injury is nearly non-existent in the CNS, but occurs readily in the
PNS? To begin addressing some of these questions, I took two approaches using a
combination of traditional molecular genetics as well as genomics techniques in both
zebrafish and mouse. First, I used a candidate approach to investigate the role of adhesion
G protein-coupled receptors (aGPCRs) in myelinating glia during development and after
injury. And second, I conducted a large-scale forward genetic screen in zebrafish to take
an unbiased approach to find novel regulators of myelinating glial cell development.
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1.5

ADHESION GPCRs IN MYELINATING GLIA

The adhesion G protein-coupled receptor (aGPCR) family regulates many cellular
processes in a wide variety of cell types and contexts[8]. Despite being the second largest
class of GPCRs, aGPCRs are relatively understudied, in part owing to their complex
structure. aGPCRs are defined by a large extracellular N-terminus and a GPCR
autoproteolysis-inducing (GAIN) domain that can cleave the receptor at the GPCR
proteolysis site (GPS) into an N-terminal fragment (NTF) and a 7-transmembrane (7TM)containing C-terminal fragment (CTF) during the maturation process (Figure 3) [9, 10].
The NTF and CTF are thought to remain non-covalently attached at the cell surface[9,
11]. In addition to their characteristic autoproteolytic cleavage, aGPCRs are distinct from
other GPCR families in that their N-termini often contain protein domains that are
classically associated with cell-cell or cell-ECM adhesion, hence the name “adhesion
GPCR.” There are a total of 33 aGPCRs in humans, 31 in mice and rats [12], and over 50
in zebrafish [13]. In vertebrates, there are nine distinct subgroups of aGPCRs that can be
separated based on the phylogeny of their 7TM regions [12].

1.5.1

GPR126 is essential for Schwann cell development and myelination

The first evidence of a role for aGPCRs in myelination was the discovery that Gpr126 is
required for the normal progression from a promyelinating SC to a fully mature
myelinating SC in both zebrafish and mice [14, 15]. In Gpr126 mutants, SCs express the
transcription factor Sox10, which is required for SC specification, maintaining SC
identity, and proper progression of the lineage [16-18]. However, Gpr126 mutant SCs fail
to upregulate later-stage transcription factors Oct6 (Pou3f1) and Krox20 (Egr2). Oct6 and
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Krox20 are required to activate the expression of many myelin-associated genes,
including Mbp, which encodes a structural component of the myelin sheath.
Ultrastructural analyses demonstrated that Gpr126 mutant SCs can associate with axons
in the proper 1:1 ratio, but are arrested at the promyelinating stage of development, and
fail to ever elaborate a myelin sheath [14, 15].

Interestingly, myelination defects in gpr126 mutant zebrafish can be suppressed by
treating the animals with forskolin, an adenylate cyclase activator that potently elevates
cAMP. Specifically, SCs of forskolin-treated gpr126 mutant zebrafish express oct6,
krox20, mbp, and produce ultrastructurally normal myelin [14]. Additionally, elevating
cAMP levels and activating protein kinase A (PKA) restored myelination in myelinating
cultures from Gpr126-/- knockout mice [19], and PKA activation suppressed myelination
defects in gpr126 mutant zebrafish [20]. Moreover, cAMP is downregulated in the sciatic
nerves of mutant mice in which Gpr126 has been deleted specifically in SCs [19].
Finally, GPR126 was shown to directly couple to the Gs-protein and Gi-protein families
[19], which are associated with modulating cAMP levels. All together, these data suggest
that Gpr126 is a major, if not the sole receptor, that elevates cAMP in SCs to initiate
myelin-gene expression and terminal differentiation.

Gpr126 has cAMP-independent roles in Schwann cell development
Until quite recently, it was unclear if aGPCRs functioned as adhesion molecules by virtue
of the NTF, as traditional GPCRs signaling through heterotrimeric G proteins by virtue of
the 7TM, or if the same molecule could perform both functions. Notably, studies on
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Gpr126 have contributed to answering this question, as Gpr126 SC myelination studies
strongly suggested that aGPCRs could behave as traditional GPCRs [19, 21]; later, the
Gpr126-NTF was reported to have a CTF-independent role in heart development [22].
Together, this suggested that a given aGPCR can have domain-specific roles, at least in
different cellular contexts. Interestingly, recent structure-function studies of Gpr126 in
SCs have shown that aGPCRs can also have multiple independent functions in
modulating the development of a single cell [21].

Preliminary analyses of gpr126 zebrafish mutants suggested that Gpr126 functions
specifically in the final maturation of SCs. This function of Gpr126 is conserved in
mammals; however, both global and SC-specific Gpr126 mutant mice display additional
defects that were not observed in gpr126 zebrafish mutants, including severe delays in
radial sorting, axon degeneration, and limb contracture abnormalities [15, 19]. While
species differences may certainly be at play, there are key differences between the alleles
in Gpr126 mutant mice and zebrafish. The targeted deletion in Gpr126 null mice
produces an early premature stop codon that results in the near absence of Gpr126-NTF
mRNA, and these mice have severely impaired radial sorting and completely lack
peripheral myelination as mentioned above [15, 19]. In contrast, two previously studied
mutant alleles in zebrafish were likely not null alleles; the gpr126st49 allele is a point
mutation resulting in a premature codon near the GPS [14], such that the NTF might be
intact while the CTF signaling domain is absent. Similarly, the gpr126st63 allele is a
missense mutation that disrupts a highly conserved cysteine in the 7TM, thus the NTF
and CTF both remain intact [14]. Importantly, neither gpr126st49 nor gpr126st63 display
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defective radial sorting. In contrast, recently generated gpr126stl47 mutants represent a
very early premature stop codon (amino acid position 96), which is more similar to the
targeted deletion in Gpr126 mutant mice [21]. Interestingly, SCs in gpr126stl47 mutants
phenocopy the radial sorting defects observed in mouse mutants. These defects could be
rescued by genetically “adding back” the Gpr126-NTF but could not be rescued by
cAMP elevation, suggesting that Gpr126 has CTF-independent roles in SC development.
These findings are consistent with earlier studies highlighting NTF- and CTF-specific
functions for aGPCRs in C. elegans axon migration, fertility, and viability [10, 23],
though future work is required to determine how the Gpr126-NTF might direct radial
sorting in a cAMP-independent fashion.

Control of Gpr126 signaling in Schwann cells
Given that aGPCRs have both CTF-dependent and independent roles, an important
question centers around binding partners that might modulate these functions. Notably,
most aGPCRs are orphaned [8, 24], meaning their ligands and activation methods are
unknown. aGPCRs are unique relative to other GPCRs in that they undergo an
autoproteolysis event at the GPS motif that separates the protein into an NTF and CTF,
which then remain non-covalently associated with one another at the cell membrane [9,
11]. Interestingly, a spate of recent studies have shown that several aGPCRs, including
GPR126, generate a tethered agonist ligand, termed the Stachel sequence (German word
for “stinger”), which potently activates the CTF of the receptor in vitro [25-28].
Moreover, analysis of zebrafish mutants suggested that activation of Gpr126 by the
Stachel sequence is required for SC myelination [25], and it was recently suggested that
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Gpr126-interacting proteins in the extracellular matrix (ECM) might modulate
availability of the Stachel sequence.

The NTFs of several aGPCRs can bind to ECM molecules; Gpr126 is no exception, as
the Gpr126-NTF can bind to collagen-IV and Laminin-211 [21, 29], which are both
components of the SC basal lamina. In rodent SCs and GPR126-expressing heterologous
cells, exogenous application of collagen-IV induced cAMP elevation, which is required
for SC differentiation. Additionally, GPR126 derivatives lacking the NTF were
constitutively active, suggesting that the NTF is important for inhibiting Gpr126-CTF
signaling [29]. Interestingly, Laminin-211 also binds Gpr126 in a different region of the
NTF than the collagen-IV binding site. Overexpression of lama2 rescued myelination
defects in hypomorphic gpr126st63 zebrafish mutants in a cAMP-dependent manner [21].
Intriguingly, and in contrast to type-IV collagen, addition of Laminin-211 to GPR126expressing heterologous cells suppressed cAMP accumulation under static conditions.
However, under dynamic culture conditions, Laminin-211 activated GPR126. The in vivo
relevance of this result was underscored by the observation that a polymerizationdefective mutant form of lama2 could no longer restore myelination in gpr126 zebrafish
mutants. Taken together, these studies suggest that ECM molecules in the basal lamina
may modulate the NTF and impact Stachel sequence signaling. Moreover, the Laminin211/Gpr126 studies suggested that aGPCRs may be mechanically sensitive, consistent
with contemporaneous work on other aGPCRs in Drosophila melanogaster [30].
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Importantly, these data tie in with the model that Gpr126 has CTF-independent functions
in SC development. Low levels of cAMP promote SC proliferation and facilitate an
immature state, while elevated cAMP drives myelination [31]. Perhaps in early SC
development, the Gpr126-NTF remains tightly associated with the CTF such that cAMP
elevation is suppressed. Changes in ECM proteins in the SC basal lamina, including
Laminin-211 polymerization, may modulate the NTF such that the Stachel sequence can
bind the 7TM and induce Gpr126 signaling cascades through Gs, which elevate cAMP,
activate myelin-related gene expression, and allow terminal maturation of myelinating
SCs.

1.5.3

GPR126 is also a critical regulator of peripheral nerve repair after injury

In addition to their role in nerve development, SCs are also vital players in peripheral
nerve repair after an injury. Axons distal to an injury site undergo Wallerian
degeneration, a programmed cellular response that drives axon fragmentation. SCs
associated with these degenerating axons also respond in a stereotyped fashion, becoming
“Büngner” or repair SCs, which are essential mediators of nerve repair. Repair SCs
downregulate the expression of genes associated with myelination and upregulate genes
associated with immature SC stages. Further, repair SCs also upregulate neurotrophic
factors and cytokines, which promote neuronal survival and macrophage recruitment,
respectively [32]. The macrophages recruited by SCs phagocytose axon and myelin
debris, and SCs themselves also efficiently clear debris by a specialized form of
autophagy [33]. Following nerve injury, axons regrow through Büngner bands – repair
SC-containing basal lamina tubes – back to their targets. Once SC-axon contact is
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reestablished, repair SCs differentiate and remyelinate the regenerated axons, which is
necessary to restore optimal nerve function following repair. Although there are some
differences between developmental myelination and remyelination following injury,
many of the same molecular programs are reinitiated during repair. For example, the
transcription factors Oct-6 (Pou3f1) and Krox-20 (Egr2) are similarly expressed in both
contexts, with transient Oct-6 expression following axon contact that in turn regulates
Krox-20 and subsequent myelin gene expression [34, 35].

Despite the essential function of Gpr126 in SC development, it is unknown if this
aGPCR is similarly required for remyelination following injury. Moreover, Gpr126 is
robustly expressed in mature SCs [19], but its function in adult nerve is not known.
Therefore, we recently investigated the role of Gpr126 in SCs following nerve injury by
employing tamoxifen-inducible conditional mouse models. We showed that while
Gpr126 is dispensable for myelin maintenance up to four months, this aGPCR has key
SC-autonomous and non-autonomous functions during injury and repair. Mirroring its
role in development, Gpr126 is required in SCs for remyelination. Unexpectedly, we also
find that Gpr126 is required in SCs for increased macrophage numbers in the distal stump
as well as efficient axon regeneration following injury. This work is described in detail in
Appendix B of this thesis.

1.5.4

GPR56 regulates oligodendrocyte development

Although Gpr126 is essential for SC development and myelination, it has no known
function in OLs, suggesting that there might be another aGPCR that is similarly
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important for OL maturation and myelination. Previously published data sets indicate that
Gpr56, an aGPCR in the same subfamily as GPR126, is highly expressed in OPCs in the
developing mouse CNS [36, 37]. In humans, mutations in GPR56 cause bilateral
frontoparietal polymicrogyria (BFPP) [38], a cortical brain malformation associated with
a variety of devastating neurological impairments such as epilepsy and mental
retardation. Interestingly, brains of BFPP patients also exhibit reduced white matter
volume by MRI and signal changes in T2 weighted images[31, 39, 40], which are
indicative of myelin defects. Two complementary studies have recently defined key
functions for GPR56 in OL development [41, 42].

In these studies, the authors analyzed both zebrafish and mouse Gpr56 mutants. gpr56stl13
mutant zebrafish harbor a 6 bp deletion that removes a completely conserved tryptophan
residue in the GPS motif that is essential for autoproteolysis [42]. Since previous reports
show that disruption of autoproteolytic cleavage of GPR56 prevents the protein from
being trafficked to the membrane and thus severely impairs GPR56 signaling [43], stl13
is likely a strong loss-of-function allele. Although loss of Gpr56 function in stl13 mutants
did not result in abnormal OPC specification or initial OPC numbers, both Gpr56
knockout mice and gpr56stl13 zebrafish displayed significantly fewer OL lineage cells
over time [41, 42]. GPR56 is expressed in many CNS cell types including
oligodendrocyte precursor cells (OPCs) and immature oligodendrocytes [41], which
could impact some of the OL phenotypes observed in Gpr56 mutants. Giera et al. also
used OL-specific deletion of Gpr56 to demonstrate that this aGPCR functions cell
autonomously in OLs to regulate their development. Ultrastructural analyses show that
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zebrafish and mouse Gpr56 mutants possess fewer myelinated axons as compared to
controls in the spinal cord and corpus callosum, respectively. However, axons that are
myelinated appear to be myelinated normally, suggesting that GPR56 regulates the
number of OL lineage cells, but is not required for myelination per se. Marker analyses in
both species demonstrated that the reduction in OL number is not due to increased OPC
cell death, but instead a lack of OPC proliferation [41, 42]. Additionally, overexpression
of gpr56 in wild-type zebrafish larvae induced increased OPC proliferation, while the
ventral spinal cord was precociously myelinated in gpr56stl13 zebrafish mutants at early
developmental stages [42]. Together, these studies support the notion that loss of GPR56
results in OPCs prematurely exiting the cell cycle in favor of differentiation.

Gpr56 regulates oligodendrocyte development via Gα12/13 and RhoA
Previous studies established that GPR56 couples to Gα12/13 and activates RhoA to control
migration of neural precursor cells in vitro [44, 45]. RhoA is highly expressed in
mammalian OPCs, but is downregulated at later stages to facilitate terminal
differentiation of OLs [46], paralleling the early function of GPR56 in these cells. In
zebrafish, knockdown of the genes encoding Gα12/13 proteins or overexpression of a
dominant-negative RhoA phenocopied OL lineage defects in gpr56stl13 mutants, while
overexpression of constitutively active RhoA rescued the defects [42]. In mouse, levels of
active RhoA were significantly reduced in Gpr56 knockout optic nerves while there were
no observable changes in PKCα, the only other effector reported to be downstream of
GPR56 [41]. Taken together, these experiments strongly support a model in which
GPR56 couples to Gα12/13 and signals through RhoA to promote OPC proliferation and
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inhibit terminal differentiation to ultimately regulate appropriate levels of CNS
myelination. In the future, it will be interesting to determine if this activation is
dependent on the Stachel sequence as well as what ligand(s) might influence GPR56dependent OL development.

1.5.5

Other aGPCRs in myelinating glia

Beyond GPR126 and GPR56, VIGR/GPR98 (ADGRV1) is expressed in OLs, and
modulation of this aGPCR can affect levels of a key myelin protein, MAG (Myelinassociated glycoprotein). In vitro, VIGR knockdown reduces, while overexpression
increases, MAG expression [47]. Additionally, expression studies suggest that there may
be yet undiscovered aGPCR players in glial cell development and myelination as
RNAseq analyses in the mouse CNS indicates that Gpr125 (Adgra3), BAI1-3, Lphn1,
Lphn3, and Celsr2 are all expressed (FPKM > 5) in OL lineage cells [48].
Importantly, the zebrafish has proven to be an incredibly useful model for studying the
roles of aGPCRs in many different contexts, especially in myelinating glia. However, a
major limitation for the advancement of aGPCR studies in zebrafish has been the lack of
a complete aGPCR gene repertoire in zebrafish, as well as inadequate expression
information. To help fill this gap, I mined the zebrafish genome to define the aGPCR
repertoire and found that the zebrafish genome encodes at least 59 aGPCRs. Further, I
used high-throughput quantitative real-time PCR (qPCR) to characterize the expression
profiles of all 59 zebrafish aGPCRs in adult tissues from every major organ system,
including the optic nerve and posterior lateral line nerve (pLLn), which are enriched in
oligodendrocytes and Schwann cells, respectively. Importantly, I found that zebrafish
16

aGPCRs display similar expression profiles in adult tissues to their mammalian
homologs. Interestingly, I also showed that many aGPCRs are highly enriched in tissues
enriched with myelinating glia. This suggests that the zebrafish may continue to be a
critical model for uncovering the roles of aGPCRs in myelinating glia. Finally, since the
zebrafish has been a powerful model for studying early embryogenesis, I also profiled
zebrafish aGPCRs at 12 different stages of development. These data are discussed in
detail in Chapter 2 and Appendix C of this thesis.

1.6 GENETIC SCREENS FOR NOVEL REGULATORS OF MYELINATION
Aside from a candidate approach, I also took an unbiased forward genetics approach to
identify novel regulators of myelinating glial cell development. Genetic screens have
been a very powerful discovery tool in a wide variety of systems and model organisms
for decades. Myelinating glia and zebrafish are no exception. However, previously
reported screens have not approached saturation, suggesting that additional genetic
regulators of myelination may still be unidentified.

Therefore, in an unrelated but complementary line of work, my colleagues and I
conducted a large-scale three-generation forward genetic screen in zebrafish. Mutations
were randomly introduced in the genomes of zebrafish males using 3-3.5 mM N-ethyl-Nnitrosourea (ENU). We then screened progeny in the F3 generation for mutants with
myelination defects using a transgenic reporter line in which the mbp promoter drives
expression of a red fluorescent protein, mCherry [Tg(mbp:mCherry-CAAX)]. Since Mbp
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is an essential structural component of myelin, mbp expression is often used as an
indicator of myelin integrity. Putative mutants were re-screened using whole-mount in
situ hybridization (ISH) with an mbp riboprobe to confirm mbp expression phenotypes
and heritability in the F4 generation. In total, we screened 680 genomes from 1126 F2
families, and we recovered 31 mutations affecting myelination. To our knowledge, this is
the largest genetic screen that has ever been conducted in search of regulators of
myelinating glial development. The details of this screen and its results are outlined in
Chapter 3 of this thesis.

stl64 is one of the most intriguing mutants we recovered in our screen, as it is the only
mutation that resulted in mbp overexpression. stl64 mutants display dramatically
increased mbp expression in the CNS relative to siblings at 5 days post fertilization (dpf).
To map the causative lesion in stl64 mutants, I analyzed whole genome sequencing
(WGS) data from mutants compared to phenotypically normal siblings. To find regions
of homozygosity in mutants, I used an in-house analysis pipeline that I developed in
collaboration with postdoctoral fellows in the Solnica-Krezel and Johnson labs (see
Appendix E of this thesis). This analysis mapped stl64 to an 800-kilobase region on
chromosome 1, in which the only mutation that did not result in a synonymous change
introduced a premature termination codon (PTC) in fbxw7, which encodes the E3
ubiquitin ligase, Fbxw7. The stl64 mutation (S/STOP) is in exon 11, and disrupts the last
(seventh) WD40 repeat in the target recognition domain. I then used both zebrafish and
mouse mutants to determine the mechanism by which Fbxw7 controls myelinating glial
cell development.
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1.7 FBXW7 REGULATES MYELINATION IN BOTH THE CNS AND PNS
Fbxw7, or F-box/WD-repeat domain-containing protein 7, is the substrate recognition
component of SCF (SKP1-Cullin-F-box) ubiquitin ligase complexes (Figure 4). These
complexes catalyze the addition of ubiquitin moieties on proteins to target them for
degradation by the proteasome [49]. Importantly, the proteasome regulates the
concentration of proteins and removes deleterious misfolded proteins. Thus, members of
the protein degradation network, including Fbxw7, are essential for fundamental cellular
processes such as proliferation [50], differentiation [51, 52], and apoptosis [51, 53].

Fbxw7 has three important domains - a dimerization domain (DD); the F-box, which
binds the rest of the E3 complex members; and the WD40 repeat domain, which is
responsible for target recognition (Figure 5). Fbxw7 recognizes its targets through a four
amino acid phosphodegron motif in the target protein sequence (Figure 5). Protein
database searches suggest that this motif is present in more than 1600 protein sequences
in the human genome (data not shown). Although many of those 1600+ predicted
possible targets may not receive the appropriate phosphorylation required for Fbxw7
recognition, the abundance of possible targets highlights the importance of Fbxw7 in
maintaining cellular homeostasis. Indeed, many of the confirmed Fbxw7 target proteins
are master regulators of critical cellular processes, such as: transcription factors (e.g., cMyc [54, 55], c-Jun [51, 56], and NICD [57-59]) and key cell cycle proteins (e.g., cyclin
E [60, 61], mTOR [62] and Aurora A [63]). However, the exact roles of Fbxw7 appear to
be context dependent and vary based on the specific Fbxw7 targets that are relevant in a
given cell type or disease.
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1.7.1 Fbxw7 regulates oligodendrocyte development and myelination
Fbxw7 modulates the development of the oligodendrocyte lineage by regulating Notch
Importantly, another mutant allele of fbxw7, vu56, has been isolated from a forward
genetic screen in zebrafish [64]. The vu56 lesion is a missense mutation that results in a
glycine to glutamic acid (G/E) substitution in the third of seven WD40 repeats in the
target recognition domain. As mentioned above, this is the same domain in Fbxw7
disrupted by PTC introduced by the stl64 mutation. Snyder et al., showed that fbxw7vu56
mutants display increased number of OLs as measured by the number of dual Sox10positive and Olig2-positive cells in the spinal cord. The authors suggest this is a result of
biased specification of neural precursors to the OL fate. However, fbxw7vu56 mutants did
not display any changes in the number of neurons, and instead possessed an increase in
the number of Sox2-positive neural precursors. Pharmacological inhibition of the Notch
intracellular domain (NICD) demonstrated that the excess OLs in fbxw7vu56 mutants
resulted from enhanced NICD signaling as a consequence of reduced Fbxw7 regulation
on Notch [64]. As further evidence that stl64 truly disrupts fbxw7, we performed ISH
using a riboprobe to nkx2.2a, a transcription factor expressed by immature OLs that are
destined to become myelinating OLs [65], and demonstrated that stl64 mutants possess
more nkx2.2a(+) cells than siblings at 65 hours post-fertilization (hpf). This suggests that
the increased mbp expression phenotype in stl64 mutants is, at least in part, attributable to
an increase in OL cell number. Thus, stl64 mutants phenocopy the increase in OL cell
number observed in fbxw7vu56 mutants (See Chapter 4 of this thesis).
It is important to note that some of the data in the Synder et al. study contradict previous
findings in conditional knockout (cKO) mice that loss of Fbxw7 specifically in neural
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stem cells (NSCs) using Nestin:cre had no effect on oligodendrocyte number [66].
Instead, Matsumoto and colleagues found that loss of Fbxw7 resulted in enhanced NSC
proliferation and severely biased NSC differentiation towards astrogenesis at the expense
of neurons. Fbxw7 mutants also displayed large accumulations of both Notch1 and
Notch3. Pharmacological inhibition of NICD attenuated the defects in both NSC
proliferation and differentiation, suggesting that these phenotypes were the consequence
of reduced Fbxw7 regulation of Notch signaling [66].

It is possible that these differences can be explained by species differences, such as the
fact that astrocytes have yet to be clearly identified in zebrafish. However, there is
perhaps a more parsimonious explanation for the increase in OL number observed in
fbxw7vu56 mutants. Although it did not reach statistical significance, Snyder and
colleagues also noted a trend towards increased OPC proliferation [64]. Since fbxw7vu56
zebrafish mutants display an increase in NSCs similar to that seen in NSC-specific
Fbxw7 conditional knockout mice, it is possible that the increased OPC number is
initially due simply to the presence of more progenitors at the time of gliogenesis, and
sustained by increases in OPC proliferation.

Fbxw7 limits oligodendrocyte myelination via control of mTOR
Recently, the Appel group followed up the initial study on the role of Fbxw7 on OL cell
number, and found that the CNS of fbxw7vu56 mutants are also hypermyelinated [67].
fbxw7vu56 mutants also overexpress myelin genes in the spinal cord. Transmission electron
microscopy (TEM) analyses showed that fbxw7vu56 mutant OLs generate thicker myelin
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as they produce more wraps of myelin around each axon. Further, the authors expressed a
GFP-labeled dominant negative Fbxw7 construct specifically in OLs by driving it under
the sox10 promoter (sox10:dnFbxw7-eGFP). Here, they found that loss of Fbxw7
function also results in the elaboration of longer myelin sheaths when compared to those
in wildtype controls. These data suggest that Fbxw7 limits OL myelination in addition to
OPC development, and that Fbxw7 is regulating OL myelination in a cell-autonomous
manner. Therefore, we conducted TEM on the spinal cord of fbxw7stl64 mutants at the
same timepoint (8 dpf), and showed that stl64 mutants are similarly hypermyelinated in
the CNS. This not only supports the findings in fbxw7vu56 mutants, but also provides
further evidence that fbxw7 is the causative gene in stl64 mutants.

Interestingly, Kearns and colleagues demonstrated that phospho-S6 levels are increased
in fbxw7vu56 mutant OLs, suggesting that loss of Fbxw7 results in elevated mTOR
signaling [67]. Treatment with the mTOR inhibitor, rapamycin, rescued the phospho-S6
levels in fbxw7vu56 mutants. Similarly, when the authors expressed the sox10:dnFbxw7eGFP construct in an mTOR mutant background, myelin sheath length was no longer
increased, but in fact was actually decreased relative to wildtype, as is observed in the
mTOR mutants. Together, these data suggest that Fbxw7 regulates mTOR levels to
control OL myelination.

1.7.2

Fbxw7 limits the myelinating capacity of Schwann cells

We first identified fbxw7stl64 mutants due to the massive overexpression of mbp in the
CNS. As mentioned above, previous studies have shown that Fbxw7 regulates Notch and
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mTOR to control oligodendrocyte development and myelination. However, a role for
Fbxw7 in Schwann cells has not been defined. Therefore, we performed TEM on
fbxw7stl64 mutants and analyzed the pLLn at 8 days post fertilization (dpf). We found that
both heterozygous and homozygous fbxw7stl64 mutants display an increase in the number
of Schwann cells, as well as thicker myelin in the PNS.

Fbxw7 functions cell-autonomously to control SC development and myelination
To determine if Fbxw7 is functioning cell autonomously in SCs, I generated a cKO
mouse line in which Fbxw7 was deleted specifically in Schwann cells. Importantly,
sciatic nerves from Dhh:Cre;Fbxw7fl/fl animals recapitulate the increased SC number and
hypermyelination phenotypes that are observed in the global fbxw7stl64 zebrafish mutants.
This demonstrates not only that Fbxw7 is functioning cell autonomously in SCs, but also
that the function of Fbxw7 is evolutionarily conserved. These data also support the notion
that Fbxw7 is in fact the causative gene in the stl64 zebrafish mutants.

To determine if early stages of SC development are affected by loss of Fbxw7, I analyzed
sciatic nerves from controls and cKO mice at P3, when most of the SCs are still
undergoing radial sorting and adopting either a myelinating or non-myelinating fate.
Interestingly, mutant nerves are hypersegregated at P3, with fewer axons per bundle.
Nerves lacking Fbxw7 also display myelination of axon bundles, or polyaxonal
myelination, another hallmark of radial sorting defects. We also very unexpectedly
discovered that myelinating SCs lacking Fbxw7 extrude processes from their outer
cytoplasmic pockets to interact with additional unsorted axons. Upon closer inspection,
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we found multiple instances in which a single SC had myelinated multiple axons, as
evidenced by the fact that the SC cytoplasmic processes interacting with and myelinating
each axon were surrounded by continuous basal lamina. To our knowledge this
phenomenon has never been observed before in reported mutants with myelination
defects in any species.

Balance within the mTOR signaling axis is key for proper PNS development
We next wanted to determine which Fbxw7 target was responsible for these phenotypes.
Previous studies have shown that several members of the PI3K/mTOR signaling axis
must be tightly regulated for Schwann cell development and myelination. When PI3K
function is abrogated through pharmacological inhibition of PI3K itself or genetic
deletion of the PI3K effector, Akt, Schwann cell myelination is blocked [68-70]. In
contrast, enhanced PI3K function either via loss of Pten, a PI3K pathway inhibitor, or
through constitutive activity of Akt results in hypermyelination, enhanced segregation of
unmyelinated axons, and aberrant wrapping of unmyelinated axons [70-72]. Importantly,
PI3K, Pten and Akt are all upstream of the serine/threonine kinase, mTOR, which is a
known target of Fbxw7 [62]. The importance of mTOR in PNS myelination is
underscored by the fact that deletion of mTOR in SCs results in dramatic
hypomyelination [73]. Further, loss of a key mTOR interacting partner, regulatoryassociated protein of mTOR (Raptor), specifically in SCs, phenocopies mTOR mutants in
that Raptor cKO nerves are severely delayed in radial sorting and hypomyelinated [74].
Therefore, we hypothesized that loss of Fbxw7 regulation of mTOR may be responsible
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for the phenotypes observed in Fbxw7 cKO nerves.

Fbxw7 controls SC myelination via mTOR-dependent and –independent mechanisms
We performed western blot and qPCR analyses on Fbxw7 cKO nerves, and found that
mTOR and its downstream targets are elevated at both the protein and mRNA levels.
Pharmacological inhibition of mTOR in fbxw7stl64 mutants restored myelin thickness to
wildtype levels (Appendix F), and genetic deletion of mTOR in the Fbxw7 cKO animals
phenocopied mTOR cKO mutants in that there were normal numbers of SCs, the nerves
were delayed in radial sorting, and hypomyelinated. This suggests that Fbxw7 regulates
mTOR to control SC number, radial sorting, and myelin thickness (Figure 6).
Interestingly, however, we found that SCs mutant for both Fbxw7 and mTOR were still
capable of myelinating multiple axons and inappropriately generating myelin around
some axons while simultaneously encompassing small-caliber unmyelinated axons. Thus,
the myelinating capacity of SCs is independent of mTOR.

1.8
1.8.1

THE IMPORTANCE OF MYELINATING GLIA IN HUMAN HEALTH
CNS myelin is critical for human health

In the United States alone, more than 20,000 people are diagnosed with malignant brain
tumors each year [75]. Glial cell tumors, or gliomas, make up at least 30% of all CNS
tumors, and approximately 80% of all brain cancers [76]. In the United States,
approximately 5% of malignant brain tumors are at least in part oligodendrocyte-derived
according to the American Brain Tumor Association.
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Moreover, disruption of OL development and myelination is associated with several
debilitating neurological diseases. Multiple sclerosis, which affects nearly 2.5 million
people worldwide [77], is an autoimmune disorder in which immune cells aberrantly
attack OLs, causing demyelinating lesions in the white matter of the brain. OL
demyelination is also characteristic of bi-lateral frontoparietal polymicrogyria (BFPP),
leukodystrophies, and other CNS neuropathies such as those caused by vitamin B12
deficiency. Additionally, the inability of OPCs to effectively remyelinate dramatically
hinders functional recovery after spinal cord injury [78].

1.8.2

Schwann cell myelination in health and disease

The PNS is also subject to devastating consequences when Schwann cells are disrupted.
Approximately 10% of all soft tissue sarcomas are SC-derived malignant peripheral
nerve sheath tumors (MPNSTs), which affect more than 3,000 Americans each year [79].
Moreover, disruption of SC development and myelination is associated with a wide
variety of peripheral neuropathies, some of which are genetically based while others are
due to environmental changes. One of the most common genetic forms of peripheral
neuropathy is Charcot-Marie-Tooth disease (CMT), which affects more than 125,000
Americans in total [80]. Interestingly, subtypes of CMT characterized by myelination
defects can display either hypomyelination or hypermyelination, as both of these
conditions are detrimental to the proper functioning of peripheral nerves. Similarly, 80%
of patients with merosin-deficient congenital muscular dystrophy (MDC1A) present with
dysmyelinating neuropathy [81-83]. Although comparatively rare, Guillan-Barré
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syndrome and anti-MAG peripheral neuropathy are both similar to multiple sclerosis in
that the immune system inappropriately attacks and destroys peripheral myelin. And like
multiple sclerosis, the causes of Guillan-Barré syndrome and anti-MAG peripheral
neuropathy are unknown. Environmental factors can also play a significant role in the
health of peripheral myelin. Perhaps the most common occurrences of peripheral
demyelination are in diabetic neuropathies and chemotherapy-induced neuropathies in
cancer patients.

Thus, understanding the molecular mechanisms that govern the development and
functions of myelinating glia is of direct importance to human health.
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1.9 FIGURES

Figure 1: Schwann cell (SC) development. Schwann cells derive from sox10+ neural
crest cells. Schwann cell precursors (SCPs) then migrate and proliferate along bundles of
growing axons. When they have stopped migrating, an immature SC will begin radial
sorting by interdigitating cytoplasmic processes into bundles of axons and selecting
axons to associate with. Large caliber axons will be encompassed by a single promyelinating SC, which “hugs” the axon and awaits additional cues such as the transient
expression of oct6, which then turns on krox20 resulting in mbp expression. mbp+ fully
mature SCs will then iteratively spiral around and myelinate a single axon segment.
Immature SCs that associate with many small caliber axons will never express mbp, or
make myelin. Instead they are non-myelinating Remak SCs, which encompass many
axons, but do not wrap them. Figure adapted from [1].
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Figure 2: Oligodendrocyte (OL) development. Neural stem cells (NSCs) generate
radial glia (RGCs), which then differentiate into the various neural lineages –
oligodendrocyte precursors (OPCs), neuron precursors, and astrocyte precursors. sox10
and olig2 expressing OPCs then further differentiate into pro-OLs, marked by nkx2.2a as
they begin to generate processes and contact axons. Terminally differentiated OLs
express mbp and begin to iteratively wrap axons.
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Figure 3: Adhesion GPCRs (aGPCRs) are a unique combination of adhesion and
signaling properties. Cartoon depicts the typical domain structure of an aGPCR. A
special characteristic of aGPCRs is their ability to cleave themselves into an N-terminal
fragment (NTF) and a C-terminal fragment (CTF) through an autoproteolytic event that
occurs within the GAIN domain, specifically at the GPS motif. The NTF of most
aGPCRs contains many protein domains classically associated with either cell-cell or
cell-matrix adhesion including but not limited to: cadherin, pentraxin, CUB,
thrombospondin, Leucine-rich-repeats, calmodulin, and laminin-binding domains. The
CTF contains the canonical 7-transmembrane-pass domain that is typical of all GPCRs.
As with other GPCRs, the intracellular domain of aGPCRs can interact with and thus
signal through heterotrimeric G-proteins. Recent evidence suggests that this signaling
activity is modulated by either removal or conformational change of the NTF, which
frees up the stachel sequence to act as a tethered agonist and activate the CTF.
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Figure 4: Fbxw7 is a member of the SCF E3 ubiquitin ligase complex. Fbxw7 is an Fbox protein, which acts as the target recognition component in Skp1-Cul1-Rbx1 E3
ubiquitin ligase complexes. The stl64 mutation disrupts Fbxw7, and thus would be
predicted to interrupt target recognition. Cartoon modified from [84].
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Figure 5: Fbxw7 consists of three critical domains. Fbxw7 is made up of a
dimerization domain (DD; yellow), which allows Fbxw7 to homo- or hetero- dimerize
with other F-box proteins. The F-box domain (grey) binds Fbxw7 to the rest of the SCF
complex. Finally, the target recognition domain (WD; green) contains seven WD40
repeats that recognize a 4 amino acid phosphodegron motif in the target protein sequence.
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Figure 6: A model of Fbxw7 regulation of mTOR in Schwann cells. The stl64
mutation presumably results in either Fbxw7 degradation or a truncated protein that is
incapable of targeting mTOR. This results in elevated mTOR signaling, which causes
increased myelin gene expression and hypermyelination.
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Chapter 2

Defining the gene repertoire and spatiotemporal
expression profiles of adhesion G protein-coupled
receptors in zebrafish
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PREFACE
This chapter was reproduced and adapted in its entirety from the following published
manuscript:
Harty BL, Krishnan A, Sanchez NE, Schiöth HB, Monk KR. Defining the gene
repertoire and spatiotemporal expression profiles of adhesion G protein-coupled
receptors in zebrafish. BMC Genomics. 2015; 16:62. Doi: 10.1186/s12864-0151296-8.
BLH and KRM conceived and designed the project. BLH performed the initial genome mining
in Zv8, AK performed the secondary search in Zv9, and BLH and AK compiled the final gene
list. BLH performed all primer quality control assays, qPCR experiments (except the highthroughput Fluidigm IFC, which was run by the Washington University Genome Technology
Access Center), and qPCR validation. BLH performed phylogenetic analysis using maximum
likelihood. AK and HBS validated all phylogenetic analyses using maximum likelihood and
Bayesian analyses, as well as constructed the final tree and protein domain figures. BLH and
NES analyzed qPCR data, and BLH constructed all expression figures. BLH, AK, and KRM
wrote the manuscript, and all authors edited the manuscript and approved of the final version.

We thank members of the Monk lab for helpful feedback and suggestions as well as members of
the Washington University Zebrafish Consortium for constructive feedback. We are indebted to
Ting Wang and Andrew Yoo for helpful comments on the manuscript. We also thank Chris
Sawyer at the Genome Technology Access Center for his qPCR expertise and for performing the
high-throughput qPCR experiments, the DeGuzman-Strong lab for use of their ViiA7 qPCR
machine, and Charleen Johnson and other Washington University Zebrafish facility staff for
excellent fish care.
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Related to this chapter: see Appendix C for the expression of zebrafish aGPCRs in tissues
enriched for myelinating glia and early preliminary data on follow up studies for some of these
aGPCRs.
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2.1 ABSTRACT
Adhesion G protein-coupled receptors (aGPCRs) are the second largest of the five GPCR
families and are essential for a wide variety of physiological processes. Zebrafish have proven to
be a very effective model for studying the biological functions of aGPCRs in both developmental
and adult contexts. However, aGPCR repertoires have not been defined in any fish species, nor
are aGPCR expression profiles in adult tissues known. Additionally, the expression profiles of
the aGPCR family have never been extensively characterized over a developmental time-course
in any species.

Here, we report that there are at least 59 aGPCRs in zebrafish that represent homologs of 24 of
the 33 aGPCRs found in humans; compared to humans, zebrafish lack clear homologs of
GPR110, GPR111, GPR114, GPR115, GPR116, EMR1, EMR2, EMR3, and EMR4. We find that
several aGPCRs in zebrafish have multiple paralogs, in line with the teleost-specific genome
duplication. Phylogenetic analysis suggests that most zebrafish aGPCRs cluster closely with their
mammalian homologs, with the exception of three zebrafish-specific expansion events in Groups
II, VI, and VIII. Using quantitative real-time PCR, we have defined the expression profiles of 59
zebrafish aGPCRs at 12 developmental time points and 10 adult tissues representing every major
organ system. Importantly, expression profiles of zebrafish aGPCRs in adult tissues are similar
to those previously reported in mouse, rat, and human, underscoring the evolutionary
conservation of this family, and therefore the utility of the zebrafish for studying aGPCR
biology.

Our results further support the notion that zebrafish are potentially a very useful model to the
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study of aGPCR biology from a functional perspective. The zebrafish aGPCR repertoire,
classification and nomenclature, together with their expression profiles during development and
in adult tissues, provides a crucial foundation for elucidating aGPCR functions and pursuing
aGPCRs as therapeutic targets.
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2.2 INTRODUCTION
The G protein-coupled receptor (GPCR) superfamily comprises the largest class of cell
membrane receptors found in metazoan proteomes [1]. In humans, more than 800 genes
encoding different GPCRs have been identified and phylogenetically divided into five discrete
families: glutamate, rhodopsin, adhesion, frizzled/taste2, and secretin (GRAFS classification) [2].
Adhesion GPCRs (aGPCRs) are the second largest of the five GPCR families, with 33 and 31
members in humans and mice, respectively [3]. The aGPCRs are further subdivided into nine
groups based on phylogenetic analysis of the 7-transmembrane domain (7TM) [4]. Although
members of this family follow the same general structural pattern as other GPCRs, they differ in
that they are characterized by an extremely long N-terminus that contains the GPCR
autoproteolysis-inducing (GAIN) domain, [5] which encompasses the highly conserved GPCR
proteolytic site (GPS). Most aGPCRs undergo autoproteolysis at the GPS motif, which results in
a protein that is separated into an N-terminal fragment (NTF) and C-terminal fragment (CTF)
that are thought to remain non-covalently attached at the cell surface [6]. The “adhesion”
classification was given to this family of GPCRs due to the large number of classical cell
adhesion domains found in the NTFs of many of these receptors [4, 7]. In other proteins, these
“adhesion” domains (e.g., EGF-like domains and cadherin domains) are involved in proteinprotein, cell-matrix, and cell-cell interactions, leading to the idea that they perform similar
functions in aGPCRs [7]. Recent data for multiple aGPCRs suggests that these proteins can
function as adhesion molecules by virtue of the NTF, and as classical GPCRs that signal through
G-proteins by virtue of the CTF, in addition to the roles the NTF and CTF have in concert with
one another [8-13].
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In addition to their protein domain complexity, aGPCRs have been difficult to study due to their
large size and complex genomic structures, with many small exons separated by very large
introns [4]. Additionally, aGPCRs have numerous splice isoforms, often lacking one or more
protein domains in the NTF, which may have functional or regulatory roles [14]. The study of
aGPCRs is further complicated by the fact that this family is identified primarily based on
structural similarity at the protein level because, on a sequence level, aGPCRs can be extremely
divergent from one another [4]. However, despite the divergence between family members,
aGPCRs in general are evolutionarily ancient and highly conserved, with a homolog found in
social amoeba, Dictyostelium discoideum [15].

In recent years, the zebrafish (Danio rerio) has become a premiere model organism for the study
of a wide variety of physiological processes and disease states during development and in adult
animals [16, 17]. Moreover, zebrafish have proven to be useful models to study aGPCRs,
especially in the context of development. For example, the functions of Gpr126 in Schwann cell
myelination and inner ear morphogenesis were discovered in zebrafish [18, 19]. Zebrafish
studies also demonstrated that multiple aGPCRs - Celsr1a [20], Celsr1b [20], Celsr2 [21], and
Gpr125 [22] - are critical modulators of planar cell polarity during vertebrate gastrulation.
Additionally, Celsr3 is essential for normal development of visual circuitry in the zebrafish retina
[23]. Although advances have been made in understanding aGPCR biology using zebrafish, the
utility of this model has been impaired by the lack of a complete aGPCR repertoire and gene
expression profiles. To address this deficit, we mined the Danio rerio genome to determine
which aGPCRs are encoded in the zebrafish genome. We also performed qPCR to characterize
aGPCR expression over a developmental time-course, as well as in a wide collection of adult

48

tissues. Our studies demonstrate that there are at least 59 aGPCRs in zebrafish representing 24 of
the 33 human aGPCRs, with similar expression profiles as their mammalian homologs.
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2.3 RESULTS
2.3.1 Defining the zebrafish aGPCR repertoire
To define the zebrafish aGPCR repertoire, we first compiled a list of nucleotide and protein
sequences for 33 aGPCRs annotated in the Zv8 release of the zebrafish genome using three
genomic databases: GenBank [24], Ensembl (release 75) [25], and the zebrafish model organism
database (ZFIN) [26]. Next, we used genome alignment and search tools - BLAST [27], UCSC
Genome Browser [28], and Sequencher (http://www.genecodes.com) - to further mine the
zebrafish genome for additional predicted aGPCR sequences. We conducted BLAST [27]
searches using both the nucleotide and amino acid sequences of all of the 33 previously
annotated zebrafish aGPCRs, as well as aGPCR sequences from five additional species:
stickleback (Gasterosteus aculeatus), mouse (Mus musculus), rat (Rattus norvegicus), dog
(Canis lupus familiaris), and human (Homo sapiens). With this first pass of analysis, we
obtained 40 putative aGPCRs encoded in the zebrafish genome.

Next, we took these 40 putative zebrafish aGPCR sequences and BLASTed them a second time
against the zebrafish genome (Zv8). This step was essential for two reasons: 1) to determine if
multiple predicted aGPCR sequences could be consolidated because they actually represented
the same gene, and 2) to search for more divergent paralogous sequences (e.g. gene duplicates).
Indeed, further analysis of BLAST results suggested that several of the initial predicted aGPCR
sequences might belong to the same genes. For example, one predicted sequence encoded the Nterminal domains and another encoded the GAIN and 7TM domains. In these instances, RT-PCR
using primers overlapping both sequences was used to determine if sequences were indeed part
of the same transcripts (data not shown). Similarly, it was important to determine if any of the
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initial 40 putative aGPCRs had paralogs because a whole genome duplication event occurred in
the ray-finned fish lineage approximately 300 million years ago, which coincided with the
radiation of teleost species [29-31]. Moreover, several lineage-specific tandem duplication events
have occurred in zebrafish following the whole genome duplication event [29]. Therefore, many
zebrafish genes are present in multiple copies. These searches resulted in a total of 50 predicted
aGPCRs.

Upon the release of Zv9, we performed additional searches using our previously defined list of
50 aGPCRs from Zv8, as well as the updated BioMart feature in Ensembl for all proteins with a
GPS motif and an aGPCR-like 7TM domain. This second round of genome mining recovered an
additional 9 aGPCRs, most of which appear to be zebrafish-specific. Our results indicate that
there are at least 59 full-length aGPCRs in the zebrafish genome. Phylogenetic analysis suggests
that they encode homologs for 24 of the 33 human aGPCRs, and that nine human family
members, EMR1, EMR2, EMR3, EMR4, GPR110, GPR111, GPR114, GPR115, and GPR116 do
not appear to have clearly defined homologs in zebrafish (Figure 1). Consistent with the
evolutionary history of zebrafish, we determined that 13 of the 24 zebrafish aGPCRs that have
human homologs are present in multiple copies. See Additional File 1 for all accession numbers.

Here we present complete nomenclature for these zebrafish homologs based on phylogenetic
analysis. We refer to the aGPCRs we uncovered with gene names lower-case and italicized. Any
gene present in multiple copies is denoted as the gene name followed by a letter, such as
“lphn1a” and “lphn1b”. For the predicted aGPCR sequences that appear to be members of
zebrafish-specific expansions that are not clear homologs of any human aGPCRs, we named
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them based on the group that they cluster with phylogenetically followed by a number (e.g.,
zfG8L1 is most phylogenetically similar to aGPCRs in Group VIII). However, we note that
further analysis is necessary to be sure of the true identity of some of the predicted aGPCR
sequences. The phylogenetic analysis of the 7TM regions shows how the zebrafish aGPCRs
either cluster closely with their mouse and human orthologs or into distinct zebrafish-specific
clades (Figure 1). Separate phylogenetic analyses were performed on each cluster in order to
determine nomenclature of the genes that had unstable positioning in the overall analysis (data
not shown). For example, zfLphn1b and zfGpr56 do not clearly cluster with their mammalian
homologs in the overall analysis, but when Bayesian analysis was conducted on Groups I and
VIII independently, these genes clearly cluster with their mammalian counterparts (Additional
File 2). Importantly, the zebrafish aGPCRs cluster into nine groups in the same manner as was
previously described for human and mouse aGPCRs [4, 32].

The domain architectures of zebrafish aGPCRs (Figure 2) were predicted using the latest
versions of Conserved Domain Search service (CD-Search) [33], Pfam search [34] and the
InterProScan software package [35]. Although the phylogenetic tree shown in Figure 1 was built
based on the protein sequence of the 7TM domains, most zebrafish aGPCRs also share relevant
protein domains found in the N-termini of their mammalian counterparts (Figure 2). This
includes the zebrafish-specific aGPCRs, as the predicted protein sequences share protein
domains found in the N-termini of various members of their group, providing further support for
the tree topology and nomenclature. For consistency, the domain architectures shown were
made using the protein sequences in Ensembl, as these have been manually annotated. However,
it is important to note that in some cases, the predicted protein sequences in GenBank are more

52

complete, and may contain additional predicted domains that are not shown here, as they have
not yet been confirmed. Additionally, as for many zebrafish genes, the coding domain sequences
(CDS) for zebrafish aGPCRs are often incomplete. Therefore, it is difficult to determine if the
differences in domain architectures of zebrafish versus mammalian aGPCRs are real differences
or simply because the CDS is incomplete at the 5’ end and thus the domains have not yet been
annotated.

Importantly, although the only other GPCRs for which the repertoire has been defined in
zebrafish are the trace amine GPCRs, this group underwent a large expansion relative to other
vertebrates similar to the zebrafish-specific expansion we have described here for the aGPCRs
[36]. Similarly, our data are consistent with global characteristics of the zebrafish genome
relative to the human genome. For example, 72.7% of human aGPCRs have at least one ortholog
in zebrafish, as opposed to 71.4% of human genes in general [37]. Further, among the
orthologous aGPCRs, 45.8% of human aGPCRs are in a one-to-one relationship with their
zebrafish ortholog, as compared to 47% of orthologous human genes overall [37].

2.3.2 Expression profiling of aGPCRs in zebrafish
The expression profiles of aGPCRs have been previously determined in a collection of adult
tissues in mouse [32], rat [32], and human [38]; however, to our knowledge, the expression of
this family of GPCRs has never been extensively characterized throughout development, in any
species. Additionally, expression profiles of the aGPCR repertoire in adult tissues are not
resources currently available for the zebrafish research community. To address this, we defined
the gene expression profiles of each of the zebrafish aGPCRs using a combination of high-
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throughput qPCR (for the first 50 genes identified in Zv8) [39] and conventional qPCR (for the
remaining 9 genes identified later in Zv9). We chose 10 adult tissues to represent nearly every
major organ system: brain, eye, heart, intestine, kidney, liver, skeletal muscle, skin, ovaries, and
testes. We chose 12 developmental time-points to represent major milestones: 1 hour postfertilization (hpf; cleavage period, ~4 cells), 3 hpf (blastula period; ~1000 cells), 5.3 hpf (early
gastrulation), 10 hpf (late gastrulation, early segmentation), 14 hpf (segmentation), 24 hpf (most
organ systems have formed), 3 days post-fertilization (dpf, larvae have hatched from chorions), 5
dpf (swimming), 7 dpf, 11 dpf, 14 dpf, and 21 dpf (juvenile stages defined by active hunting and
rapid body growth). qPCR data was analyzed using the ΔΔCt method [40] (raw data is provided
in Additional File 3). To control for starting input amount, we normalized all Ct values to a
control gene, importin-8 (ipo8), which showed stable expression in all time-points and tissues.
We calculated fold change in expression relative to the 21 dpf time-point, as it represents a
middle point between development and adulthood, where the fish has undergone all major
developmental milestones and has acquired all tissues and organs, but is not yet a fully mature
adult.

Figures 3-14 show fold change in expression for each of the nine aGPCR groups. Tissues and/or
time-points for which fold change < 1 are described as “lowly expressed” or “not enriched”, fold
changes between 1 – 3 are described as “slight enrichment”, and fold changes > 3-fold are
described as “highly enriched”. It is important to emphasize that this method of analysis is meant
to show enrichment over expression levels in the whole fish at 21 dpf, and does not depict raw
expression. Therefore, an aGPCR might be expressed in and play an important role in certain cell
types within a tissue even if that gene does not appear to be enriched in that tissue given these
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analyses. Similarly, it is possible that some of the tissue-specific expression could be due to such
things as: residual blood, tissue-resident immune cells, or fat cells. For example, the thymus,
kidney, and spleen are known to be the major lymphoid organs in teleosts [41], so adult kidney
expression in these analyses may represent expression in kidney tissue or in immune cells.

Importantly, nearly all of the zebrafish aGPCRs display expression profiles similar to their
rodent and human orthologs in adult tissues [32, 38], and our developmental data corroborates
previous studies on individual family members in zebrafish [18-23, 42-45]. We validated
expression of all genes by performing RT-PCR on cDNA samples obtained from a subset of
developmental time-points and adult samples (data not shown). We further validated qPCR
results by comparisons to previously described whole-mount in situ hybridization (WISH) data
for a subset of aGPCRs [42-44, 46].

In zebrafish, early development proceeds in the absence of de novo zygotic transcription and
relies upon maternal mRNA contribution. Zygotic transcription of some genes begins at
approximately 2.25 hpf (128-cell stage), while for most other zygotic genes it begins after 3 hpf
(1000-cell stage), as the maternal transcripts gradually become diluted [45]. Previous reports on
the zebrafish maternal transcriptome suggest that 34% of all protein-coding genes are expressed
exclusively as maternal transcripts, 61% are expressed both maternally and zygotically, and 5%
only undergo zygotic transcription [45]. In agreement with these data, 96% of aGPCRs have at
least some level of maternal expression, while only 4% of aGPCRs appear to be exclusively
zygotically expressed. Interestingly, however, we did not observe any aGPCRs that were only
expressed maternally (at 1 hpf), suggesting that this class of receptors is important throughout
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additional stages of development.

Zebrafish aGPCRs – Group I
Group I aGPCRs are composed of the Latrophilins and Eltd1 (Figures 1, 2, and 3). The two
paralogs of lphn1, lphn1a and lphn1b, have nearly identical expression profiles with low
expression during development until 3 dpf and specific enrichment in the adult brain and eye
(Figure 3A-B). In contrast to the other Group I members, lphn2a and lphn2b are enriched earlier
in development during gastrulation, with no significant enrichment in adult tissues (Figure 3CD). Interestingly, the expression profile of lphn3 is remarkably similar to that of lphn1a and
lphn1b, with the exception of slightly higher maternal and adult eye expression (Figure 3E).
eltd1 is expressed ubiquitously during development with slight enrichment maternally (1 hpf)
and during gastrulation (5.3 hpf), but is highly enriched in the adult heart, liver, and muscle
(Figure 3F).

Zebrafish aGPCRs – Group II
Group II aGPCRs are composed of Cd97 and the Emrs (Figures 1, 2, and 4-6). With the
exception of cd97b, which is slightly enriched during gastrulation and segmentation stages
(Figure 4B), the cd97 paralogs do not show enrichment during development. In contrast, all four
cd97 paralogs are highly enriched in adult muscle, and to varying degrees in the intestine and
liver (Figure 4A-D). All cd97 paralogs except cd97d also show some enrichment in the kidney
(Figure 4A-C). Finally, cd97a and cd97b are enriched in the adult heart (Figure 4A-B), and
cd97a and cd97c are enriched in testes (Figure 4A, C).
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Whereas humans possess EMR1-4 and mice have homologs of EMR1 and EMR4, zebrafish
possess at least 14 EMR-like proteins (Figure 1, 2, 5, and 6). Although GenBank defines some of
these predicted zebrafish Emr-like genes into “emr1-like” or “emr3-like”, we did not find
sufficient evidence to suggest that the zebrafish Emr-like sequences were more similar to any of
the four human EMRs. However, these sequences did cluster with Group II, but distinctly from
the Cd97 clade (Figure 1). Therefore, we named these genes emr-like followed by a number (i.e.,
emrl1-emrl14).

Interestingly, although the zebrafish EMR-like proteins phylogenetically cluster together in a
zebrafish-specific expansion of Group II (Figure 1), and not clearly with the human and mouse
orthologs of EMR1-4, the zebrafish gene expression profiles in adult tissues resemble those of
human EMR1-3 [38] and mouse Emr1 and Emr4 [32]. It is important to note that two of the
zebrafish Emr-like genes, emrl1 and emrl2, are so similar at the nucleotide level that they could
not be distinguished by unique primers that were compatible with qPCR assays. Therefore,
primers were designed that could amplify emrl1 and emrl2 distinctly from the other 12 zebrafish
emr-like genes, and the expression of emrl1/emrl2 is shown on the same graph (Figure 5A).
Interestingly, all but four of the zebrafish emr-like genes (emrl10, emrl11, emrl12, and emrl14)
are lowly expressed during early development, and only begin to show very slight enrichment
between 11 dpf and 21 dpf. Additionally, at least 9 of the 14 emr-like genes show enrichment in
the adult liver (Figure 5A-B, D, F, and Figure 6A-E) and in the testes (Figure 5A-D, F, and
Figure 6A-E). In terms of specific enrichment, emrl1 and/or emrl2 are enriched in the brain
(Figure 5A), emrl3, emrl7, and emrl10 are also highly enriched in skeletal muscle (Figure 5B, F
and Figure 6A), and emrl4 is slightly enriched in the skin (Figure 5C). emrl6 and emrl8 are very
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lowly expressed, showing no enrichment over 21 dpf at any stage of development or in any adult
tissue (Figure 5E, G). Interestingly, emrl11 is the only emr-like gene that is highly enriched
during maternal transcription and in adult ovaries, in addition to its enrichment in the liver,
muscle, and testes (Figure 6B). Finally, emrl13 and emrl14 have broader expression profiles than
their fellow emr-like genes, with varying degrees of enrichment in the adult heart, intestine,
kidney, liver, muscle, skin, and testes (Figure 6D-E).

Zebrafish aGPCRs – Group III
Group III aGPCRs are composed of Gpr123, Gpr123L, Gpr124, and Gpr125 (Figure 1, 2, and 7).
Interestingly, gpr123 and gpr123l are differentially expressed both during development as well
as in adult tissues. Both genes are slightly enriched at all developmental stages after 3 dpf, except
at 11 dpf, as well as in the adult brain and eye (Figure 7A-B). However, gpr123 is also enriched
during maternal and early gastrulation stages (1 hpf – 5.3 hpf) and in the adult liver, muscle, and
ovaries (Figure 7A). gpr124 is ubiquitously expressed at very low levels during early
development with slightly higher expression after 3 dpf and a slight enrichment in the adult heart
(Figure 7C). Developmental expression data for gpr125 are consistent with previous reports in
zebrafish, which show that it is highly enriched during early development [22] and then
ubiquitously expressed at very low levels at later larval stages and in adult tissues (Figure 7D).

Zebrafish aGPCRs – Group IV
Group IV aGPCRs are composed of the Celsr proteins (Figures 1, 2, and 8). Consistent with
previous studies in zebrafish [20, 21, 23], we found that all Group IV aGPCRs except celsr3 are
highly expressed during gastrulation and segmentation stages and then expressed at lower levels
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during later development and in adult tissues (Figure 8A-C). In contrast, celsr3 is lowly
expressed until 3 dpf, and then highly enriched in the brain, eye, and skeletal muscle in adults
(Figure 8D).

Zebrafish aGPCRs – Group V
Group V aGPCRs are composed of Gpr133 and Gpr144 (Figures 1, 2, and 9). gpr133 is
expressed ubiquitously at low levels both during development and in adult tissues, with the
exception of slight enrichment in the adult eye and heart (Figure 9A). In contrast, gpr144 is
slightly maternally enriched and highly enriched beginning at segmentation stages (14 hpf).
gpr144 is also slightly enriched in the adult brain and skeletal muscle and highly enriched in
adult testes (Figure 9B).

Zebrafish aGPCRs – Group VI
Group VI aGPCRs are composed of Gpr113a, Gpr113b, and five Group VI-like genes (G6L1-5)
that appear to be zebrafish specific (Figure 1, 2, and 10). We note that the sequences for g6l1-5
are labeled as “predicted gpr110-like” or “predicted gpr116-like” in GenBank; however, there
was not sufficient evidence based on sequence similarities, protein structure, or phylogenetics to
confidently call these genes homologs of mammalian Gpr110 and Gpr116. With the exception of
gpr113b, and a very slight enrichment of g6l3 at 10 hpf, Group VI aGPCRs are expressed at low
levels during early development. gpr113a is lowly expressed at all stages of development, but is
enriched in the adult liver, skin, and testes (Figure 10A). gpr113b is highly expressed maternally
and during early gastrulation; additionally, gpr113b is enriched in the adult kidney, liver,
ovaries, and testes (Figure 10B). g6l1 and g6l3 are slightly enriched after 7 dpf and in the adult
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skin (Figure 10C, E). g6l2 is slightly enriched after 11 dpf and in the adult intestine, kidney, and
muscle, and is highly enriched in skin and testes (Figure 10D). g6l4 is expressed very lowly
during development; however, it is highly and specifically enriched in the adult skin (Figure
10F). g6l5 is not significantly enriched at any stage of development, but is highly enriched in the
adult liver (Figure 10G).

Zebrafish aGPCRs – Group VII
Group VII aGPCRs are composed of the BAIs (Figure 1, 2, and 11). Expression analysis of
Group VII aGPCRs is consistent with previous reports in zebrafish [42] and mammals [32, 38,
47, 48], with significant enrichment in the brain for all members (Figure 11A-D). Additionally,
with the exception of bai2, all of the Group VII aGPCRs do not show enrichment during
development until 3 dpf. Interestingly, bai2 also shows slightly enriched maternal expression,
and is the only group member to show higher enrichment in the adult eye than in the adult brain
(Figure 11C).

Zebrafish aGPCRs – Group VIII
Group VIII aGPCRs are composed of Gpr56, Gpr97, Gpr64a, Gpr64b, Gpr112a, Gpr112b and
Gpr126, as well as five zebrafish-specific Group VIII-like genes (G8L1-5) (Figure 1, 2, 12, and
13). With the exception of gpr56, gpr64b, and g8l2, Group VIII aGPCRs are lowly expressed
during early development, and do not show significant enrichment until 3-5 dpf. In contrast,
gpr56 is highly enriched at segmentation stages (Figure 12A). gpr56, gpr97, gpr112a, gpr112b,
and g8l5 are all enriched in the adult intestine (Figure 12A-B, E-F and Figure 13E), consistent
with observations in the rat gastrointestinal tract for Gpr56, Gpr97, and Gpr112 [49].

60

Additionally, gpr97 is enriched in the adult heart, kidney, liver, muscle, and skin (Figure 12B).
Both paralogs of gpr64 are enriched in the skin (Figure 12C-D), but interestingly, gpr64a is also
highly enriched in the eye (Figure 12C). Similarly, while both paralogs of gpr112 are highly and
specifically enriched in the adult intestine (Figure 12E, F), gpr112b is also enriched in the liver
and testes (Figure 12F). In adult tissues, gpr126 is slightly enriched in the kidney and highly
enriched in skeletal muscle (Figure 12G).

The genes that make up the zebrafish-specific expansion of Group VIII show broadly similar
expression profiles to other Group VIII members, with low expression during development and
specific enrichment in a few adult tissues (Figure 13A-E). g8l1, g8l2, and g8l3 are all
specifically enriched in the adult liver (Figure 13A-C). g8l4 and g8l5 are slightly enriched after
11 dpf, as well as in the adult intestine, kidney, and skin (Figure 13D-E). Additionally, g8l4 is
slightly enriched in skeletal muscle and highly enriched in testes (Figure 13D), while g8l5 is also
enriched in the adult eye (Figure 13E).

Zebrafish aGPCRs – Group IX
The final group of aGPCRs consists of Gpr98, Gpr128a, and Gpr128b (Figure 1, 2, and 14).
However, it should be noted that these genes do not phylogenetically cluster together into a
clade, but considered together here because they do not cluster distinctly with any of the other
eight groups (Figure 1). Interestingly, gpr128a and gpr128b are both expressed very lowly
during early development, but are differentially enriched specifically in the adult liver and
kidney, respectively (Figure 14A-B). gpr98 is highly enriched during late gastrulation stages as
well as in the adult eye (Figure 14C). These results are consistent with a role of GPR98 in retinal
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disease and Usher syndrome in humans [46]
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2.4 DISCUSSION
Here we have shown that there are at least 59 aGPCRs in the zebrafish genome that represent
homologs of 24 of the 33 aGPCRs found in humans. Phylogenetic analysis of the 7TM suggests
that the zebrafish aGPCRs cluster closely with their mammalian homologs and separate into the
same nine groups as previously described for the human aGPCR repertoire [4]. In adult tissues,
zebrafish aGPCR expression profiles are quite similar to those previously described for aGPCRs
in rodents [32] and humans [38]. This study provides the first quantitative description of the
expression profiles of this gene family over an extensive developmental time-course.
Importantly, our data also agrees with previously reported WISH data for a subset of aGPCRs at
a few different developmental stages [18-23, 42-45]. A summary of aGPCRs at their peak
enrichment during zebrafish development is shown in Figure 15. Interestingly, none of the
zebrafish aGPCRs were most highly enriched at 3 hpf (1000 cell stage) when zygotic
transcription is beginning; however, whether or not there is any functional significance to this
observation is unknown.

Our data suggests it is likely that aGPCRs play important roles in fish as at least 59 members are
found in a single teleost species, compared with 33 members in humans and 31 in mouse and rat.
The majority of these proteins are classified as “orphan” receptors meaning the ligand(s) is
unknown, and for most family members, precise biological functions remain mysterious. Despite
our incomplete understanding of aGPCRs, they have been implicated in many crucial
physiological processes, both during early development as well as in adult tissues, including but
not limited to the role(s) of Celsr proteins [20, 21] and Gpr125 [22] in gastrulation, Celsr1-3 in
the migration of facial brachiomotor neurons during hindbrain development [50], Gpr126 in the
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development of the ear [19] and Schwann cells [18, 51-53], Gpr124 in regulating CNS
angiogenesis [54], CD97 in leukocyte trafficking and adaptive T-cells responses [55], EMR1 in
the production of CD8+ cells [56], GPR64 in male infertility [57], and BAI1-3 in inhibiting
angiogenesis in the brain [47, 48].

The importance of aGPCRs in human health is further underscored in diseases in which they are
disrupted, such as bilateral frontoparietal polymicrogyria (GPR56) [58, 59], Usher Syndrome
(GPR98) [60-62], glioblastomas (BAI1) [63, 64], susceptibility to brain arteriovenous
malformation (GPR124) [65], and breast cancer metastasis (GPR116) [66].

Our data likely represent the majority of zebrafish aGPCRs, although it is difficult to be sure that
we have identified every aGPCR in the zebrafish repertoire for several reasons. First, zebrafish
possess 26,206 protein-coding genes, more than any previously sequenced vertebrate species
[67], and yet the zebrafish genome is not as well sequenced or as well annotated as the human
and mouse genomes. The release of Zv9 significantly improved the quality of the zebrafish
reference sequence and demonstrated that the zebrafish genome has an overall repeat content of
52.2%, the highest reported in any vertebrate species to date [37]. However, the highly repetitive
nature of the zebrafish genome makes correct annotation of different gene duplicates without
manual curation challenging. Additionally, we only included full-length aGPCR sequences that
have the appropriate hallmark aGPCR domains (GPS, and 7TM) in this study. However, we also
identified several partial putative aGPCR sequences that appear to only contain some of the
domains found in the N-termini of these proteins (ENSDARG00000075133,
ENSDARG00000075899, ENSDARG00000074366, ENSDARG00000088231,
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XM_003197748.2, XM_005163532.1, XM_005163531.1, XM_005171021.1,
XM_005163529.1). Further analysis will be necessary to determine if these sequences are
pseudogenes, actually belong to one of the full-length sequences (perhaps as misannotated splice
isoforms), or if their remaining domains have not yet been found and annotated. It is also
important to note that our approach of using whole animals for developmental time-points and
whole adult organs has limited sensitivity and might not reveal instances in which an aGPCR
functions, or is expressed, in very specific and/or scarce cell types. For example, Gpr126 is
expressed in Bergmann glia of the cerebellum in mouse [68], but in zebrafish, gpr126 is not
enriched in whole brain. Additionally, several aGPCRs are known to be highly expressed and
play critical roles in immune cells, however the relative abundance of resident immune cells in
different tissues is unknown in zebrafish. Therefore, we cannot rule out the possibility that some
of the expression signal found in some tissues might in part due to immune cell infiltration of
that tissue, or residual blood in or on the tissue at the time of sample processing. However, future
work, including cell type-specific expression analyses, global and cell-specific mutant studies,
and additional curation of the zebrafish reference genome should address these limitations.

In sum, aGPCR biology is a highly active field of research that is also attractive for its potential
implications in human health. Approximately 30% of newly introduced drugs target GPCRs [69],
suggesting that aGPCRs may represent potentially novel therapeutic targets for a wide variety of
human pathologies. Zebrafish are genetically tractable vertebrates that can rapidly produce large
numbers of progeny that are transparent during early development. This allows for
straightforward genetic manipulation and the use of live animal imaging techniques for
phenotypic analysis. The recent advent of TALEN [70] and CRISPR-Cas [71] technologies have
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also made genome editing very fast and efficient in zebrafish. Additionally, zebrafish are highly
amenable to drug screens, and have already proven to be a useful model for the study of aGPCR
biology. Therefore, the provision of the zebrafish aGPCR repertoire and their expression profiles
herein should allow for significant advancement of aGPCR research in the zebrafish community
which will eventually result not only in our further understanding of this unique GPCR family,
but may also lead to important drug discoveries for modulating the roles of these proteins in
human disease.
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2.5 MATERIALS AND METHODS

2.5.1 Alignments and Phylogenetic analysis
Multiple sequence alignments analyzed in this study were generated using MAFFT version 6
(http://mafft.cbrc.jp/ alignment/server/), with BLOSUM62 as the scoring matrix and using option
E-INS-I. [72]. The evolutionary history of the 7TM domain of zebrafish, mouse, and human
aGPCRs was inferred using the Maximum Likelihood method based on the Jones-TaylorThornton (JTT) matrix-based model using MEGA5 [73]. Amino acid sequences of the 7TM
domains were obtained from GenBank or by using protein domain prediction software [74, 75]
for those zebrafish aGPCR sequences not found in GenBank. The bootstrap consensus tree
inferred from 1000 replicates [76] is shown in Figure 1. To account for input-order bias, similar
trees were made with 5 different randomized alignments. Importantly, changing the input order
did not dramatically alter tree structure under the following analysis parameters. Branches
corresponding to partitions reproduced in less than 50% bootstrap replicates are collapsed. Initial
tree(s) for the heuristic search were obtained by applying the Neighbor-Joining method to a
matrix of pairwise distances estimated using a JTT model [73]. A discrete Gamma distribution
was used to model evolutionary rate differences among sites (5 categories (+G, parameter =
2.2124)). The rate variation model allowed for some sites to be evolutionarily invariable ([+I],
0.6155% sites). The analysis involved 123 amino acid sequences. All ambiguous positions were
removed for each sequence pair. There were a total of 339 positions in the final dataset, and all
sites were taken into account for phylogenetic tree construction.
The topology inferred from ML analysis was verified using the using the Bayesian
approach implemented in MrBayes version 3.2. Markov Chain Monte Carlo (MCMC) analysis
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was used to estimate the posterior probabilities (PP) and branch lengths of the trees. The best
amino acid substitution model was determined using a mixed model as implemented in MrBayes
and the gamma shaped model was used to estimate the variation of evolutionary rates across sites
(lset rates = gamma). The Bayesian analysis included two independent MCMC runs, where each
MCMC run uses 4 parallel chains composed of three heated and one cold chain. Each Markov
chain was started from a random tree and was set to run for 3,000,000 generations and every
hundredth tree was sampled. The convergence of the two independent MCMC runs was tested
using diagnostic frequency generations and diagnostics were calculated for every 1000
generations. A stop rule was applied (standard deviation of split frequencies, 0.01) to terminate
the MCMC generations. The first 25% of the sampled trees were discarded to ensure that the
parameter estimates were only made from data drawn from the distributions that were derived
after the MCMCs had converged. Thereafter a consensus tree was built from the remaining 75%
of the sampled trees with the MrBayes sumt command using the 50% majority rule method. The
phylogenetic tree was drawn in FigTree 1.3.1 (http://tree.bio.ed.ac.uk/software/figtree/).

2.5.2 Prediction of zebrafish aGPCR domain architecture
The domain architectures of zebrafish aGPCRs were predicted using the
Conserved Domain Search service (CD-Search) [33], Pfam search [34] and InterProScan [35],
with default settings. CD-Search employs a RPS-BLAST (Reverse PSI-BLAST) search strategy
and aligns the query sequence against a database containing PSSMs (position-specific scoring
matrices) of protein domain models. Similarly, the Pfam search engine pairwise aligns the query
sequence against a Pfam-A database of manually curated profile HMMs (Hidden Markov Model)
built using the HMMER3 software package. The Pfam database ensures better predictions and
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sensitivity through curated Pfam-A entries built from high quality alignments with gathering
threshold [34]. This curated threshold is set for each family/domain to prevent false positives
from being included in the multiple sequence alignments that are used to make the HMM profile
of a protein family/domain [34]. On the other hand, InterProScan integrates the predictions from
an array of databases/search engines and capitalizes on their individual strengths to provide a
relatively reliable protein family/domain(s) annotation for a given sequence [35]. To ensure
reliable predictions of potential domains and repeats of zebrafish aGPCRs, all 59 aGPCRs were
searched using these three search engines employing varied strategies and database resources.
The predicted domain architectures are illustrated in Figure 2.

2.5.3 Zebrafish husbandry and sample procurement
All experimental procedures involving zebrafish were performed in compliance with Washington
University’s institutional animal protocols. All samples were from wild-type (AB*) zebrafish.
Embryos were raised and staged using standard methods [77], and different developmental
stages were collected from pools of embryos from multiple pairwise matings on two separate
occasions. The parents were then used for the collection of adult tissues at 6 months of age. Prior
to collection, zebrafish embryos/larvae were anesthetized in 0.24% tricaine. Prior to dissection,
adult zebrafish were humanely euthanized by submersion in ice-cold water. Dissections were
performed as previously described [78], and all tissues were rinsed briefly in 1X PBS prior to
freezing in an attempt to minimize blood and fat cell contamination. For all developmental
stages, two separate pooled samples were collected to control for slight daily variations in egg
quality. RNA was extracted separately from each pool (see section on RNA extraction), but then
all of the RNA for a given time point was combined prior to cDNA synthesis (see section on
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Reverse Transcription). At all stages up through 7 dpf, 25 embryos/larvae were pooled in each of
the two samples, for a total of 50 embryos/larvae. For the 11 dpf time point, the two pools
consisted of 22 larvae and 23 larvae for a total of 35 larvae. Finally, 10 larvae/fry were pooled in
each of the two replicates for the 14 dpf and 21 dpf time points, for a total of 20 larvae/fry
represented in the final pooled RNA samples. All adult tissues were collected and pooled from 4
animals (2 males and 2 females) with the exception of reproductive organs, which were collected
and pooled from 3 animals of the appropriate sex. After collection, all samples were immediately
flash-frozen in liquid nitrogen and stored at -80° C until RNA extraction was performed. For the
developmental samples, egg-water was removed just prior to submersion in liquid nitrogen.

2.5.4 RNA extraction
Total RNA was extracted from each of the two separate pools for all developmental stages, as
well as the adult samples using standard methods [79]. Briefly, TRIzol (Life Technologies,
Carlsbad, CA) was added to the frozen tissue samples, which were then homogenized using a
combination of vortexing, disruption with a plastic-tipped electric homogenizer, and passage
through syringe and successively smaller needles (22.5 g and 27 g) ten times each.

2.5.5 Reverse Transcription
Prior to reverse transcription, the two separate RNA samples for each developmental time point
were combined. Total RNA (1.0–5.0 µg) was then reverse transcribed in 20 µl using the High
Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Carlsbad, CA) using random
hexamers. The reaction mixture was incubated for 10 min at 25° C, 120 min at 37° C, and for 5
min at 85° C, as per the instructions from the manufacturer (Applied Biosystems). RT reactions
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were diluted 5–10-fold prior to qPCR. To control for genomic DNA contamination, a no reverse
transcriptase reaction (RT-) was also performed for each RNA sample.

2.5.6 Assay design and quality control
If possible, qPCR assays were designed to amplify 100-150bp of the 7TM domain and
oligonucleotide primers were designed to span exon-intron boundaries, as assessed by alignment
of cDNA sequences to genomic regions (alignments generated using Sequencher software). All
primers were 20-29 nucleotides in length, with approximate melting temperatures of 62° C, and
were manufactured by Integrated DNA Technologies (IDT, Coralville, IA). BLAST searches
were performed with every primer to ensure specificity of binding. All primers BLASTed
specifically to the appropriate gene and the corresponding chromosomal region (Query Coverage
= 100%, Identity = 100%) with no other “hits” having a query coverage or identity greater than
85%. All gene accession numbers, their corresponding primer sequences, standard curve slopes,
and R2 values are provided in Additional File 1.

Standard curves and qPCR assays for the 9 new aGPCRs found after the release of Zv9
(gpr113a, emrl3, emrl5, emrl8, emrl9, g8l1, g8l2, g8l3, g8l5) were performed using conventional
qPCR in 10 µl volumes in 384-well plates. Standard curve assays were run in duplicate using a
4-point serial dilution beginning with 200 ng 21 dpf cDNA. These assays were performed in
triplicate on a ViiA7 (Applied Biosystems) qPCR machine with 2X SsoFast Evagreen Supermix
(Applied Biosystems), and an assay concentration of 100 nM. To control for any genomic DNA
(gDNA) contamination in the cDNA samples, no-reverse-transcriptase (RT-) controls were
performed for all primer sets on all samples. Cycling parameters were 95° C (10 min) followed
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by 40 cycles of 95° C (15 s), then 60° C (1 min). Melting curve analysis was completed as
follows: 95° C (15 s), 60° C (1 min), and a progressive increase up to 95° C (0.5° C/min).
Calculations of slopes and R2 values were performed with the ViiA7 software.

2.5.7 Quantitative real-time PCR
High-throughput qPCR was performed at the Washington University in St. Louis Genome
Technology Access Center (GTAC) using the 96X96 Dynamic Array Interfluidic circuit for the
microfluidic BioMarkTM system (Fluidigm Corporation, San Francisco, CA) [39]. All assays
were run in all cDNAs in triplicate, in addition to an RT- control for each sample. Specific-target
amplification, the sample mix, assay mix, and qPCR conditions were performed as previously
described [39] with the following modifications: pre-amplification was performed on 37.5 ng
cDNA from zebrafish samples.

qPCR data was analyzed using Microsoft Excel. Relative expression was calculated using the
ΔΔCt method [40]. All Ct values derived from reverse-transcribed (RT+) samples were then
corrected to remove signal from gDNA (RT- controls) using the following formula: CtRNA = log2 (2

-CtRT+

- 2-

CtRT-

). All tissues were normalized to a stably expressed control gene, importin8

(ipo8), to control for variation in amount of starting material (ΔCt). importin8 was chosen from
among 3 housekeeping genes tested (ipo8, tbp, and gapdh) because it only has one known
transcript and it is expressed at stable levels in all developmental stages and tissues. ΔΔCt was
then calculated relative to expression at 21 days post fertilization (dpf). Relative expression
(RQ), or fold change (2-ΔΔCt), is shown in Figures 3-14. Error bars depict RQmax and RQmin,
which are the maximum and minimum limits of possible RQ values based on the standard error
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of the ΔCt values.

All qPCR experiments and provision of data in this study were conducted in line with the
guidelines for the minimum information for publication of quantitative real-time PCR
experiments (MIQE) [80].
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2.6 SUPPORTING DATA
All supporting data are available as additional files and can be found online at:
https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-015-1296-8

Additional File 1.
Excel spreadsheet containing database accession numbers, primer sequences, primer slopes, and
primer R2 values for all zebrafish aGPCRs and reference genes used in the qPCR studies.

Additional File 2.
Phylogenetic tree topologies obtained using Bayesian analysis for Group I (left) and Group VIII
(right) independently. These trees were used to confirm the nomenclature for zfLphn1b and
zfGpr56 as the zebrafish homologs of human LPHN1 and human GPR56, respectively.

Additional File 3.
Excel spreadsheet containing raw qPCR data for all full-length zebrafish aGPCRs.
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2.7 FIGURES

Figure 1: Phylogenetic analysis of zebrafish, mouse, and human aGPCRs.
The evolutionary history of the zebrafish aGPCRs relative to their mammalian orthologs was
inferred using the Maximum Likelihood (ML) method based on the JTT matrix-based model
using MEGA5. The bootstrap consensus tree inferred from 1000 replicates is shown as a
representation of the possible evolutionary history of the 7TM domain of zebrafish (zf), mouse
(m) and human (h) aGPCRs. The topology inferred from ML analysis was also supported by
Markov Chain Monte Carlo (MCMC) analysis, using the Bayesian approach implemented in
MrBayes version 3.2. Blue circles with solid red outlines were shown for the nodes that had
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more than 90% confidence support from ML bootstrap analysis and Bayesian posterior
probabilities (PP). White circles with solid red outlines denote nodes that had 90% PP support
but less than 90% bootstrap support. Supports are only shown for nodes recovered by both ML
and Bayesian inference, with BPP>0.9 and bootstrap>50%. Zebrafish gene identifiers/names are
highlighted in brown text. It must be noted here that the topology supported by ML and Bayesian
methods for Group 1 and Group VIII slightly differ from each other, although both methods
recovered the overall clusters of Group 1 and Group VIII. The variations are that zfLphn1b and
zfGpr56 are placed basal to their respective groups in the ML tree, however, with a relatively
low bootstrap support. Nevertheless, the topology showing the homologous relationships of
zfLphn1b and zfGpr56 with their mammalian counterparts are supported by Bayesian topology
with PP>90% (see Additional File 2).
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Figure 2: Schematic drawing of domain organizations of aGPCRs encoded in the zebrafish
genome. aGPCR domain architectures were predicted using CD-search, Pfam, and InterProScan
prediction algorithms. Each panel shows the intracellular C-terminal end, seven integral
transmembrane helices embedded in the membrane, and the long N-termini with multiple
functional domains for each zebrafish aGPCR. For display purposes, the length of the N-termini
of each panel does not correspond to a measured scale of amino acids; instead, the overall length
of the receptors is shown in parentheses at the N-terminal end of each cartoon. The depicted
domains are: seven-pass transmembrane domain (7TM), Cadherin domain, Calx-beta domain
(CALXβ), CUB domain (for complement C1r/C1s, Uegf, Bmp1), Domain of unknown function
3479 (DUF3479), Epidermal growth factor (EGF), Calcium-binding EGF domain (EGF_Ca),
Gal_lectin, GPCR-proteolytic site (GPS), Hormone receptor motif (HRM), immunoglobulin
domains (IG), Immunoglobulin I-set domain (I-set), Laminin EGF domain (Laminin_EGF),
Laminin_G_2, Latrophilin C-terminal domain (Latrophilin), Leucine Rich Repeats (LRR),
Olfactomedin, Pentraxin domain, SEA domain, and Thrombospondin type 1 domain (TSP_1).
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Figure 3: Group I aGPCR expression data. (A-F) Relative expression of zebrafish Group I
aGPCRs obtained with high-throughput quantitative real-time PCR from a collection of 12
developmental time-points and 10 adult tissues. (A) lphn1a, (B) lphn1b, (C) lphn2a, (D) lphn2b,
(E) lphn3, (F) eltd1. Error bars display the upper (RQmax) and lower (RQmin) limits of possible
relative quantification values. Fold changes shown are relative to expression at 21 dpf (denoted
by gray line at y = 1).

79

Figure 4: Group II aGPCR expression data – part 1. Relative expression of zebrafish Group
II aGPCRs obtained with high-throughput quantitative real-time PCR in a collection of 12
developmental time-points and 10 adult tissues. (A) cd97a, (B) cd97b, (C) cd97c, (D) cd97d.
Error bars display the upper (RQmax) and lower (RQmin) limits of possible relative
quantification values. Fold changes shown are relative to expression at 21 dpf (denoted by gray
line at y = 1).
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Figure 5: Group II aGPCR expression data – part 2. Relative expression of zebrafish Group
II aGPCRs obtained with either high-throughput quantitative real-time PCR or conventional
qPCR in a collection of 12 developmental time-points and 10 adult tissues. (A) emrl1/emrl2, (B)
emrl3, (C) emrl4, (D) emrl5, (E) emrl6, (F) emrl7, (G) emrl8, and (H) emrl9. Error bars display
the upper (RQmax) and lower (RQmin) limits of possible relative quantification values. Fold
changes shown are relative to expression at 21 dpf (denoted by gray line at y = 1). emrl1 and
emrl2 could not be distinguished at the nucleotide level with unique primers and so emrl1/emrl2
expression is shown (A).
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Figure 6: Group II aGPCR expression data – part 3. Relative expression of zebrafish Group
II aGPCRs obtained with either high-throughput quantitative real-time PCR or conventional
qPCR in a collection of 12 developmental time-points and 10 adult tissues. (A) emrl10, (B)
emrl11, (C) emrl12, (D) emrl13, and (E) emrl14. Error bars display the upper (RQmax) and
lower (RQmin) limits of possible relative quantification values. Fold changes shown are relative
to expression at 21 dpf (denoted by gray line at y = 1).
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Figure 7: Group III aGPCR expression data. Relative expression of zebrafish Group III
aGPCRs obtained with high-throughput quantitative real-time PCR in a collection of 12
developmental time-points and 10 adult tissues. (A) gpr123, (B) gpr123l, (C) gpr124, (D)
gpr125. Error bars display the upper (RQmax) and lower (RQmin) limits of possible relative
quantification values. Fold changes shown are relative to expression at 21 dpf (denoted by gray
line at y = 1).
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Figure 8: Group IV aGPCR expression data. Relative expression of zebrafish Group IV
aGPCRs obtained with high-throughput quantitative real-time PCR in a collection of 12
developmental time-points and 10 adult tissues. (A) celsr1a, (B) celsr1b, (C) celsr2, (D) celsr3.
Error bars display the upper (RQmax) and lower (RQmin) limits of possible relative
quantification values. Fold changes shown are relative to expression at 21 dpf (denoted by gray
line at y = 1).
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Figure 9: Group V aGPCR expression data. Relative expression of zebrafish Group V
aGPCRs obtained with high-throughput quantitative real-time PCR in a collection of 12
developmental time-points and 10 adult tissues. (A) gpr133, (B) gpr144. Error bars display the
upper (RQmax) and lower (RQmin) limits of possible relative quantification values. Fold
changes shown are relative to expression at 21 dpf (denoted by gray line at y = 1).

85

Figure 10: Group VI aGPCR expression data. Relative expression of zebrafish Group VI
aGPCRs obtained with either high-throughput quantitative real-time PCR or conventional qPCR
in a collection of 12 developmental time-points and 10 adult tissues. (A) gpr113a, (B) gpr113b,
(C) g6l1, (D) g6l2, (E) g6l3, (F) g6l4, (G) g6l5. Error bars display the upper (RQmax) and lower
(RQmin) limits of possible relative quantification values. Fold changes shown are relative to
expression at 21 dpf (denoted by gray line at y = 1).
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Figure 11: Group VII aGPCR expression data. Relative expression of zebrafish Group VII
aGPCRs obtained with high-throughput quantitative real-time PCR in a collection of 12
developmental time-points and 10 adult tissues. (A) bai1a, (B) bai1b, (C) bai2, (D) bai3. Error
bars display the upper (RQmax) and lower (RQmin) limits of possible relative quantification
values. Fold changes shown are relative to expression at 21 dpf (denoted by gray line at y = 1).
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Figure 12: Group VIII aGPCR expression data – part 1. Relative expression of zebrafish
Group VIII aGPCRs obtained with high-throughput quantitative real-time PCR in a collection of
12 developmental time-points and 10 adult tissues. (A) gpr56, (B) gpr97, (C) gpr64a, (D)
gpr64b, (E) gpr112a, (F) gpr112b, (G) gpr126. Error bars display the upper (RQmax) and lower
(RQmin) limits of possible relative quantification values. Fold changes shown are relative to
expression at 21 dpf (denoted by gray line at y = 1).
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Figure 13: Group VIII aGPCR expression data – part 2. Relative expression of zebrafish
Group VIII aGPCRs obtained with conventional quantitative real-time PCR in a collection of 12
developmental time-points and 10 adult tissues. (A) g8l1, (B) g8l2, (C) g8l3, (D) g8l4, (E) g8l5.
Error bars display the upper (RQmax) and lower (RQmin) limits of possible relative
quantification values. Fold changes shown are relative to expression at 21 dpf (denoted by gray
line at y = 1).
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Figure 14: Group IX aGPCR expression data. Relative expression of zebrafish Group IX
aGPCRs obtained with high-throughput quantitative real-time PCR in a collection of 12
developmental time-points and 10 adult tissues. (A) gpr128a, (B) gpr128b, (C) gpr98. Error bars
display the upper (RQmax) and lower (RQmin) limits of possible relative quantification values.
Fold changes shown are relative to expression at 21 dpf (denoted by gray line at y = 1).

90

summary of aGPCR peak enrichments during zebrafish development. Light microscope images of wild-type AB* zebrafish
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Chapter 3

A large-scale forward genetic screen in zebrafish
to identify novel regulators of myelinating glial
cell development
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PREFACE

The screen discussed in this chapter was conducted as a large collaborative effort
between members of the Monk and Solnica-Krezel laboratories as well as the staff of the
Washington University School of Medicine Zebrafish Facility. Although the Monk and
Solnica-Krezel labs were screening for different phenotypes, the mutagenesis and
zebrafish husbandry was conducted collaboratively, as was the general organization of
the screen. From the Monk lab, the following individuals contributed substantial effort at
various points during the screen: Kelly R. Monk, Breanne L. Harty, Sarah D. Ackerman,
Amy L. Herbert, Charleen L. Johnson, Melanie Holmgren, Christopher Raciti, Jeffrey Ni,
Ian Hakkinen, and Zachary Spence. We also extend many thanks to members of the
Solnica-Krezel lab both past and present that helped with the screen over the years,
especially Lila Solnica-Krezel, Anna Hindes, and Ryan Gray. Finally, this screen would
not have been possible without the help and fabulous fish care from Stephen Canter and
John Engelhard in the Zebrafish Facility.

Some parts of this chapter may be reproduced or adapted at a later date in the following
manuscript in preparation:
Nicholas E. Sanchez, Breanne L. Harty, Sarah D. Ackerman, Thomas O’Reilly-Pol,
Ryan S. Gray, Lilianna Solnica-Krezel, Stephen L. Johnson, Kelly R. Monk.
Whole genome sequencing-based mapping and candidate identification of
mutations from fixed or fresh zebrafish tissue from forward genetic screens. 2017.
In preparation.
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Related to this chapter:
See Appendix E for a detailed protocol on genomic DNA isolation for WGS, and a stepby-step beginner’s guide on analyzing WGS to map mutations
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3.1 A FORWARD GENETIC SCREEN IN ZEBRAFISH
A genetic screening method is considered saturated when a given screen uncovers
multiple alleles in the same genes repeatedly. Although screens for myelinating glial
development have been reported in zebrafish [1-3], these have not approached saturation,
as only one allele was recovered for most genes identified. Further, there are many
aspects of myelinating glial cell development that remain largely mysterious, such as
axon selection, myelination capacity differences between OLs and SCs, and myelin
compaction, to name a few. Therefore, in collaboration with members of the Monk and
Solnica-Krezel laboratories, I conducted a standard three-generation forward genetic
screen in zebrafish to uncover novel regulators of myelinating glial development. The
crossing scheme for this screen, named the “LM” screen, is illustrated in Figure 1.

3.1.1 ENU mutagenesis of male founders
To generate founders (F0 generation), 80 wild-type males of the SAT strain
were mutagenized under one of two treatment groups: 40 males were subjected to 3.0
mM N-ethyl-N-nitrosourea (ENU) for 1 hour per week for 6 weeks (LM1 group), and the
other 40 males were exposed to 3.5 mM ENU 1 hour per week for 4 weeks (LM2 group).
ENU mutagenesis was carried out using previously established protocols [4]. To enhance
the probability of survival, we modified the protocol in two ways. First, to reduce stress
during transfer into the ENU bath, we placed the fish in a pre-mutagenesis preparation
buffer containing 10 mL of tricaine (4 g/L) per liter of egg water that had been chilled to
approximately 20°C for approximately 30 min prior to transfer into ENU. Second, we
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doubled the amount of tricaine added to the first recovery buffer from 5 mL/L to 10 mL/L
to reduce stress and activity during recovery. After a 4-week recovery period, 30 of the
original 80 males survived mutagenesis – 18 from the LM1 group and 12 from LM2.

3.1.2 Specific-locus tests suggest mutagenesis was highly effective
In order to determine the efficiency of mutagenesis, we performed a specific-locus test
using homozygous albino mutants, and double homozygous albino/golden mutants,
which both display a readily observable lack of pigmentation. Founder mutagenized
males were out-crossed to these “tester” females and then the F1 progeny were screened
for pigmentation defects at 3 days post fertilization (dpf) [4]. Between both the albino
and golden loci, our calculated average mutation efficiency was approximately 1/750,
meaning we could expect to see deleterious mutations in roughly 35 genes per
mutagenized genome. Therefore, with the most current estimate of 26,000 genes in the
zebrafish genome [5], we estimated we would need to screen ~1400 genomes to detect
95% of genes.

3.1.3 LM screen crossing scheme
We next outcrossed the founder males to wild-type SAT females to produce over 10,000
F1 individuals, which should be heterozygous for any given mutation of interest. Note, in
some cases the F0 male died or had to be humanely euthanized prior to crossing with
SAT females, therefore some of the F1 individuals were actually the progeny from the
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specific-locus test, and thus carry the albino and/or golden lesions in the background. At
approximately 3 months of age, F1 individuals were out-crossed to animals that were
double homozygous for two fluorescent-reporter transgenes: tg(lhx1a:eGFP) and
tg(mbp:mCherry-CAAX). Every F1 animal crossed produced a single F2 family, in which
approximately 50% of the individuals are heterozygous for any given mutation of
interest. To find potential heterozygous carriers, members of F2 families were randomly
intercrossed to produce F3 progeny. To maximize the number of genomes screened per
family, we crossed up to ten pairs from a given family. With an average crossing success
of 50-70%, this allowed us to screen an average of 5-6 pairs, or 0.72-0.82 genomes [6],
per F2 family. F3 progeny from each pair were then screened at 5 days post fertilization
(dpf) for disruptions in myelinating glial cell development using the two transgenic
reporters.

3.1.4 Fluorescent transgenes enhance screening efficiency
Lhx1a is a transcription factor expressed in a subset of sensory neurons, therefore the
lhx1a:eGFP transgene allowed us to rule out any myelination phenotypes that might be
due simply to the absence of axons. Visualizing GFP in neurons also allowed us to screen
for certain axonal phenotypes that are characteristically caused by defects in Schwann
cells, such as nerve defasciculation, which indicates an absence of Scwhann cells [7].
Similarly, Mbp is a small but essential structural component of myelin in both the CNS
and the PNS, and is a very commonly used readout for myelin integrity. We screened 2040 F3 progeny per pair for changes in the intensity and/or distribution of both
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tg(lhx1a:eGFP) and tg(mbp:mCherry-CAAX). However, unfortunately, we found that the
mbp:mCherry-CAAX transgene was weakly expressed, especially in the PNS, which
made it difficult to confidently call mutants. Therefore, once we identified a clutch of F3
progeny carrying a potentially interesting mutant phenotype, those progeny were fixed
and saved for whole mount in situ hybridization (ISH). All potential mutants called by
transgene were followed up with ISH using a riboprobe against mbp (Figure 3, top left),
which allowed us to weed out false positives immediately, and to screen these families
more carefully for any PNS myelination defects.

3.1.5 Confirming identified mutations
To confirm that our mutations of interest and determine if they were worth following up,
we needed to be sure they were both real and heritable. Therefore, we re-crossed the
original pairs in order to re-screen their progeny and confirm that the phenotype could be
observed multiple times. As an extra stringency, we also always had at least two people
screen each clutch to be sure that any phenotypes scored were readily observable and not
due to any bias in the screener. Every mutation was then assigned a Washington
University-specific allele designation of “stl” followed by a number, e.g. stl64. Finally, to
confirm that the phenotypes we observed were a result of heritable and not de novo
mutations, we raised the F3 progeny to adulthood, performed random intercrosses, and
then screened the F4 progeny by ISH. If the F4 progeny produced the same phenotype
that was observed in the F3 generation, the mutation was considered real and heritable. In
total we screened approximately 680 genomes from over 4500 clutches from nearly 1100
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F2 families. From this effort we initially identified 31 recessive mutations affecting
myelinating glial development (Figure 3 and Table 1). Of these, 14 have been confirmed
as real and heritable, 12 were cryo-preserved after initial identification and await further
analyses, and 5 have been thrown out after extensive re-screening.

3.2 MAPPING MUTATIONS TO DETERMINE THE CAUSATIVE GENES
3.2.1 Map crosses to SJD
For any confirmed mutations, the original F2 carriers were outcrossed to the SJD strain, a
wild-type isogenic zebrafish line that has been sequenced with deep coverage and has
well described simple sequence length polymorphism (SSLP) marker maps [8] (SJD fish
courtesy of Stephen L. Johnson). In some cases, the F2 carriers had died prior to being
outcrossed to SJD, and in those cases we outcrossed an F3 carrier instead. These SAT* x
SJD crosses were our “map-crosses” as the hybrid progeny had one copy of the SJD
genome and one copy of the mixed mutagenized background (SAT*). As previously
described, map crosses aid in traditional positional cloning approaches as the well
characterized SSLPs provide good anchor points for placing a mutation within a given
genomic region.

3.2.2 Using whole genome sequencing to map causative mutations
Once the map-crosses reached maturity, we set up random intercrosses and screened the
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progeny by ISH to identify carriers of our mutation of interest. We then bred these
carriers to generate many progeny, which were then fixed and subjected to ISH and
screened for mbp expression at 5 dpf. We then grouped larvae into two pools –
phenotypically normal (siblings) and phenotypically mutant. Each pool contained a
minimum of 20 whole larvae. It is important to note that the segregation of the two pools
was very strict with as little ambiguity as possible, such that if a larva could not
confidently be placed in one pool or another it was thrown out entirely. We then extracted
genomic DNA from both pools (see Appendix E for full protocol), and submitted these
pools for whole genome sequencing (WGS) at the Genome Technology Access Center
(GTAC) at Washington University in St Louis. GTAC performed all quality control
assays and library preparation. For all of our mutants, we sequenced the sibling and
mutant pools together on a single lane of the paired-end 100 bp Hi-Seq Illumina platform.
Using an in-house analysis pipeline, which is summarized in detail in Appendix E, we
calculated mutant/sibling allele ratios across the genome to identify regions of
homozygosity that should be linked to the mutation responsible for whatever phenotype
was common to the mutant pool. This approach enabled us to identify the linked
chromosome in a matter of minutes, and in most cases we were able to identify the most
likely causative region in just a few days. In some cases, as it was with stl64 described in
Chapter 4 of this thesis, WGS was sufficient to highlight exactly the causative gene as it
was the only gene in the region containing a non-synonymous deleterious mutation.
However, in most cases, WGS was primarily able to identify a region containing 5-9
candidate genes, and then we had to use traditional linkage mapping, and other molecular
genetics approaches to confirm the identity of the causative lesion. As of January 2017,
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we had sequenced 11 confirmed mutations and putatively identified 8 different genes
affecting myelinating glial development (Table 2). The remaining 3 have undergone
sequencing, but we are awaiting subsequent analyses before calling a putative gene.
Importantly, our analysis pipeline has also helped successfully identify causative lesions
in several related screens from the Monk and Solnica-Krezel labs as well as in completely
unrelated screens in other labs.

3.3 LESSONS LEARNED AND NOTES FOR FUTURE SCREENS
This was the first forward genetic screen that I had ever participated in, in any species,
and I certainly took away many valuable lessons from the whole process. Overall, our
screen strategy very much resembled the countless zebrafish ENU screens that had come
before it, but the use of transgenic reporters and whole genome sequencing were
relatively new to the field at the time and therefore presented some unique challenges.
Therefore, for those who may want to conduct screens in zebrafish using these tools, I
thought I would take a moment to reflect on some of the lessons we learned that won’t
likely ever see the light of publication in a manuscript.

3.3.1 Challenges with weak transgenic reporters
First and foremost, the transgenic reporters used should be of utmost importance and
given extreme consideration. The weakness of the mbp:mCherry-CAAX transgene in the
PNS was the single most frustrating hurdle in this particular screen, and choosing an
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alternative reporter or an mbp transgene with brighter fluorescence would have made
screening much faster. The original goal of using transgenic reporters was that mutant
larvae would be easily identifiable and separable from their siblings while still alive. This
would promote easy extraction of high quality genomic DNA for sequencing, the ability
to raise mutant progeny separately, and hasten many other downstream analyses.
However, because we could not confidently separate mutants from siblings by transgene,
we had to resort to the much more laborious and time-consuming strategy of ISH.
Unfortunately, the fixatives and harsh detergents used during ISH hinder genomic DNA
isolation, thus making it more difficult to obtain sufficient high-quality DNA for
sequencing.

3.3.2 Transgene copy number can result in a high rate of false positives
We experienced a considerable amount of variability in fluorescence intensity of both
transgenic reporters that we ultimately discovered was due simply to transgene copy
number. Individuals homozygous for the transgene appeared much brighter than those
with only a single copy of the transgenes, which dramatically increased the number of
false positives from the transgenic screening. Maintaining the transgenes as strictly
heterozygous or strictly homozygous throughout every generation could have easily
solved the transgene copy number problem. One option would have been to mutagenize
the double homozygous transgenic line, and then outcross to any wild-type strain, which
would have resulted in every F1 individual being heterozygous for the transgenes. These
F1 could then have been outcrossed to another wild-type strain and the F2 progeny sorted
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into two tanks - double positive and double negative. Once adults, we could have
randomly crossed the double transgenic F2s with the double negative individuals, which
would have maintained the heterozygosity of the transgenic reporter and eliminated any
copy number variability. A second option would have been to again, mutagenize the
double homozygous transgenic males, and then outcross to the normal double
homozygous females to create F1 progeny. We could have then intercrossed the F1
progeny [4, 6], which would have allowed us to screen nearly twice as many genomes in
the same amount of time, but also may have introduced complications in mapping due to
potentially excessive background mutations. In sum, great care should be taken when
considering not only which transgenic reporters to use in a zebrafish screen, but also
when to incorporate the transgene into the crossing scheme so as to keep track of
transgene copy number.

3.3.2 Increasing heterozygosity is more important than the map-cross strain
In hindsight, map-crossing to the SJD strain did not end up serving us much purpose, as
the WGS was able to take the place of most of the traditional positional cloning where
SJD would have been most useful. Instead, what was most useful was that SJD was
distantly related to SAT, and therefore, the outcross helped increase the heterozygosity in
our background and provided additional opportunities for recombination, thus narrowing
the region of homozygosity in the WGS data. Therefore, since SJD was sometimes
laborious to work with simply because they do not breed well naturally, for later mutants
we simply outcrossed our carriers to another wild-type strain such as AB, and were able
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to achieve similar success with the WGS analyses. In a few instances, both with LM
screen mutants and mutants from completely different screens, we were forced to
sequence the original F3 progeny from the F2 intercross for fear of potentially losing the
mutation due to death of the F2 carriers or other unforeseen circumstances. Although we
were eventually able to narrow these down to the putative causative genes, these cases
were significantly more challenging and required a lot more traditional positional cloning
than those cases in which the mutation had been outcrossed multiple times. In fact, those
mutants that descended from the specific-locus test, such as stl64, in which the F1
progeny resulted from F0 SAT* x albino crosses instead of F0 SAT* x SAT were by far
the easiest to map. These lines technically had the advantage of one more true outcross
than those mutants resulting from the typical F0 SAT* x SAT crosses. Therefore,
introducing many outcrosses to increase heterozygosity enhances the probability that
WGS will successfully highlight a small candidate region containing only a few genes
and limit the need for positional cloning in identifying the causative lesion.
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3.4 FIGURES

Figure 1: The lhx1a/mbp (LM) screen crossing scheme. Founder (F0) SAT males were
mutagenized with ENU. These males were crossed to SAT females to generate F1
individuals, which are heterozygous for any given mutation (m) of interest. F1s were then
outcrossed to a double homozygous transgenic line carrying the Tg(lhx1a:eGFP) and
Tg(mbp:mCherry-CAAX) transgenes, which label neurons and myelinating glia,
respectively. The F2s were thus heterozygous for both transgenes and 50% were carriers
for a potential mutation of interest. F2 individuals were then randomly intercrossed to
identify putative carriers. F3 larvae were screened for disruptions in the levels or
distribution of fluorescence. Representative images of each transgene are pictured at the
bottom. Tg(lhx1a:eGFP) (bottom left) labels a subset of sensory neurons in the spinal
cord (CNS, white bracket), and in the pLLn (PNS, white arrow). Tg(mbp:mCherryCAAX) (bottom right) labels myelinating glia red in the CNS (white bracket) and the PNS
(white arrow).
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Figure 2: A specific locus test suggests mutagenesis was highly effective. To
determine if the ENU had efficiently mutagenized our founder males, we crossed the F0s
to either homozygous albino or golden mutants. Both of these mutants display very
striking pigmentation defects. The resulting F1 progeny were then screened for these
pigmentation deficits, to determine how often the albino or golden loci were
mutagenized. Our founders had a wide range of efficiency, but on average either albino
or golden were mutagenized sufficiently to produce pigmentation phenotypes in
approximately 1 in every 750 larvae, indicated we needed to screen 750 genomes to
achieve 1X coverage of the zebrafish genome. The table at the bottom shows how many
genomes we would have to screen to reach various levels of coverage of the zebrafish
genome (left) and the likelihood of sampling a gene (right).
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Figure 3: Examples of the different mutant phenotypes obtained in the LM screen.
Due to dimness of the mbp:mCherry-CAAX transgene, especially in the PNS, we
eventually began screening by ISH for mbp expression (purple). A representative wildtype larva at 5 dpf is shown from the dorsal view in the upper left panel. The head is
always at the top of the panels, and the tails are out of the images shown. The “Y” in the
hindbrain (white arrows) leads into the spinal cord at the center of the fish, making up the
CNS, which is myelinated by oligodendrocytes. The pLLn (black arrows) runs along
either side of the fish, representing the PNS, which is myelinated by Schwann cells. We
observed a variety of disruptions in mbp expression including reduced expression in the
CNS (stl92 and stl90), punctate/abnormally distributed expression in the CNS (stl68),
reduced mbp expression in the PNS (stl71 and stl91), axon pathfinding defects (stl159),
and reduced mbp expression in both the CNS and PNS (stl83).
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one mutation resulted in an overexpression of mbp, and four mutations resu
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15

Table 2: The LM screen has identified mutations in 8 different putative genes thus
far using WGS. Of the 11 mutants that have been submitted for sequencing, we have
been able to call the putative causative genes for 8 of them so far. The other 3 require
additional linkage mapping before we can call the likely gene. Of the 8 genes thus far, 4
of the mutations introduced STOP codons, while the other 4 are missense lesions.
Interestingly, the 8 genes appear to have a wide variety of cellular functions, and do not
appear linked by any particular pathway.
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Chapter 4
The E3 ubiquitin ligase, Fbxw7, restricts the
myelination capacity of Schwann cells via mTORdependent and –independent mechanisms
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4.1 ABSTRACT
Myelinating Schwann cells (SCs) in the peripheral nervous system are restricted to a 1:1
SC:axon ratio, and Remak SCs ensheath, but do not myelinate, multiple small caliber
axons. Here, we show that the E3 ubiquitin ligase Fbxw7 is a novel regulator of SC
development. Zebrafish and SC-specific Fbxw7 mouse mutants revealed a variety of
defects including hypermyelination and enhanced segregation of small-caliber axons.
Strikingly, Fbxw7 mutant SCs can myelinate multiple axons and interact with
unmyelinated and myelinated axons at the same time. Loss of Fbxw7 in SCs elevates
mTOR and its downstream targets, and genetic inhibition of mTOR in SCs suppresses
many Fbxw7 mutant phenotypes, suggesting that Fbxw7 directly targets mTOR in SCs.
However, loss of mTOR does not rescue aberrant SC-axon interactions observed in
Fbxw7 mutants, suggesting that another Fbxw7 target controls SC myelination capacity.
Our work provides the first evidence of an evolutionarily conserved role for Fbxw7 in SC
development and myelination through both mTOR-dependent and mTOR-independent
pathways.

120

4.2 INTRODUCTION
Complex cell-cell interactions between neurons and glia are essential for proper nervous
system function. In vertebrates, specialized glial cells, oligodendrocytes (OLs) and
Schwann cells (SCs), generate the myelin sheath in the central nervous system (CNS) and
peripheral nervous system (PNS), respectively [1]. In both the CNS and PNS, this process
facilitates fast action potential propagation and protects the axon segment it surrounds,
and the importance of myelin is underscored by the fact that disruptions in myelinating
glia result in many neurological disorders including peripheral neuropathies [2].
However, although OLs and SCs evolved to perform analogous functions using highly
overlapping genetic programs, these cell types also possess important differences. For
example, SCs secrete proteins that form a basal lamina on their abaxonal surface, while
OLs do not [3]. Another major difference between OLs and SCs is the ratio by which
they myelinate axons; a single OL is capable of myelinating dozens of axon segments,
while myelinating SCs are restricted to a single axon segment [4]. Factors driving this
differential myelination capacity in OLs versus SCs remain mysterious. Furthermore,
during PNS development, unlike in the CNS, SCs select axons in a process called radial
sorting. Upon completion of radial sorting, large-caliber axons are associated 1:1 with a
SC that will myelinate an axon segment, while small-caliber axons are organized into
“Remak bundles” by non-myelinating Remak SCs. Here again, the molecular
mechanisms controlling the fate decision between Remak or myelinating SCs are
incompletely understood.

Despite differences between OLs and SCs, several characteristics of the myelin sheath
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are ultrastructurally stereotyped in both the CNS and the PNS, including distinct
organization of membrane domains, the periodicity of myelin wraps, and an optimal
thickness of myelin to a given axon diameter (g-ratio). In SCs, an essential regulator of
this precision with respect to myelin thickness is the Neuregulin 1 type III (Nrg1 type
III)-ErbB2/3 signaling axis, which activates the phosphatidylinositol-4,5-bisphosphate 3kinase (PI3K) pathway. Pharmacological inhibition of PI3K blocks myelination in vitro
[5], while gain of PI3K function through loss of the inhibitor Pten (Phosphatase and
tensin homolog) results in hypermyelination [6]; suggesting that activity through this
pathway must remain balanced for proper SC development and myelination. For
example, inhibition of the PI3K effector Akt in SCs blocks myelination while constitutive
activity of Akt causes hypermyelination, enhanced segregation of unmyelinated axons,
and aberrant wrapping of unmyelinated axons [7]. Importantly, both Pten and Akt are
upstream of the serine/threonine kinase, mTOR (mechanistic target of rapamycin), which
performs a wide variety of functions via two different complexes – mTORC1 and
mTORC2. The importance of mTOR in PNS myelination is underscored by the fact that
deletion of mTOR in SCs results in dramatic hypomyelination [8]. Although both
mTORC1 and mTORC2 are required for many critical cellular processes, the downstream
targets of these complexes are quite different and thus result in different cellular outputs
[9, 10]. Accordingly, when a key mTORC1 interacting partner, regulatory-associated
protein of mTOR (Raptor), is conditionally ablated (essentially inactivating mTOR in
SCs), dramatic hypomyelination is observed, similar to mTOR mutants [11].
Additionally, SC-specific Raptor mutants display significant deficits in radial sorting
[11]. However, when the mTORC2 interacting partner Rictor was deleted in SCs, radial
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sorting and myelination defects were not observed, suggesting that mTOR primarily acts
through mTORC1 in SC development and myelination [11].

Here we describe a mutant isolated from a forward genetic screen, stl64, which displays
overexpression of myelin basic protein (mbp) in the CNS and PNS. We found that stl64
disrupts F-box and WD-repeat domain containing 7 (fbxw7), which encodes a substrate
recognition component of E3 ubiquitin ligase complexes. Another mutation in fbxw7
isolated in zebrafish, vu56, has previously been shown to cause increased OL number
[12] and CNS hypermyelination [13] by loss of regulation on Notch and mTOR,
respectively. Here, using the fbxw7stl64 mutants, we provide the first evidence that Fbxw7
is also a key regulator of SC development and myelination. Furthermore, we used
conditional knockout mice to demonstrate that Fbxw7 function is conserved in mammals
and that it acts cell-autonomously in SCs as a negative regulator of early SC number,
radial sorting, myelin thickness, and wrapping of traditionally unmyelinated axons. These
ultrastructural phenotypes are reminiscent of those observed in Pten loss-of-function
mutants [6] and Akt gain-of-function mutants [7], which both result in excessive mTOR
activity. Indeed, mTOR is a known target of Fbxw7 in other contexts [14, 15], and here
we show that loss of Fbxw7 in SCs leads to elevated levels of mTOR and its downstream
targets. Furthermore, the aforementioned phenotypes observed in Fbxw7 mutants are
ameliorated upon loss of mTOR. Finally, we found that loss of Fbxw7 results in aberrant
wrapping of collagen fibrils by SCs, disrupted SC basal lamina, and, strikingly, the
ability of a single SC to generate a myelin sheath around one axon while interacting with
multiple small caliber axons, as well as the ability of a single SC to myelinate multiple
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axon segments. The aberrant SC-axon ratios and the ability to myelinate multiple axons
persists even in the absence of mTOR, suggesting that the myelination capacity of SCs is
not mTOR-dependent. Our findings demonstrate that Fbxw7 is an evolutionarily
conserved regulator of SC development and myelination with both mTOR-dependent and
mTOR-independent functions in the developing PNS.
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4.3 RESULTS
4.3.1 stl64 disrupts the E3 ubiquitin ligase, Fbxw7
Myelin is a jawed vertebrate innovation [1]; thus, the zebrafish represents one of the
simplest genetically tractable models for studying myelinating glia. To dissect the genetic
governors of myelinating glial cell development, we conducted a three-generation
forward genetic screen in zebrafish. After driving mutations to homozygosity, F3
progeny were screened using whole-mount in situ hybridization (WISH) with a riboprobe
against mbp to observe the levels and distribution of mbp expression in both the CNS and
PNS. One mutant isolated from the screen, designated stl64, displayed striking
overexpression of mbp relative to siblings at 5 days post fertilization (dpf) (Figure 1A).
To determine the causative lesion in stl64 mutants, we separated pools of siblings and
mutants by phenotype and performed whole genome sequencing (WGS). We then used
the mutant/sibling allele ratio to map stl64 to an 800-kilobase region of chromosome 1
(Figure 1B) (Sanchez et al., in prep). Closer inspection of this region revealed that the
only non-synonymous mutation was a C/A transition that introduced a premature
termination codon (PTC) in the gene fbxw7 (Figure 1C). Importantly, stl64 disrupts an
Hpy188I restriction site (Figure 1D), and genotyping confirmed that more than 85% of
individuals scored as phenotypically mutant by ISH genotyped as homozygous for the
stl64 mutation (117/136), while the remaining ~15% were heterozygous for stl64
(19/136). Phenotypic mutants were never genotyped as homozygous wild type (WT).

Fbxw7 is a substrate recognition component of SCF (SKP1-Cullin-F-box) ubiquitin
ligase complexes, which catalyze the addition of ubiquitin moieties on certain proteins to
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target them for degradation by the proteasome [16]. Some important Fbxw7 targets
include master regulators of cell cycle, differentiation, and apoptosis such as cyclin E, cMyc, c-Jun, Notch, Aurora A and mTOR [14, 17-21], several of which have been
implicated as key players in myelinating glial development. Importantly, although the
PTC resulting from the stl64 mutation occurs quite late in the Fbxw7 protein (Figure 1E),
it is predicted to truncate the highly conserved 7th WD-repeat containing domain (Figure
1F) that is responsible for target recognition. Previously, zebrafish fbxw7vu56 mutants
(Figure 1E) were shown to possess increased OL numbers and hypermyelination in the
CNS [12, 13]. To determine if the overexpression of mbp in the CNS of stl64 mutants
was similarly due increased OL numbers, we performed WISH using a riboprobe against
nkx2.2a, which marks the OL lineage. At 65 hours post fertilization (hpf), stl64 mutants
displayed more nkx2.2a positive cells in the spinal cord than their WT siblings (Figure S1
A-B). Furthermore, ultrastructual analyses by transmission electron microsopy (TEM)
revealed increased numbers of myelinated axons as well as thicker myelin in the spinal
cords of stl64 mutants at 8 dpf (Figure S1 C-J). Finally, we employed an established
antisense oligonucleotide morpholino (MO) [12] to reduce fbxw7 levels in WT embryos,
and assessed mbp expression by WISH. Injection of the fbxw7-MO indeed increased mpb
expression (Figure S1 K-L). Together, genetic mapping, phenocopy between stl64 and
fbxw7vu56 mutants, and MO analyses firmly indicate that fbxw7 is disrupted by the stl64
mutation.

4.3.2 Fbxw7 regulates peripheral myelination in zebrafish
A role for Fbxw7 in the PNS has never been described, but given the striking CNS
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phenotypes observed in fbxw7vu56 mutants [12] [13] and fbxw7stl64 mutants (Figure 1,
Figure S1), we wondered if Fbxw7 is also required in SCs. To test this, we performed
TEM to analyze the ultrastructure of myelin in the posterior lateral line nerve (pLLn), a
major sensory nerve in fish (Figure 2). Interestingly, at 8.5 dpf, fbxw7stl64 mutants
displayed similar hypermyelination phenotypes in the PNS as in the CNS, and more SC
nuclei were observed in fbxw7stl64 mutant pLLns compared to WT siblings (Figure 2 AD). Loss of Fbxw7 also resulted in a higher percentage of myelinated axons (Figure 2E)
without a corresponding increase in the total number of axons (Figure 2J), and mutant
SCs also generate more wraps of myelin per axon than their WT siblings (Figure 2 F-I).
Notably, heterozygous fbxw7stl64/+ larvae were statistically indistinguishable from their
homozygous fbxw7stl64/stl64 mutant siblings with regard to SC number and increased
myelination phenotypes (Figure 2 D,E,I). This is consistent with previous findings that
Fbxw7 is haploinsufficient [22], and also explains why some individuals scored as
phenotypically mutant by ISH genotyped as heterozygous.

4.3.3 Fbxw7 is a conserved cell-autonomous regulator of SC development
Although axons appear grossly normal in fbxw7stl64 mutants, we cannot conclude if the
PNS phenotypes observed in these larvae are SC-autonomous or non-autonomous
because stl64 is a global mutation affecting all cells in the organism. Additionally, the
relatively late location of the stl64 mutation suggests that it may not be a null allele, but
may instead lead to a truncated protein product. Furthermore, homozygous fbxw7stl64/stl64
mutants do not survive to adulthood and generally die between 7 – 14 dpf, precluding the
ability to assess myelination in mature nerves. Therefore, to circumvent these caveats and

127

to determine if the PNS functions of Fbxw7 are conserved in mammals, we employed a
conditional knockout strategy in the mouse. The Dhhcre transgenic line results in Cre
recombinase expression under the Desert hedgehog promoter beginning at approximately
E12.5 at the SC precursor stage [23]. To delete Fbxw7 specifically in SCs, we crossed the
Dhhcre transgene into an Fbxw7fl/fl transgenic line in which loxP sites surround exons 5
and 6 of the Fbxw7 gene [24]. This creates a frameshift upon Cre exposure, resulting in a
null allele. Dhhcre(+);Fbxw7fl/+ and Dhhcre(+);Fbxw7fl/fl animals are hereafter referred to as
“Het” and “cKO,” respectively. Controls included both Dhhcre(-);Fbxw7fl/+ and Dhhcre()

;Fbxw7fl/fl animals. To confirm that Fbxw7 was successfully deleted in SCs, we

performed RT-PCR and showed that Fbxw7 mRNA is dramatically reduced in sciatic
nerves from cKO animals (Figure 3A). We then analyzed sciatic nerve ultrastructure by
TEM at several stages throughout development and found that at P3 and P21, Het and
cKO mice displayed an increase in SC nuclei as well as in the percent of axons that are
myelinated compared to controls (Figure 3 B-K). By P42, there were no longer
significant differences in SC number or the percentage of myelinated axons (Figure 3 LP); however, g-ratio analysis indicated that myelin was considerably thicker in Het and
cKO mice compared to controls at this stage (Figure 3 Q-T). Moreover, hypermyelination
appeared to disproportionately affect small caliber axons (Figure 3T). These data
demonstrate that the function of Fbxw7 is evolutionarily conserved and that Fbxw7
functions cell-autonomously to regulate SC number and myelin thickness.

4.3.4 Fbxw7 is required for normal SC-axon interactions in both myelinating and
Remak SCs
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Further analysis of the cKO mice revealed that in addition to its roles in controlling
myelin thickness and early SC numbers, Fbxw7 is also critical at several other stages of
SC development. At P3, loss of Fbxw7 in SCs resulted in enhanced segregation during
radial sorting (Figure 4 A-C) as evidenced by fewer axons per bundle (Figure 4D) and a
greater percentage of bundles with five or fewer axons (Figure 4E) in both Het and cKO
nerves. This enhanced segregation persisted until at least 6 months of age (Figure 4 F-J).
Mutant SCs also displayed aberrant process extensions leading to interactions with
multiple axons simultaneously despite one or more of those axons being myelinated
(Figure 4 K-O). This striking phenotype was observed in every Het and cKO nerve
examined, even in adulthood, but was never observed in control animals (Figure 4 P-T).

With regard to these aberrant process extension phenotypes, we observed instances of
multi-axonal myelination (Fig 4 L, N, R) as well as instances in which a SC myelinated
an axon while also associating with unmyelinated axons (Figure 4 M, Q). Importantly,
both of these phenotypes are distinct from what has been termed “polyaxonal
myelination” in which a small bundle of axons is myelinated as though the bundle of
axons is one larger axon. In both scenarios, we were able to trace continuous basal lamina
on the abaxonal surface of the SC and confirm that it was in fact the same SC interacting
with these axons (Figure 4Q, inset), suggesting that the SCs were generating multiple
cytoplasmic processes, and that more than one of these processes could go on to make
myelin. Indeed, in some cases we were able to visualize the outer cytoplasmic pocket of
myelinating SCs aberrantly extending long projections (Figure 4S). Further, the presence
of a basal lamina reinforces the notion that these cells were indeed SCs and not OLs that
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might have infiltrated the PNS.

Additionally, at 6 months of age, we observed a variety of Remak SC defects in cKO
nerves compared to WT nerves (Figure 5 A-D), including SC cytoplasm surrounding
collagen fibers (Figure 5B’) and excess basal lamina (Figure 5B’’) as well as excessive
wrapping of unmyelinated axons (Figure 5C). We also observed instances in which
multiple axons were connected not by SC cytoplasm, but by basal lamina trails (Figure
5E, arrowheads), suggesting that a SC process had existed in that space at one point. We
also saw axons surrounded by “onion bulbs” (i.e., rosettes of basal lamina trails) (Figure
5F) as well as SCs that were not associated with axons but that possessed a basal lamina
(Figure 5G). Importantly, these aberrant SC-matrix phenotypes, in addition
hypermyelination are hallmarks of peripheral neuropathies including hereditary
neuropathy with liability to pressure palsies (HNPP) [25] and some subtypes of CharcotMarie-Tooth disease [26].

4.3.5 Loss of Fbxw7 results in mild motor and sensory deficits
Given the numerous neuropathy-like phenotypes we observed in cKO nerves, we next
wanted to determine the functional consequences of loss of Fbxw7 in SCs. To this end,
we performed motor and sensory behavioral analyses using cKO mice and their littermate
controls at 6 months of age (Figure S2 A-K). Interestingly, several peripheral
neuropathies display increased incidence in women including: small fiber neuropathy
[27], carpel tunnel syndrome (NINDS Carpal Tunnel Syndrome Fact Sheet, 2012), and
neuropathy associated with anti-retroviral treatment [28]. Because we noted many defects
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in Fbxw7 mutant Remak SCs, which encompass the small caliber non-myelinated axons
that are primarily impacted in small fiber neuropathy in human nerves, we chose to
specifically analyze female mice for behavior. However, the cKO mice displayed only
modest behavioral deficits. The largest difference was in the vertical pole test, where the
cKO mice took longer to both turn around and climb back down the pole than their
control siblings, suggesting a mild defect in complex motor behavior [29] (Figure S2 EF). Through gait analyses, we also found that the cKO mice were mildly hypersensitive
as demonstrated by decreased maximum contact intensity (Figure S2G) as well as
decreased print area (Figure S2H) in the front paws. Additionally, the cKO animals
trended towards a mild hypersensitivity to cold when the time spent in pain behavior was
measured after the paws were exposed to acetone [30] (Figure S2K), although these
results did not reach statistical significance. Finally, we performed electromyography
(EMG) to measure conduction velocity; surprisingly, we found that there was not a
significant difference in conduction velocity in cKO versus control nerves, although
mutants trended towards slightly faster conduction (Figure S2L), perhaps explaining why
the behavioral deficits observed were not severe.

4.3.6 Fbxw7 orchestrates SC biology through mTOR-dependent and –independent
mechanisms
We next sought to understand how Fbxw7 orchestrates SC biology. As mentioned
previously, several of the phenotypes observed in cKO animals including
hypermyelination, basal lamina defects, and aberrant Remak bundles are observed in
human neuropathy patients. Furthermore, the aberrant SC-axon ratio seen in Fbxw7
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mutants is a novel phenotype that, to our knowledge, has never been reported in vivo.

Notably, multiple phenotypes observed in the Fbxw7 cKO nerves including
hypermyelination, enhanced axon segregation, and wrapping of unmyelinated axons are
reminiscent of the phenotypes caused by SC-specific deletion of Pten or overactivation of
Akt [6, 7]. Pten and Akt are both major components of the mTOR signaling pathway,
which has been repeatedly shown to be crucial for proper myelinating glial development
and myelination in both the CNS and the PNS [5-8, 11, 13]. Further, activity of the
mTOR signaling cascade likely acts as a critical checkpoint for generating myelin of the
appropriate thickness, as loss of either mTOR or one of its interacting partners, Raptor, in
SCs results in hypomyelination [8, 11]. Conversely, enhanced mTOR signaling via Akt
activation or Pten loss results in excessively thick myelin [6, 7]. Moreover, Raptor
mutant SCs are severely delayed in radial sorting [11], while constitutively active Akt
leads to enhanced segregation similar to Fbxw7 cKO mice [7] (Fig. 4 A-J). mTOR is a
bona fide target of Fbxw7 in other contexts, such that loss of Fbxw7 function results in a
buildup of mTOR protein and subsequently of mTOR targets [14, 15]. Given this and a
recent report that mTOR is the critical target responsible for the CNS hypermyelination
observed in fbxw7vu56 mutants [13], we hypothesized that loss of Fbxw7 in SCs results in
a buildup of mTOR protein, leading to increased signaling downstream of mTOR and
subsequently the defects observed in Fbxw7 mutants.

To test this hypothesis, we first examined the levels of total mTOR protein in both the
fbxw7stl64 zebrafish mutants as well as in cKO mouse sciatic nerve. Whole mount
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immunofluorescence of zebrafish larvae at 5 dpf showed that total mTOR levels are
approximately 2-fold higher in fbxw7stl64/stl64 mutants compared to WT siblings (Figure 6
A-C). Similarly, western blot analyses of sciatic nerve lysates again revealed an
approximate 2-fold increase in total mTOR levels in cKO nerves relative to littermate
controls at P42 (Figure 6 D-E). Next, we performed quantitative reverse-transcription
PCR (qPCR) analysis on cDNA generated from cKO and control sciatic nerves of 84
genes associated with the mTOR cascade, including both upstream and downstream
members. We found that in addition to a ~2-fold elevation of mTOR mRNA levels in
cKO nerves at P21 (Figure 6F), several other members of the mTOR pathway were also
significantly elevated in cKO nerves, including Eif4b, Eif4ebp1, Eif4ebp2, and
PKCa (Figure 6F). We also noted a trend towards increases in Rps6kb1 (S6 kinase),
Ddit4, Ilk, Sgk1, and Vegfa, as well as trending decreases in Ins2 and Ddit4l (Figure 6F,
#) in cKO nerves. Interestingly, although mTORC1 is thought to be more important than
mTORC2 in myelination, the mTOR targets dysregulated in cKO nerves represent
pathways downstream of both mTORC1 and mTORC2 [9, 10]. This suggests that
perhaps in conditions of mTOR overexpression, mTORC2 can also contribute to the
various defects observed in cKO nerves.

The observed changes in mTOR levels and related genes in Fbxw7 cKO nerves suggest
that mTOR is involved in the phenotypes observed in these mutants. To directly test if
mTOR is the causative target of Fbxw7 in SCs, we generated double SC-specific
Fbxw7;mTOR knockouts by crossing mTORfl/fl mice [31] to our cKO mice. We then
analyzed Dhhcre(+);Fbxw7fl/+;mTORfl/fl animals, hereafter be referred to as “HetΔmTOR”
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(Figures 7-8). We note that the HetΔmTOR animals analyzed were heterozygous for
Fbxw7 because we were unable to obtain sufficient numbers of double homozygous
Dhhcre(+);Fbxw7fl/fl;mTORfl/fl (“cKOΔmTOR”) mutants from trans-heterozygous
intercrosses (1/32 expected, 1/126 obtained; images from the single cKOΔmTOR animal
shown in Figure 8). Therefore, we chose to proceed with Fbxw7 Het animals because
they were statistically indistinguishable by every measure from the cKO animals (Figures
3-4). If mTOR is the Fbxw7 target responsible for SC defects observed in cKO animals,
then we would expect genetic loss of mTOR in Fbxw7 Het animals to suppress mutant
phenotypes. If mTOR is downstream and epistatic to Fbxw7, we would also expect
HetΔmTOR animals to present with phenotypes similar to SC-specific mTOR knockouts.
Indeed, at P3, we found that HetΔmTOR animals had significantly fewer SC nuclei and a
lower percentage of myelinated axons than their Fbxw7 Het siblings, but were
indistinguishable from their control siblings (Figure 7 A-E). Furthermore, at P21,
HetΔmTOR SCs did not display the enhanced axon segregation phenotype observed in
Fbxw7 Hets but instead, were significantly delayed in radial sorting compared to controls
(Figure 7 F-J), consistent with a requirement for precise regulation of mTOR levels for
proper radial sorting. Loss of mTOR also resulted in dramatically thinner myelin in
HetΔmTOR animals relative to both control and Fbxw7 Het siblings (Figure 7 K),
confirming that mTOR is epistatic to Fbxw7. Together these data suggest that Fbxw7
regulates many aspects of SC development and myelination via its tight control of mTOR
protein levels, and thus mTOR activity. Very interestingly, however, multi-axonal
myelination and aberrant SC interactions were not rescued in the HetΔmTOR animals
(Figure 8 A-D) or in the single cKOΔmTOR animal we were able to analyze (Figure 8
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E). Together, these data suggest that while mTOR is critical for many aspects of SC
development and myelination, the myelination capacity of SCs is mTOR-independent,
and likely regulated by an as yet undefined Fbxw7 target (Figure 9).
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4.4 DISCUSSION
Multiple members of the PI3K/mTOR signaling axis have been implicated in PNS
myelination, including PI3K itself, the PI3K inhibitor, Pten, as well as the downstream
effectors Akt, mTOR, and Raptor [6-8, 11]. Both loss- and gain-of-function
perturbations within this pathway result in myelination deficits, suggesting that flow
through this signaling cascade must be tightly controlled and balanced in order to achieve
proper peripheral nerve development. One classical mechanism by which cells control
signaling pathways is through the ubiquitin-mediated proteasome, which regulates
homeostatic concentrations of proteins and removes deleterious misfolded proteins.
Members of the protein degradation network are essential for fundamental cellular
processes such as proliferation [32], differentiation [7, 33], and apoptosis [7, 34].
Therefore, many target proteins are master regulators of these critical cellular processes,
including but not limited to: transcription factors such as c-Myc [17, 35], c-Jun [7, 18],
Notch [19, 36, 37], and key proteins involved in cell cycle, protein synthesis, and
cytoskeletal rearrangements like cyclin E [20], mTOR [14], and Aurora A [21]. However,
the specific targets of Fbxw7 that are important in a given developmental or disease
context vary greatly based on the cell-type(s) involved. Here, we have shown that the
highly conserved E3 ubiquitin ligase substrate receptor, Fbxw7, acts as a key modulator
of the PI3K pathway in SCs at least in part by maintaining appropriate levels of mTOR
protein.

In addition to the overexpression of mbp used to first identify fbxw7stl64 zebrafish mutants,
we noted increased SC numbers and enhanced myelin thickness in the PNS. However,
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the stl64 mutation is global; thus, to define the cellular autonomy of Fbxw7, we generated
a transgenic mouse model in which Fbxw7 is specifically deleted in SCs. Here we found
that Fbxw7 is a conserved cell-autonomous regulator of early SC number as well as
myelin thickness, particularly of small-caliber axons. Notably, the bias towards
enhancing myelin thickness especially on small diameter axons was also observed in Pten
mutants [6]; however, this phenotype was not seen with overactive Akt [7]. Further, Loss
of Fbxw7 in SCs resulted in enhanced segregation of unmyelinated axons, especially
during early stages of radial sorting, which was not reported in Pten mutants [6], but was
also present with gain of Akt function [7]. Fbxw7 ablation also resulted in onion bulb
formation and other aberrant SC behaviors, particularly in Remak SCs: mutant SCs
encompassed both collagen fibrils as well as basal lamina trails, and occasionally
generated multiple membrane wraps around unmyelinated axons. In addition, Fbxw7
cKO mutants displayed multiple types of aberrant SC-axon interactions that were not
previously described in the Pten mutants or constitutively active Akt mutants, including:
multi-axonal myelination, and single SCs encompassing unmyelinated axons and
generating myelin around other axons simultaneously. However, despite numerous
ultrastructural abnormalities, Fbxw7 cKO mutants displayed only modest motosensory
deficits, which may be reflective of the very slight change in nerve conduction velocity.

Given the similarity of phenotypes observed in Fbxw7 mutants to human neuropathies,
and the novelty of the aberrant SC-axon ratio defects, we sought to elucidate the
molecular mechanisms by which Fbxw7 regulates SC behavior. Importantly, the PI3K
pathway is heavily implicated in SC development and myelination, and one of its major

137

effectors, mTOR, is a known target of Fbxw7 [14, 15]. mTOR was also recently
implicated as a regulator of process extension in addition to myelination in OLs [13].
Thus, we tested the hypothesis that buildup of mTOR was responsible for the phenotypes
observed in cKO nerves. Our analyses showed that total mTOR protein as well as mTOR
mRNA levels are approximately doubled in Fbxw7 mutants. Some key mTOR targets are
also upregulated in cKO sciatic nerves, suggesting that mTOR activity is also elevated.
To directly test for the involvement of mTOR, we produced HetΔmTOR animals in
which deletion of both Fbxw7 and mTOR is driven specifically in SCs. Double transgenic
analysis demonstrated that mTOR is epistatic to Fbxw7 and is responsible for regulation
of early SC numbers, proper radial sorting, and appropriate myelin thickness.

Excitingly, however, loss of mTOR was unable to rescue the multi-axonal myelination or
the ability of a single SC to both make myelin and interact with multiple smaller caliber
non-myelinated axons that were seen in Fbxw7 mutants, suggesting that these phenotypes
are mTOR-independent. Instead, a different Fbxw7 target likely regulates this behavior,
and in the future, it will be very interesting to determine the non-mTOR targets of Fbxw7
in SCs. To our knowledge, a similar phenotype has only been reported once before: upon
pharmacological inhibition of the serine/threonine kinase, Rho-associated coiled-coil
containing protein kinase 1 (ROCK1), single SCs formed multiple Mbp+ internodes in
vitro [38]. However, because these studies were conducted in vitro and axons were not
visualized ultrastructurally in cross-section, it is unclear if ROCK1 inhibition might also
have resulted in the ability of single SCs to interact with multiple small caliber axons
while simultaneously making myelin around larger caliber axons, in addition to the multi-
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axonal myelination described. Under normal conditions, ROCK1 promotes stabilization
of the actin cytoskeleton [39], suggesting that this pathway may be involved in normal
inhibition of excess process extension by SCs. To parse out the potential connection
between Fbxw7 and ROCK1 and confirm the cell fate of these aberrant SCs, further
experimentation is required.

Beyond these interesting cell biological questions, Fbxw7 also represents a possible
therapeutic candidate for patients with myelinating glial deficits. Approximately 2% of
all sarcomas are SC-derived malignant peripheral nerve sheath tumors (MPNSTs) [40],
and about 5% of malignant brain tumors are at least in part OL-derived [41, 42].
Moreover, disruption of myelination is associated with several debilitating neurological
diseases in both the CNS and PNS including multiple sclerosis [43] and peripheral
neuropathies such as Charcot-Marie-Tooth disease (CMT) [44]. Combined, myelinating
glial-derived tumors and myelin-associated neurological diseases affect well more than
half a million Americans ([40]; Multiple Sclerosis Foundation; National Institute of
Neurological Disorders and Stroke; American Brain Tumor Association). Notably,
Fbxw7 is well known as a tumor suppressor and its disruption, or disruption of its targets,
is associated with tumorigenesis in many different cancers [45-47], including glialderived tumors. For example, reduced expression of FBXW7 is both associated with
glioma formation in humans [48] and considered to be a marker of high-grade aggressive
gliomas that have poor prognoses [49]. Overexpression of the Fbxw7 target mTOR is
also a marker of very poor prognosis in MPNSTs [50, 51]. Furthermore, combinatorial
inhibition of mTOR and the proteasome leads to reduced proliferation and increased
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apoptosis in MPNST cells [52]. Finally, transient and partial proteasome inhibition
enhances remyelination in mouse models of demyelination in the CNS [53]. Therefore, in
addition to its potential utility for understanding fundamental questions in myelinating
glial cell biology, Fbxw7 might also be a potential therapeutic option in glial tumors as
well as neurological disorders characterized by demyelination.
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4.5 MATERIALS AND METHODS
4.5.1 Animal husbandry
All animal experiments were performed in compliance with Washington
University’s institutional animal protocols.

Zebrafish: All zebrafish (Danio rerio) stocks were maintained in the Washington
University Zebrafish Consortium facility (http://zebrafish.wustl.edu/husbandry.htm).
Embryos were collected from pair-wise or harem matings and raised in egg water (5 mM
NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4) at 28.5°C. At 5 days post
fertilization (dpf), larvae were transitioned to a rotifer-based diet for approximately 10-14
days before incorporating flake food and flowing water. Traditional morphological
markers were used to stage embryos [54]. For experiments prior to 5 dpf, embryos were
dechorionated manually with forceps. When necessary, pigmentation was prevented in
embryos > 24 hours post fertilization (hpf) by adding 0.003% phenylthiourea (PTU) to
egg water.

Mouse: The Fbxw7 conditional-ready mice (Fbxw7fl/fl) [24] were obtained from Jackson
laboratories (Stock #: 017563) on a pure C57BL/6 background. Fbxw7fl/fl mice were
mated to DhhCre(+) mice [23] that had also been maintained as pure on C57BL/6 (> 7
generations) to generate DhhCre(+);Fbxw7fl/+ (Het) mice. Fbxw7 Hets were backcrossed to
Fbxw7fl/fl animals to obtain cKO mice. For all cKO experiments, we used DhhCre()

;Fbxw7fl/+ or DhhCre(-);Fbxw7fl/fl littermates as controls. For the double mutant

experiments, we obtained mTOR conditional-ready (mTORfl/fl) mice [31] from Jackson
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laboratories (Stock #: 0110009), also on a pure on C57BL/6 background. The mTORfl/fl
mice were crossed with DhhCre(+);Fbxw7fl/fl animals to generate
DhhCre(+);Fbxw7fl/+;mTORfl/+ animals. Finally, to obtain double mutants, we crossed
DhhCre(+);Fbxw7fl/+;mTORfl/+ to DhhCre(-);Fbxw7fl/+;mTORfl/+ animals and analyzed
DhhCre(+);Fbxw7fl/+;mTORfl/fl animals (“HetΔmTOR” for brevity). All mouse lines were
genotyped as previously described [23, 24, 31]. In all cases except the functional
analyses, mice of both sexes were analyzed. In all cases mutants were compared with
littermate sibling controls.

4.5.2 Forward genetic screen
We performed a standard three-generation forward genetic screen in zebrafish
using the chemical mutagen, N-ethyl-N-nitrosourea (ENU) [55]. Briefly, adult wild-type
(WT) (SAT strain) males were mutagenized using 3-3.5 mM ENU over the course of 4-6
weeks, allowed to recover for 1 month, and then crossed to WT (SAT) females, resulting
in the F1 generation. Each F1 individual was then outcrossed to a double transgenic line
[tg(lhx1a:egfp) [56]; tg(mbp:mcherry-CAAX) (kind gift from Dave Lyons, University of
Edinburgh ), on a mixed-strain WT background], which marked a subset of neurons
(lhx1a) and myelinating glia (mbp). This cross produced F2 families, which were raised
together and then intercrossed to drive putative mutations to homozygosity in the F3
progeny. F3 larvae were then screened for homozygous recessive mutations that affected
the level or pattern of transgene expression. Clutches suspected of carrying interesting
mutations were then screened by whole mount in situ hybridization (described below) to
directly assess myelin basic protein (mpb) expression.
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4.5.3 Whole mount in situ hybridization
We used standard protocols [57] to perform whole mount in situ hybridization
(WISH) on zebrafish larvae at 5 dpf. Briefly, embryos were raised in egg water
supplemented with PTU to prevent the development of pigment. Then, at 5 dpf, pools of
25-40 larvae were anesthetized with a low-dose of tricaine and then fixed in 4%
paraformaldehyde (PFA) for 2 hours at room temperature or 4°C overnight with gentle
agitation. Samples were then dehydrated in 100% methanol overnight at -20°C.
Following dehydration, embryos were washed in 0.2% PBS-Tween (PBSTw),
permeabilized with proteinase K (20 mg/µl diluted 1:1000 in 0.2% PBSTw), and
incubated with digoxygenin-labeled riboprobe against either mbp or nkx2.2a overnight at
65°C in hybridization buffer. Following probe treatment, embryos were washed to
remove formamide, and then blocked for at least 1 hour at room temperature in a solution
of 2% blocking reagent made in maleic acid buffer with 0.2% triton (MABTr)
supplemented with 10% normal sheep serum. Samples were then incubated overnight at
4°C in primary antibody (Anti-Dig, Fab fragments (1:2000); Roche, Pleasanton, CA)
diluted in blocking solution, with gentle agitation. Following primary antibody treatment,
embryos were repeatedly washed in MABTr, and developed by alkaline phosphatase
reaction. Embryos were then post-fixed in 4% PFA, passaged through increasing
concentrations of glycerol, and stored long-term in 70% glycerol at 4°C, protected from
light. The mbp [58] and nkx2.2a [59] riboprobes have been previously described. All
scoring was performed blinded to genotype.
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4.5.4 Mapping with whole genome sequencing
After identifying stl64 carriers from the F2 generation (SAT background), we performed
a “map cross” in which putative stl64/SAT animals were crossed to individuals of the SJD
isogenic WT strain [60] in order to increase genomic diversity for mapping. The F3
progeny from this cross were randomly intercrossed to identify new carriers of the stl64
mutation. Once carrier pairs were isolated, we analyzed mbp expression in the F4
generation by WISH at 5 dpf. Larvae were then scored and combined into a sibling or
mutant pool by phenotype (phenotypically WT, N = 30) and a mutant pool
(phenotypically mutant, N = 22). Next, we extracted genomic DNA from each pool using
the DNeasy Blood and Tissue Kit (69504, Qiagen, Valencia, CA). The kit was used as
described with the following modifications: 1) pooled embryos were digested in Buffer
AL plus proteinase K at 56°C, shaking at 220 rpm, for at least 3 hours and 2) DNA was
eluted in 100 ml Buffer AE and incubated at room temperature for at least 1-1.5 hours.

At least 1 µg of genomic DNA from each pool was submitted to the Genome Technology
Access Center (GTAC, Washington University School of Medicine) for indexing and
paired-end sequencing (100 bp) using the Illumina Hi-Seq platform (Illumina, San Diego,
CA). At GTAC, reads were mapped back to the zebrafish genome (Zv9) to call single
nucleotide polymorphisms (SNPs). Using an in-house sequence analysis pipeline
(Sanchez et al., in prep), we then analyzed the ratio of homozygous SNPs in the mutant
versus sibling pool across the genome to find broad regions of linkage (chromosomes).
To identify putative causative SNPs, we performed repeated analyses specifically on the
most highly linked chromosome using varied bin sizes, compared candidate gene lists to
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published literature, and used algorithms such as SIFT (Sorting Intolerant from Tolerant)
(Ng and Henikoff, 2003) to determine if a putative mutation was predicted to be
deleterious.

4.5.5 Morpholino injections
The morpholino targeting fbxw7 has been previously described and validated [12]. For
injections, morpholino was diluted in ultrapure water supplemented with phenol-red dye
(10%) to obtain a final concentration of 2.5 mg/ml. We then injected embryos at or
before the 1-cell stage with 2.5 ng of morpholino in a total volume of 2 nl. To control for
potential adverse effects of the injections, we also injected control siblings with an equal
volume of phenol-red dye diluted 1:10 in ultrapure water. Finally, we scored morpholino
and control-injected animals by mbp WISH. All scoring was blind to treatment.

4.5.6 Genotyping
The fbxw7stl64 mutation was genotyped using the following primers: 5’–
CTCTCCAGTGTGACCAGGTT–3’ and 5’–GCTCTCAGGTCCTCACAAGC–3’, which
amplify a 147 base pair (bp) region surrounding the stl64 lesion. PCR was performed for
40 cycles with an annealing temperature of 55°C. Because the stl64 mutation disrupts an
Hpy188I restriction site, PCR amplicons were digested with the Hpy188I enzyme (New
England Biosciences, Ipswich, MA) for at least 1 hour at 37°C, and then heat inactivated
for 20 minutes at 65°C. Products were loaded into a 2-2.5% agarose gel, and gel
electrophoresis was used to separate digested products. For all zebrafish experiments,
genotypes were determined as follows: a thick band around 75 bp was scored as fbxw7+/+
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(WT), individuals with both uncut and cut products were fbxw7stl64/+, and a single uncut
band at ~147 bp was scored as fbxw7stl64/stl64.

4.5.7 Transmission electron microscopy (TEM)
Zebrafish: TEM was performed on zebrafish larvae at 8.5 dpf using established protocols
[61]. To control for any variability along the anterior/posterior axis, we always examined
larvae between body segments 5-7 and used the head to extract genomic DNA and
genotype. To promote infiltration of the samples, we used a PELCO BioWave® Pro with
SteadyTempTM Digital Plus water-recirculating system to microwave larvae during every
step prior to EPON treatment. In brief, larval trunks were fixed in modified Karnovsky’s
fixative (4% PFA, 2% glutaraldehyde, 0.1M sodium cacodylate, pH 7.4) at least
overnight at 4°C. During this time, larvae were genotyped and individuals with identical
genotypes were pooled into microcentrifuge tubes. Samples were then washed with 0.1M
sodium cacodylate to remove fixative, and post-fixed for 1 hour in 2% osmium tetroxide
in 0.1M sodium cacodylate and 0.1M imidazole. Samples were then washed with
ultrapure water and stained en-bloc with saturated uranyl acetate. Larvae were then
dehydrated using increasing concentrations of ethanol followed by 100% acetone, and
then infiltrated overnight in 1:1 acetone:EPON with gentle agitation at room temperature.
Samples were then transferred to 100% EPON while residual acetone was allowed to
fully evaporate (>4 hours). Finally, individual larvae were embedded in 100% EPON in
small molds and baked at least 48 hours at 65°C. Thin (70 nm) sections were mounted
on copper mesh grids (Electron Microscopy Sciences, Hatfield, PA). Grids were stained
with 8% uranyl acetate for 1 hour, rinsed with ultrapure water, and then stained with
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Sato’s lead stain for 6 minutes. Sections were viewed on a Jeol (JEM-1400) electron
microscope and images were collected using an AMT V601 digital camera. All images
were processed and analyzed using FIJI (Image J) and Adobe Photoshop CS5. In all
cases, the entire posterior lateral line nerve was quantified, and whenever possible, both
nerves were quantified from a single individual. For zebrafish at 8.5 dpf, N = 3 WT (6
nerves), N = 4 fbxw7stl64/+ (7 nerves), and N = 7 fbxw7stl64/stl64 (11 nerves).

Mouse: TEM was performed on mouse sciatic nerves at P3, P21, P42 and 6 months as
described [62]. Briefly, nerves were drop-fixed in modified Karnovsky’s fixative (4%
PFA, 2% glutaraldehyde, 0.1M sodium cacodylate, pH 7.4) at least overnight at 4°C.
Samples were then washed with 0.1M sodium cacodylate to remove fixative, and then
post-fixed for 1 hour in 2% osmium tetroxide in 0.1M sodium cacodylate. Nerves were
then dehydrated with increasing concentrations of ethanol followed by propylene oxide
(PO). Samples were then infiltrated for 1-2 hours in 2:1 PO:EPON, and then overnight in
1:1 PO:EPON with gentle agitation at room temperature. Samples were then transferred
to 100% EPON while residual PO was allowed to fully evaporate (>4 hours). Sectioning,
grid staining, imaging, and image analyses were performed as described for zebrafish.
For all timepoints, four non-overlapping images at 1000X magnification were quantified,
and all mouse TEM data is expressed per 1000 mm2 area. Control genotypes were:
DhhCre(-);Fbxw7fl/+ and DhhCre(-);Fbxw7fl/fl. For P3: N = 4 controls, N = 6
DhhCre(+);Fbxw7fl/+ (Hets), and N = 5 DhhCre(+);Fbxw7fl/fl (cKO). At P21: N = 4 controls,
N = 4 Hets, and N = 4 cKO. For P42 samples: N = 4 controls, N = 3 Hets, and N = 4
cKO. At 6 months of age: N = 5 controls, N = 4 Hets, N = 5 cKO. For the double mutant
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analyses, control genotypes used were: DhhCre(-);Fbxw7fl/+;mTOR+/+ DhhCre()

;Fbxw7fl/+;mTORfl/fl, DhhCre(-);Fbxw7fl/+;mTORfl/+, DhhCre(-);Fbxw7fl/fl;mTORfl/fl, and

DhhCre(-);Fbxw7+/+;mTORfl/fl. Fbxw7 Hets were now DhhCre(+);Fbxw7fl/+;mTOR+/+
littermate siblings, and HetΔmTOR animals were DhhCre(+);Fbxw7fl/+;mTORfl/fl siblings.
At P3: N = 4 controls, N = 6 Hets, N = 5 HetΔmTOR. For P21: N = 6 controls, N = 4
Hets, and N = 3 HetΔmTOR.

4.5.8 Behavioral Studies
Behavior testing was performed using female mice from 5-6 months of age (N = 9
controls, N = 8 cKO). The experimenter was blind to the genotypes of the mice during all
data acquisition. All behavior data was analyzed using a t-test with Welch’s correction to
determine statistical significance.

Gross motor function (Rotarod): As previously described [63], five consecutive trials
were performed on an accelerating Rotarod with a 5 min rest interval between trials.

Locomotor activity (Open field): Prior to testing, mice were habituated to the test room in
their cages for 1 hour. Locomotor activity in an open field [64] was then assessed by
recording photo beam breaks in a 42 (length) × 42 (width) × 30 (height) cm chamber for
60 min using a VersaMax Animal Activity Monitoring System (AccuScan Instruments).
We then calculated the total distance traveled, time spent moving (not shown), and the
horizontal activity (beam breaks) over the entire chamber.
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Movement initiation: To assess movement initiation, we recorded the time it took each
mouse to exit an 18 × 18 cm square (all four paws outside the square) marked on a flat
horizontal surface, as previously described [65].

Complex motor function (Pole Test): We used the Pole Test to evaluate performance of a
complex motor task that requires skilled forelimb use, strength, and balance [64]. Mice
were placed on a vertical metal pole that is 49 cm in height and 0.9 cm in diameter with
the head of the mouse oriented upward. The time required for the mouse to turn around
such that the mouse’s head is oriented downward and the hind limbs are straddling the
pole was recorded. In addition, the time required for the mouse to climb down to the base
of the pole was recorded [65].

Cold sensitivity (acetone evaporation test): Cold sensitivity of the hind paws was
measured by applying a drop of acetone to the plantar surface of the hind paw. Five
separate applications of acetone were applied to each hind paw. For each application, the
mouse was observed for five minutes. The amount of time that the mouse spent shaking,
licking or elevating the hind paw was recorded and summed across all the trials for each
mouse [66].

Gait analysis: We used the Noldus CatWalk XT system to quantify multiple locomotor
and gait parameters including: run speed, stride length, paw print area (mm2), maximum
contact area (mm2), and maximum contact mean intensity (arbitrary units [a.u.]). Briefly,
The mouse voluntarily traverses a meter-long glass plate and its footprints are captured
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by a video camera. CatWalk XT quantifies parameters related to print dimensions and
gait dynamics.

Mechanical sensitivity (Von Frey): The innocuous mechanical thresholds of both hind
paws were assessed with the von Frey Test. Mice were placed in plastic behavior boxes
with open bottoms on a wire mesh. Varying diameter von Frey monofilaments (Stoelting,
Chicago, IL) were pressed against the plantar surface of the hind paw until the filament
bent. The force applied to the hind paw is dependent on the diameter of the filament. The
up/down method described by Chaplan was used to determine the withdrawal threshold
[67].

Heat sensitivity (Hargreaves): Heat sensitivity was evaluated by using a paw thermal
stimulation system in which a source of radiant heat was applied to the plantar surface of
the hind paw and the paw withdrawal latency was measured [68]. We performed 3 trials
on each paw. The withdrawal latencies obtained in each of the 6 trials were averaged to
obtain the withdrawal latency for each mouse.

4.5.9 Electromyography (EMG) Analyses
All animals (N = 9 controls; N = 8 cKO) used for electrophysiological analysis were the
same animals that had been subjected to behavior analyses (described above). Anesthesia
was induced via inhalation of 4% Isoflurane / 96% oxygen and maintained with 2%
Isoflurane / 98% oxygen. To prepare a sterile field, the fur was removed from the dorsal
side of the right hindlimb and the skin was washed with iodine solution. The right sciatic
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nerve was then exposed from the sciatic notch to below the point of trifurcation, distal to
the popliteal artery. A single-channel isolated pulse stimulator (Model 2100, A-M
Systems Inc., Sequim, WA) was used to generate cathodic monophasic electrical
impulses (duration = 50 msec; frequency = single; amplitude = 1 mA) that were delivered
to the sciatic nerve via bipolar platinum/iridium microwire electrodes (Medwire, Mt
Vernon, NY) placed proximally, near the sciatic notch. Resulting EMGs were then
differentially recorded in the tibialis anterior muscle using intramuscular microwire
electrodes (4 mil, California Fine Wire Co., Grover Beach, CA). Measured signals were
band-pass filtered (LP = 1 Hz, HP = 5 kHz, notch = 60 Hz) and amplified (gain = 1,000X
– 10,000X) using a two-channel microelectrode AC amplifier (Model 1800, A-M
Systems Inc., Sequim, WA) before being recorded with a data acquisition board
(DT3003/PGL, Data Translation, Marlboro, MA). EMG traces were digitally recorded
while peak latency and maximal amplitude were calculated using custom Matlab
software (MathWorks Inc., Natick, MA). The average time for impulses to travel the
length of the sciatic nerve to the muscle in controls versus cKO mice is depicted as
average latency (milliseconds) from the end of the stimulus (Figure S2 L).

4.5.10 Whole mount immunofluorescence
For mTOR antibody stains, zebrafish embryos were fixed in 4% PFA in 1X PBS
overnight (4°C), washed in 0.3% Triton-X in PBS (PBSTr) and then blocked for 2 hours
in PBSTr supplemented with 10% normal goat serum and 4% BSA. Embryos were then
incubated overnight at 4°C in primary anti-mTOR antibody (GeneTex, Irvine, CA;
GTX124771) diluted 1:100 in blocking solution. For secondary staining, embryos were
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incubated in Alexa Flour® goat anti- rabbit 488 IgG (Life Technologies, ThermoFisher
Scientific, Waltham, MA) diluted 1:1000 in PBSTr plus 2% normal goat serum overnight
at 4°C. Finally, embryos were washed extensively in PBSTr, the heads were removed for
genotyping, and the trunks were mounted in Vectashield® H-100 (Vector Labs,
Burlingame, CA) for imaging. Imaging was performed on a Zeiss upright
AxioImager.M2 and the accompanying AxioCam MRc digital camera. Images were
acquired at 20X magnification in a stereotyped region in the tail of the fish, using
constant exposure settings. Image processing and analyses were performed in FIJI.
Relative fluorescence was calculated by selecting a fixed area in the background negative
for mTOR stain, setting that area as the fluorescence threshold, and then measuring the
percent area of the image above threshold. All quantifications were performed blinded,
and genotypes were obtained following quantification. N = 6 WT and N = 7
fbxw7stl64/stl64.

4.5.11 Western blot analyses
To assess mTOR protein levels in the sciatic nerve, we dissected nerves from the sciatic
notch to just proximal to the trifurcation. These nerve segments were flash frozen in
liquid nitrogen, cut into small pieces with microdissection scissors, and homogenized in
lysis buffer (20 mm Tris-HCl, pH 7.5, 150 mm NaCl, 1 mm Na2EDTA, 1 mm EGTA,
1% Triton X-100, 2.5 mm sodium pyrophosphate, 1 mm β-glycerophosphate, 1 mm
Na3VO4, 1 µg/ml leupeptin) with phosphatase inhibitor mixtures 1 and 2 (Invitrogen,
ThermoFisher Scientific, Waltham, MA). Equal protein amounts (15 µg) were loaded and
analyzed by SDS-PAGE and western blot. Antibodies used were: anti-mTOR (Cell
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Signaling Technologies, Danvers, MA), and anti-α-tubulin (Abcam, Cambridge, MA).
Western blot images were quantified using FIJI, all bands were normalized to
background and mTOR bands were compared to α-tubulin levels.

4.5.12 RNA isolation and reverse transcription
Total RNA was extracted from flash-frozen P21 mouse sciatic nerves (N=3 DhhCre()

;Fbxw7fl/fl littermate controls and N=3 DhhCre(+);Fbxw7fl/fl cKO animals), using a

standard TRIzol extraction protocol (Life Technologies, ThermoFisher Scientific,
Waltham, MA). Briefly, TRIzol was added to the frozen tissue samples, which were then
allowed to thaw at room temperature for 10 min. During this incubation time, and while
still in TRIzol, nerves were cut into much smaller pieces using micro-dissection scissors.
Samples were homogenized via disruption with a plastic-tipped electric homogenizer,
followed by passage through syringe and 22.5g needle at least ten times, and then a 27g
needle at least ten more times until no lumps of tissue were observed. Once the nerves
had been homogenized, we proceeded as usual with the standard TRIzol RNA extraction
procedure as per manufacturer instructions.

Total RNA (500 ng) was then reverse transcribed in 20 ml using the Superscript III First
Strand cDNA Synthesis Kit (Invitrogen, ThermoFisher Scientific, Waltham, MA) using
random hexamers, as per manufacturer instructions. All cDNA products were diluted 1:5
prior to use in qPCR reactions.
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4.5.13 Quantitative reverse transcription PCR
To assay mRNA expression levels of mTOR and members of the mTOR signaling
pathway, we used the RT2 Profiler PCR Array for Mouse mTOR Signaling (Qiagen,
PAMM-098ZA, Valencia, CA). A complete gene list can be found on the manufacturer
website. All assays were performed on a ViiA7 Real-Time PCR system (Applied
Biosystems, ThermoFisher Scientific, Waltham, MA), in a total volume of 10ml using 2X
SsoFast Evagreen Supermix (BioRad, Hercules, CA) and 50 ng of cDNA per reaction.
Standard qPCR settings were used: 95°C for 10 min followed by 40 cycles of 95°C for 15
seconds (sec) then 60°C for 30 sec, followed by melt curve analysis. As suggested by the
RT2 profiler manual, we adjusted the ramp rate to 1°C/sec. All controls including
housekeeping genes, positive controls for amplification, and controls for genomic DNA
contamination were included as standards in the array.

qPCR data was analyzed using Microsoft Excel. Relative expression was calculated using
the ΔΔCt method [69]. Genomic contamination was negligible in all samples. To control
for input variations, ΔCt was calculated by comparing the Ct of each gene of interest
(GOI) to the average Ct of the 5 housekeeping genes (Actb, B2m, Gapdh, Gusb,
Hsp90ab1) for that sample. ΔΔCt was then calculated relative to expression compared to
that seen in the littermate control. Average relative expression (RQ), or fold change (2ΔΔCt), over controls is shown in Figure 6. All error bars depict RQmax and RQmin,
which represent the maximum and minimum limits of possible RQ values based on the
standard error of the ΔCt values. The grey line at y = 1 represents the controls.
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4.5.14 Statistical Analyses
All data are reported as mean + standard deviation (S.D.). Statistically significant
differences were determined using one-way ANOVA for all experiments with more than
two groups but only one dependent variable. Similarly, two-way ANOVA was used for
experiments with multiple groups and two dependent variables. All experiments with
only two groups and one dependent variable were compared using an unpaired t-test with
Welch’s correction, which assumes unequal variance. Figure legends specify which test
was used for specific experiments. Actual p-values are provided either within the figure
panels or the figure legends. In all cases * = p<0.05; ** = p < 0.01; *** = p<0.001; and
**** = p<0.0001; NS = not significant. When there was not enough room in the panel to
show the actual p-value, a “#” symbol was used to highlight data that was trending
towards significance (p<0.1). In all cases, asterisks immediately above a bar indicate the
significance of that sample relative to the control sample. If any other comparisons, such
as Het to cKO, were significant, this is indicated with a bar spanning above the two
samples being compared and the appropriate asterisks. If not indicated otherwise, the
comparison was not significant. In most cases, Het samples were not statistically
distinguishable from cKOs (see figure legends for p-values).
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4.6 FIGURES

Figure 1: stl64 introduces a premature termination codon in fbxw7, resulting in mbp
overexpression. Dorsal view of zebrafish larvae at 5 dpf showing mbp expression by
WISH (purple color). stl64 mutants display dramatic overexpression of mbp compared to
their siblings (A). WGS analysis of mutant/sibling allele ratios shows the stl64 lesion is
tightly linked to chromosome 1 (B, red arrow). The most highly linked region was ~1Mb,
and the only non-synonymous mutation in that region introduced a premature STOP in
the gene fbxw7 (C). The stl64 lesion is a C/A transition that disrupts an Hpy188I
restriction site, allowing easy genotyping (D). Although quite late in the protein (E), the
stl64 mutation is expected to truncate Fbxw7 in the highly conserved 7th WD-repeat (F).
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Figure 2: fbxw7stl64 zebrafish mutants display increased SC number and enhanced
PNS myelin thickness. TEM analyses of cross-sections through the pLLn between
segments 5-7 at 8.5 dpf. Relative to their WT siblings (A), fbxw7stl64/+ (B) and
fbxw7stl64/stl64 (C) animals have more SC nuclei per nerve (D) as well as an increase in the
percentage of myelinated axons (E). Myelinated axons are pseudocolored in red; white
“N” denotes a SC nucleus (A-C). fbxw7 heterozygous (G, G’) and homozygous mutant
(H, H’) SCs also generate more myelin wraps per axon (I) than WT SCs (F, F’). Blue
arrows indicate a myelin wrap (F’, G’, H’). There was no change in total axon number
across genotypes (J). Error bars depict S.D. N = 3 WT (6 nerves), N = 4 fbxw7stl64/+ (7
nerves), and N = 7 fbxw7stl64/stl64 (11 nerves). Statistics were measured by one-way
ANOVA; * = p < 0.05, ** = p < 0.01, *** = p < 0.001. NS = not significant. Asterisks
immediately above samples indicate comparisons to WT, all comparisons between
stl64/+ and stl64/stl64 samples were NS.
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Figure 3: Fbxw7 is a conserved cell autonomous regulator of SC number and myelin
thickness. RT-PCR shows that Fbxw7 mRNA is significantly reduced in sciatic nerves of
DhhCre+/Fbxw7fl/fl cKO compared to DhhCre-/Fbxw7fl/fl controls at P21 (A). TEM analyses
demonstrate that at P3 and P21 (A-K), SC-specific deletion of Fbxw7 results in increased
SC number (E, J) and percentage of myelinated axons (F, K) in both Hets and cKOs
compared to littermate controls. However, by P42 (L-P), both of these phenotypes have
been resolved (O, P). Loss of Fbxw7 in SCs also results in thicker myelin as evidenced by
decreased g-ratios (Q-T), especially on small diameter axons (T). For P3: N = 4 control,
N = 6 Het, and N = 5 cKO. At P21: N = 4 control, N = 4 Het, and N = 4 cKO. For P42
samples: N = 4 control, N = 3 Het, and N = 4 cKO. Error bars depict S.D. Statistics were
measured by one-way ANOVA for all measures except g-ratio, where we used two-way
ANOVA in order to compare by both genotype and axon diameter; * = p < 0.05, ** = p <
0.01, *** = p < 0.001. NS = not significant. Asterisks immediately above samples
indicate comparisons to controls, all comparisons between Het and cKO samples were
NS unless otherwise indicated.
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Figure 4: Loss of Fbxw7 results in enhanced segregation of axons and enhanced
myelination capacity of SCs. Ultrastructural analyses show that loss of Fbxw7 results in
increased segregation of axons during radial sorting (P3; A-E), as measured by decreased
average number of axons/bundle (D), as well as the percentage of bundles having 5 or
fewer axons (E). This phenotype persists until at least 6 months of age (P150-P180; F-J).
Also, Fbxw7 mutant SCs display aberrant SC-axon interactions as early as P3 continuing
until at least P180 (K-T). Mutant SCs myelinate multiple axons simultaneously in both
Hets and cKOs (L, N, R). Similarly, loss of Fbxw7 resulted in SCs being able to both
generate myelin as well as extend processes to encompass small caliber non-myelinated
axons (M, Q). There was a continuous basal lamina (green arrows) around these cells and
their processes (Q, inset), and it was the outer cytoplasmic pocket that extended these
additional processes (S). For P3: N = 4 control, N = 6 Het, and N = 5 cKO. At 6 months
of age: N = 5 controls, N = 4 Hets, N = 5 cKO. Error bars depict S.D. Statistics were
measured by one-way ANOVA; * = p < 0.05, ** = p < 0.01, *** = p < 0.001. NS = not
significant. Asterisks immediately above samples indicate comparisons to controls, all
comparisons between Het and cKO samples were NS unless otherwise indicated.
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Figure 5: Fbxw7 mutant Remak SCs inappropriately wrap axons and encompass
collagen fibrils and basal lamina trails. Although not observed at earlier stages, at 5-6
months, Fbxw7 mutant Remak SCs displayed several types of abnormalities by TEM (AD). SC pockets often contained collagen fibrils (B, B’) or trails of basal lamina (B, B’’,
green box). Green arrows denote basal lamina. Loss of Fbxw7 also resulted in excess
wrapping of non-myelinated axons (C). Although not as frequent, we also observed
myelinating SCs joined to other axons by basal lamina trails (E), “onion bulbs” of basal
lamina (F), as well as SCs with no apparent axonal contact that still secreted a basal
lamina (G). N = 5 controls, N = 4 Hets, N = 5 cKO. Error bars depict S.D. Statistics were
measured by one-way ANOVA; **** = p < 0.0001.
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Figure 6: mTOR and its downstream targets are misregulated in Fbxw7 mutants.
Loss of Fbxw7 results in a buildup of total mTOR protein in both zebrafish fbxw7stl64
mutants (A-C) and cKO mice (D-E). Whole-mount immunofluorescence at 5 dpf shows
that mTOR levels are ~2-fold higher (C) in fbxw7stl64 (B) relative to WT siblings (A), as
measured by the percent area above a background fluorescence threshold. Similarly,
western blot analyses of sciatic nerve lysates indicate a similar 2X increase in mTOR
protein in cKO nerves compared to littermate controls, when normalized to both
background and alpha-tubulin levels (D, E). mTOR mRNA is also upregulated in cKO
nerves (F), as are multiple mTOR targets. The gray line at y = 1 denotes control levels. N
= 10 WT, N = 8 fbxw7stl64/stl64. For westerns: N = 3 controls, N = 3 cKO at P42. For
qPCR, N = 3 control and 3 cKO at P21. Error bars depict S.D. Statistics were measured
by one-way ANOVA; # = p < 0.1, * = p < 0.05, ** = p < 0.01.
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Figure 7: Genetic inhibition of mTOR suppresses the SC number, radial sorting, and
myelin thickness phenotypes in Fbxw7 mutant nerves. Fbxw7 Hets display greater
numbers of SC nuclei as well as a higher percentage of myelinated axons relative to
controls (A, B). Loss of mTOR within the context of Fbxw7 deletion (HetΔmTOR; C)
suppresses both of these phenotypes (D, E). Similarly, at P21, deletion of mTOR
suppressed the radial sorting defects observed in Het nerves (F-J). HetΔmTOR sciatic
nerves also resembled SC-specific mTOR single mutants in displaying markedly thinner
myelin (increased g-ratios) relative to both control and Het siblings (K). For P3: N = 4
controls, N = 6 Hets, N = 5 HetΔmTOR. For P21: N = 6 controls, N = 4 Hets, and N = 3
HetΔmTOR. Error bars depict S.D. Statistics were measured by one-way ANOVA for all
measures except g-ratio, where we used two-way ANOVA in order to compare by both
genotype and axon diameter; * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p <
0.0001.
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Figure 8: Fbxw7 control of SC myelination capacity is independent of mTOR.
mTOR deletion in Fbxw7 mutant nerves failed to suppress the aberrant SC-axon
interaction phenotypes (A-D). We observed multi-axonal myelination (B) as well as
aberrant process extensions by SCs that generated myelin (C) in both Het and
HetΔmTOR nerves. Continuous basal laminae (B’, C’; green arrows) supports the
conclusion that these behaviors were the acts of single SCs. We also observed these
phenotypes in the single cKOΔmTOR animal analyzed (E, E’). SC nuclei are
pseudocolored in purple. Error bars depict S.D. Statistics were measured by one-way
ANOVA; *** = p < 0.001. P3: N = 4 controls, N = 6 Hets, N = 5 HetΔmTOR, N = 1
cKOΔmTOR.
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Figure 9: Fbxw7 orchestrates many aspects of SC biology via mTOR-dependent and
–independent mechanisms. Artistic renditions of the various phenotypes observed in
Fbxw7 mutant SCs (images on right) as compared to WT SCs (images on left). Fbxw7 is
involved in radial sorting (top), as well as both mature myelinating SCs (middle) and
Remak SCs (bottom). A simplified PI3K/mTOR pathway shows that in SCs, Fbxw7 is a
key direct inhibitor of mTOR, and therefore a critical regulator of multiple aspects of SC
biology. Fbxw7 also targets many other proteins that are essential for cellular processes,
and one of these as yet unknown targets is responsible for controlling the myelination
capacity of SCs. Steps in the pathway that were not demonstrated in this study are shown
in gray. Pencil sketches by BLH.
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4.7 SUPPLEMENTARY FIGURES

Figure S1: stl64 mutants phenocopy CNS phenotypes seen in fbxw7vu56 mutants.
stl64 mutants display more nkx2.2a+ cells in the dorsal spinal cord relative to their WT
siblings at 65 hpf (A,B). TEM analysis of the ventral (C-F) and dorsal (G-J) spinal cord at
8 dpf shows that fbxw7stl64 mutants have more myelinated axons in the dorsal spinal cord
(I) and thicker myelin in both regions (F, J). Transient morpholino knockdown of fbxw7
in WT embryos results in mbp overexpression at 65 hpf compared to control-injected
siblings (K, L). Error bars are S.D. ** = p < 0.01, *** = p < 0.001
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Figure S2: Loss of Fbxw7 causes mild motor and sensory deficits. A battery of
sensory and motor tests (A-K) showed that in female mice at 5-6 months, loss of Fbxw7
results in only mild behavioral changes. Motor tests included: accelerating rotarod (A),
open field (B,C), movement initiation (D), the pole test (E,F), and gait analyses (G,H).
Mice were also tested for possible hypersensitivity to mechanical stimuli (I), heat (J), and
cold (K). Electromyography analyses demonstrated that Fbxw7 mutant nerves do not
display dramatic differences in nerve conduction (L). Error bars are S.D. N = 9 controls,
N = 8 cKO. * = p < 0.05, ** = p < 0.01. Actual p-values displayed for all tests.
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Chapter 5
Conclusions and future directions
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5.1 SUMMARY
Glia are essential partners to neurons in both the CNS and PNS, yet far less is known
about glia relative to neurons. There are many different types of glia that perform a vast
array of critical functions including physical support of axons and synapses, insulation of
electrical impulses, provision of nutrients to neurons, and clearance of pathogens and
cellular debris [1, 2]. Oligodendrocytes (OLs) and Schwann cells (SCs) are particularly
interesting glial cells as they generate the myelin sheath by iteratively wrapping their
plasma membranes around axon segments [3, 4]. Myelination serves to increase the
conduction velocity of action potentials and provide trophic support that is vital for
neuronal survival. Although these cell types co-evolved and therefore use overlapping
sets of genes to follow similar developmental paradigms, there are some key differences
between OLs and SCs that we do not understand, including but not limited to: polarized
secretion of a basal lamina, differences in myelination capacity, signals dictating which
axons will be myelinated, and capacity to remyelinate after injury. Here, I describe our
efforts using both candidate and unbiased approaches to identify novel genetic regulators
of myelinating glial cell development in the hopes of bridging some of these knowledge
gaps.

5.2 ADHESION GPCRs AS CANDIDATE REGULATORS OF MYELINATION
From extensive work in both zebrafish and mouse mutants, we know that the adhesion
GPCRs, Gpr126 and Gpr56, are critical regulators of myelinating glial cell development,
myelination, and myelin repair (Appendices A and B). Recent studies from our lab and
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others have demonstrated that aGPCRs are incredibly complex and multifaceted proteins
with the potential to play many different roles in a highly context-dependent manner.
Given that myelinating glia undergo extensive self-adhesion and must coordinate
signaling through many layers of membrane, we hypothesized that other aGPCRs may
also be important in myelinating glial development and myelination. Therefore, we
sought to define the genetic repertoire and expression profiles of all aGPCRs in zebrafish,
throughout development and in many adult tissues, including those enriched for
myelinating glia.

5.2.1 Defining the zebrafish aGPCR repertoire
Mining the zebrafish genome revealed that zebrafish possess at least 59 adhesion GPCRs
(aGPCRs), which is nearly twice the number found in humans (33) or rodents (31) [5].
Importantly, we found that 24 of the 33 human aGPCRs had clear homologs in zebrafish
(Chapter 2; Figure 1). We noted several differences in zebrafish, such as the fact that
many of the aGPCRs were present in multiple copies, which is likely due to the teleostspecific genome duplication event as well as multiple tandem-duplication events specific
to zebrafish. Specifically, groups II and VI stood out as being distinctly different in
zebrafish. Group II aGPCRs include EMR1-4 and CD97 in humans, which play critical
roles in modulating various immune cells. However, this group has undergone a
zebrafish-specific expansion, and thus contains 14 Emr-like proteins and 4 duplicates of
Cd97. Future experiments should be done to understand the structural differences
between the zebrafish duplicates and mutant analyses may inform the functional
consequences of maintaining so many gene duplicates, or if some of these duplicates are
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in fact pseudogenes.

Group VI, which contains GPR110, GPR111, GPR113, GPR115, and GPR116 in
humans, was also quite different in zebrafish. The only member of this group with a clear
homolog in zebrafish was GPR113. GPR110 and GPR116 had potential homologs listed
as “gpr110-like” and “gpr116-like” in GenBank, however our phylogenetic analyses of
the 7TM regions could not confidently call these genes homologs of human GPR110 and
GPR116. However, the two members of this group that were definitely absent, with no
sequence similarity present in the zebrafish genome, were GPR111 and GPR115.
Interestingly, GPR111 and GPR115, which are highly expressed in the skin, did not
appear until the evolution of terrestrial mammals [6], suggesting a potential role for these
proteins in epithelial development. One intriguing experiment might be to transgenically
express mammalian GPR111 and/or GPR115 in the zebrafish lineage and assess the
consequences on epithelial development.

For those aGPCRs with clear zebrafish homologs, we showed that the expression profiles
of zebrafish aGPCRs closely resemble those of mammalian aGPCRs in most adult tissues
(Chapter 2; Figures 3-14). We also characterized the expression of zebrafish aGPCRs in
whole embryos throughout zebrafish development, and found that nearly all aGPCRs are
expressed both maternally and zygotically, suggesting that these genes are likely
important throughout early development (Chapter 2; Figure 15).

5.2.2 Other aGPCRs in myelinating glia

177

Finally, we also analyzed the expression of all zebrafish aGPCRs in tissues enriched for
myelinating glia (Figure C1). Here, we found that many other aGPCRs are enriched in
both CNS and PNS myelinated tissues; and interestingly, many of these are more highly
expressed in these tissues than Gpr126 and Gpr56. We tested several of these and showed
that they are also expressed in mouse sciatic nerves (Figure C2), suggesting that aGPCR
expression in myelinating glia is conserved in mammals. Unfortunately, analyses of
targeted mutants in three other aGPCRs - gpr97, gpr64a, and gpr133 – have thus far
yielded no insights into myelinating glial cell development (Harty and Monk,
unpublished data). However, a few key points should be noted: 1) I have not yet
performed TEM on these alleles at any time point, and this is really the gold standard
experiment for assessing myelin integrity; 2) gpr64 is duplicated in zebrafish, and while
gpr64b was not expressed in myelinating glia-rich tissues, it is possible that gpr64b is
capable of compensating upon loss of gpr64a; and 3) the expression profiles obtained by
qPCR were from adult tissues, not developing tissues, therefore an aGPCR may be
required for myelin maintenance but not during development, and vice versa. Therefore,
without extensive characterization, it is premature to assume that any of these aGPCRs
are dispensable in myelinating glia.

Together, our data suggest that zebrafish should continue to be a useful model in studying
aGPCR evolution and function in a variety of cellular contexts, especially in myelinating
glia. Future work should focus on carefully assessing mutants that have been generated,
as well as generating and characterizing additional loss-of-function mutations in aGPCRs
expressed in myelinating glia.
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5.3 SCREENING UNVEILS FBXW7 AS A NEW PLAYER IN SCs
We conducted a large-scale forward genetic screen in zebrafish for mutations that affect
myelinating glial development (Chapter 3). From this effort, we recovered many new
mutations, including stl64, which display dramatic increases in the expression of myelinrelated genes and hypermyelination in both the CNS and PNS (Chapter 4; Figures 1, 2,
S1). Using whole genome sequencing, we determined that stl64 disrupts fbxw7, which
encodes Fbxw7. Fbxw7 is the substrate recognition of E3 ubiquitin ligase complexes that
are responsible for catalyzing the addition of ubiquitin moieties to proteins to mark them
for degradation by the proteasome (Chapter 1; Figures 4 and 5). Some of the most notable
Fbxw7 targets are master regulators of transcription and cell cycle including: mTOR, cMyc, c-Jun, Notch, and cyclin E. Thus, Fbxw7 function is required for critical cellular
processes such as proliferation and differentiation.

Previous work in another zebrafish mutant (fbxw7vu56) has shown that Fbxw7 is required
for proper OL development and myelination through its regulation of Notch [7] and
mTOR [8]. Importantly, we found that stl64 mutants phenocopied the various CNS
defects observed in fbxw7vu56 mutants, further supporting fbxw7 as our causative gene.
For example, in addition to overexpression of mbp (Chapter 4, Figure 1), stl64 mutants
display an increase in the expression of two OPC markers, sox10 and olig2 (Figures F4
and F5). Further, TEM analysis revealed enhanced myelin thickness in stl64 mutant
spinal cords relative to sibling controls (Chapter 4; Figure S1). However, the PNS was
not analyzed in fbxw7vu56 mutants; therefore, we asked if Fbxw7 might also play a role in
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SCs. Here we show that Fbxw7 limits SC development and myelination in part through
its regulation of mTOR.

5.3.1 Fbxw7 regulates SC number
In both zebrafish and mouse Fbxw7 mutants, we showed that SC numbers were increased
in the PNS (Chapter 4; Figures 2 and 3). TEM analyses showed more SC nuclei per
nerve, in addition to an increased percentage of myelinated axons without a
corresponding increase in the number of axons. To determine if the excess SCs were due
to a decrease in cell death, we incubated fbxw7stl64 mutants in acridine orange, and found
that cell death was not changed in mutants relative to controls (Figure F6). Another
possibility is of course that loss of Fbxw7 may result in enhanced SC proliferation. Thus
far, our attempts to assess SC proliferation in fbxw7stl64 mutants have been inconclusive
(data not shown), therefore future experiments assessing SC proliferation in both
zebrafish and mouse Fbxw7 mutants are essential.

Finally, our marker analyses revealed that fbxw7stl64 mutants display reduced oct6
expression in both the PNS and CNS (Figure F7). As mentioned in Chapter 1, oct6 is
transiently upregulated during SC development to allow pro-myelinating SCs to fully
mature and turn on myelin gene expression in order to generate myelin. Many mutants
that display PNS hypomyelination also display decreased oct6 expression. Therefore,
initially a reduction in oct6 levels may seem contradictory to our other data; however it is
important to remember that oct6 expression is transient in SCs [9]. One possible
explanation for reduced oct6 expression would be an increased rate of SC differentiation
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in fbxw7 mutants. After a SC has differentiated, oct6 is downregulated, and in fact,
sustained oct6 expression is detrimental to SC development. Therefore, if loss of fbxw7
speeds up SC differentiation relative to wild-type controls, you might expect to see fewer
oct6+ cells in mutants than in controls at the identical developmental stage. Interestingly,
this hypothesis potentially agrees with our previous findings that, at least in mouse
Fbxw7 mutants, control nerves eventually “catch-up” to their mutant siblings in SC
numbers (Chapter 4; Figure 3). In contrast, preliminary data suggests that aged
fbxw7stl64/+ mutant nerves in zebrafish may still display increases in SC number (Figure
F3). Therefore, it is possible that this increase in SC number with advanced age may be
related to a second wave of SC proliferation. Future work to determine if mutant SCs are
indeed differentiating before their wild-type counterparts should include a TEM timecourse in fbxw7stl64/+ mutants, additional marker analyses in both zebrafish and mouse
mutants, and time-lapse imaging of SC development.

5.3.2 Loss of Fbxw7 results in enhanced axon segregation and thicker PNS myelin
Zebrafish fbxw7stl64 mutants display an increase in the number of myelin wraps per axon
(Chapter 4; Figure 2). Similarly, g-ratios were smaller in mouse Fbxw7 cKO nerves,
showing that myelin thickness is enhanced in mutants. Interestingly, this phenotype was
most pronounced on small diameter axons, which is a characteristic observed in other
hypermyelination mutants [10, 11]. However, the cause of this bias is unknown. It is
important to note that most PNS myelination studies in mouse utilize the sciatic nerve as
it is large and easy to obtain. The sciatic is a mixed nerve though, meaning it contains
both motor and sensory axons. It has been hypothesized that the smaller diameter axons
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may be primarily sensory axons; however this has not been carefully assessed. Given the
motosensory behavioral deficits we observed in Fbxw7 cKO animals (Chapter 4; Figure
S2), it would be interesting to determine if there is some bias towards hypermyelination
of sensory versus motor axons or vice versa.

We also found that loss of Fbxw7 results in enhanced radial segregation of unmyelinated
axons from early radial sorting stages into adulthood (6 months) (Chapter 4; Figure 4).
Importantly, SC numbers are no longer increased after P42, suggesting that the decreased
bundle size is not due simply an abundance of SCs. This phenotype is potentially
explained by the fact that loss of Fbxw7 also causes myelinating SCs to encompass
multiple axons, some of which do not get myelinated (see section 5.4 below). Therefore,
the pool of small caliber axons to be sorted by Remak SCs would be smaller than in
nerves where each myelinating SC is only interacting with a single axon.

5.3.3 Fbxw7 regulates mTOR to orchestrate some aspects of SC development
Importantly, the hypersegregation and hypermyelination phenotypes we observe in
Fbxw7 cKO nerves are reminiscent of those seen in Pten loss-of-function mutants [10,
12] and in mutants in which Akt is constitutively active in SCs [11]. In both cases,
signaling through the PI3K/mTOR pathway is elevated. Therefore, we hypothesized that
the PI3K/mTOR signaling axis was disrupted in Fbxw7 mutants. Since it is well
established that mTOR is a bona fide target of Fbxw7 in other contexts, including in OLs,
we tested the hypothesis that Fbxw7 regulates mTOR to control SC biology.
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We found that mTOR levels are increased at both the mRNA and protein levels in both
zebrafish and mouse Fbxw7 mutants (Chapter 4; Figure 6). Pharmacological inhibition of
mTOR using a low dose of rapamycin suppressed the myelin thickness phenotype in
fbxw7stl64 mutants (Figure F2). Similarly, genetic removal of mTOR in Fbxw7 cKO
nerves resulted in opposing phenotypes similar to those seen in SC-specific mTOR
mutants, including restored SC numbers, delayed radial sorting, and hypomyelination
[13, 14]. This suggests that mTOR is epistatic to Fbxw7, and confirms that Fbxw7
controls mTOR levels to limit SC myelination. Although this data is not surprising given
our previous understanding of the importance of mTOR in SC development and
myelination, it is a key contribution to the field as it corroborates these other studies and
fits Fbxw7 into this pathway. Suprisingly, however, is that while mTOR is essential for
controlling myelin thickness, it is not involved in the myelinating capacity of SCs (i.e. the
number of axons a SC can myelinate) (Chapter 4; Figure 8, see section 5.4)

5.4 FBXW7 AS A TOOL FOR UNDERSTANDING SC-AXON RATIOS
Intriguingly, one of the key factors distinguishing a myelinating SC from a myelinating
OL is the restriction of a SC to myelinate a single axon as opposed to an OL, which can
myelinate up to 40 axon segments simultaneously. The mechanisms required for this
distinction in myelination capacity are unknown. Similarly, non-myelinating SCs are
capable of extending processes and interacting with many axons at once; however, these
cells never proceed to make compact myelin, and the molecular factors preventing
myelination by Remak SCs are also mysterious. Here we have shown that loss of Fbxw7
results in multi-axonal myelination by SCs. Mutant SCs are also capable of myelinating
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some axons while simultaneously ensheathing multiple unmyelinated axons in a fashion
similar to Remak SCs (Chapter 4; Figure 4). While Fbxw7 regulation of mTOR is clearly
critical for many other aspects of SC development and myelination, SC myelination
capacity is independent of mTOR signaling (Chapter 4; Figure 8).

To our knowledge, this is the first report of multi-axonal myelination by SCs in vivo.
When the serine/threonine kinase, Rho-associated coiled-coil containing protein kinase 1
(ROCK1), is inhibited in cultured SCs, single SCs formed multiple Mbp+ internodes as
assessed by immunostaining [15]. Since ROCK1 normally promotes stabilization of the
actin cytoskeleton [16], it follows that this pathway may be required for regulating
process extension in SCs. As an E3 ubiquitin ligase, Fbxw7 should be a negative
regulator of its targets. Therefore, given the enhanced myelinating capacity of SCs upon
loss of Fbxw7, we would expect to see a buildup of factors that normally promote
cytoplasmic extrusion and process extension. If the ROCK1 signaling cascade is
responsible for maintaining the typical SC-axon ratio, this suggests that Fbxw7 may
normally directly or indirectly inhibit a key ROCK1 inhibitor, such that loss of Fbxw7
results in greater ROCK1 inhibition, thereby promoting process extension. Not mutually
exclusive with this model, Fbxw7 could also target a component downstream of ROCK1.
Although it seems unlikely, as we know of no precedent in other F-box proteins, it is also
technically possible that Fbxw7 is capable of functioning completely independently of its
role as a member of the E3 ubiquitin ligase complex.

Our data show that SCs are capable of myelinating multiple axons in vivo, and challenge
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the notion that the ability of a SC to extend multiple processes (e.g., Remak SC behavior)
is mutually exclusive with the capacity to make myelin. The multi-axonal myelination
observed in Fbxw7 mutants is reminiscent of an OL’s ability to simultaneously extend
multiple cytoplasmic processes that go on to myelinate multiple axon segments. Remak
SCs are also capable of extending multiple processes, but they do not make myelin under
normal circumstances. However, upon loss of Fbxw7, single SCs gain the ability to both
generate myelin around some axons, as well as encompass multiple non-myelinated
axons as well. Perhaps Fbxw7 plays a role in inhibiting the myelination capacity of SCs
by limiting the extent to which they can generate multiple processes, thus restricting
myelinating SCs to a single axonal segment. Further, it is possible that myelination could
be the default state for all SCs and Fbxw7 regulation is required for preventing Remak
SCs from myelinating their axons. Although the fact that the inappropriately interacting
SCs generate basal lamina suggests that they are indeed SCs and not OLs, future work
should include analyzing OL markers in Fbxw7 mutant nerves to confirm this. If these
are indeed SCs as we suspect, it is still unclear whether these cells should be defined as
aberrant myelinating SCs or rogue Remak SCs. Therefore, future work should also
include marker analyses for both fates as well as careful, potentially single-cell,
transcriptomic and proteomic profiling. Although much more work is required, we
believe Fbxw7 could be a useful tool in dissecting the still mysterious mechanisms that
distinguish SCs from OLs, and/or those separating Remak SCs from myelinating SCs.

5.5 FINAL THOUGHTS
The importance of myelination is emphasized by the fact that damage to or loss of this
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insulation leads to debilitating symptoms in many neurological disorders in humans. For
example, in multiple sclerosis, OL myelin is attacked and destroyed by the body’s
immune system [17]. BFPP patients present with white matter abnormalities; perhaps
GPR56 represents a new candidate target to modulate OL differentiation in the CNS.
Similarly, GPR126 may represent a viable target for patients with peripheral nerve
disease as this aGPCR is required for proper myelin gene expression in humans [18].
Further, mutations in LAMA2, which encodes the α2 chain of the Gpr126 binding partner
laminin-211, cause merosin-deficient congenital muscular dystrophy (MDC1A) in
humans, and 80% of these patients present with a dysmyelinating neuropathy [19-21].
Similarly, like all other cell types, myelinating glia are at risk of the mutations and
cellular changes that can lead to tumorigenesis. Importantly, CNS tumors are the most
common type of cancer in children and adolescents 0-20 years old, and are the second
leading cause of cancer-related deaths in all children 0-19 years of age and of males 2039 years of age [22]. Approximately 80% of all brain tumors are glial-derived [23], and
although relatively rare compared to other gliomas, approximately 1,000 Americans a
year are diagnosed with oligodendrocyte-derived brain tumors (American Brain Tumor
Association). In the PNS, MPNSTs affect more than 3,000 Americans every year [24].
Unfortunately, in both the CNS and PNS, the molecular mechanisms underlying
formation of glial tumors as well as the factors that influence tumor progression and
resistance to some treatments are poorly understood. We also lack effective therapies to
prevent demyelination and/or promote remyelination in disease and injury.
Understanding the molecular mechanisms that govern myelinating glial cell development,
myelination, and remyelination thus has direct consequences for human health.
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GPCRs are the most widely studied targets for the development of pharmacological
drugs. Therefore, studying aGPCRs is highly pertinent to increase our understanding of
these receptors in the context of human neurodevelopmental and myelin diseases and to
find efficient treatments for human disorders. Similarly, Fbxw7 and its targets have been
repeatedly implicated in glial tumorigenesis and progression. Reduced expression of
Fbxw7 and upregulation of the transcription factor, and Fbxw7 target, c-Myc are
associated with the formation of glioblastomas in humans [25]. These signatures are also
considered to be markers of high-grade aggressive gliomas, which have poor prognoses
[26]. In the PNS, overexpression of the Fbxw7 target mTOR is observed in MPNSTs and
is a marker of very poor prognosis [27, 28]. Furthermore, combinatorial inhibition of
mTOR and the proteasome leads to reduced proliferation and increased apoptosis in
MPNST cells [29]. Additionally, transient and partial inhibition of the proteasome
enhances remyelination in mouse models of CNS demyelination [30]. Combined with the
knowledge that Fbxw7 regulates both SC and OL development and myelination, these
data suggest that pharmaceutical manipulation of Fbxw7 and/or its targets might
represent an excellent therapeutic option in myelinating glia-derived tumors as well as in
neurological disorders characterized by demyelination.
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Appendix A
Adhesion GPCRs as novel actors in neural and glial
cell functions: from synaptogenesis to myelination
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A.1 ABSTRACT
Adhesion G protein-coupled receptors (aGPCRs) are emerging as key regulators of nervous
system development and health. aGPCRs can regulate many aspects of neural development,
including cell signaling, cell-cell and cell-matrix interactions, and potentially, mechanosensation.
Here, we specifically focus on the roles of several aGPCRs in synapse biology, dendritogenesis,
and myelinating glial cell development. The lessons learned from these examples may be
extrapolated to other contexts in the nervous system and beyond.

A.2 INTRODUCTION
The nervous system contains a multitude of complex cell-cell and cell-environment interactions.
Neural cells – neurons and glia – utilize a battery of electrical, chemical, and mechanical signal
transduction methods to rapidly transmit information across the nervous system and to other cells
throughout the organism, often over very long distances. To do this, neurons and glia maintain
close associations with one another to allow constant communication within individual cells,
between cells and their extracellular matrix (ECM).

The adhesion G protein-coupled receptor (aGPCR) family regulates many cellular processes in a
wide variety of cell types and contexts[1]. Despite being the second largest class of GPCRs,
aGPCRs are relatively understudied, in part owing to their complex structure. aGPCRs are
defined by a large extracellular N-terminus and a GPCR autoproteolysis-inducing (GAIN)
domain that can cleave the receptor at the GPCR proteolysis site (GPS) into an N-terminal
fragment (NTF) and a 7-transmembrane (7TM)-containing C-terminal fragment (CTF) during
the maturation process [2, 3]. The NTF and CTF are thought to remain non-covalently attached
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at the cell surface [2, 4]. In addition to their characteristic autoproteolytic cleavage, aGPCRs are
distinct from other GPCR families in that their N-termini often contain protein domains that are
classically associated with cell-cell or cell-ECM adhesion, hence the name “adhesion GPCR.”
There are a total of 33 aGPCRs in humans, 31 in mice and rats [5], and over 50 in zebrafish [6].
In vertebrates, there are nine distinct subgroups of aGPCRs that can be separated based on the
phylogeny of their 7TM regions [5].

This chapter will focus in detail on the roles of aGPCRs in two specific areas of neurobiology:
synapto-/dendritogenesis and myelination. However, it is important to note that aGPCRs have
proven to be critical for many different aspects of nervous system development including, but
not limited to, cortical lamination and blood brain barrier formation [7-9]. For an exhaustive
overview of mammalian aGPCRs and their known functional roles, please refer to other chapters
of this book and [1].

A.3 ADHESION GPCRs IN SYNAPTOGENESIS AND DENDRITOGENESIS
Neurons communicate with each other at synapses, specialized junctions that ensure the transfer
of neuronal information. Numerous types of neurons and synapses exist, characterized by
different morphologies and properties, depending on their position in the network. Among the
nine subfamilies of aGPCRs, three have come to light for their roles in synaptogenesis and/or
dendrite morphogenesis: latrophilins (ADGRLs/LPHNs), Flamingo/Cadherin, EGF-like, LAGlike, and seven-pass G-type receptors (ADGRCs/Fmi/CELSRs), and Brain-specific Angiogenesis
Inhibitors (ADGRBs/BAIs).
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A.3.1 LPHN1 and LPHN3 regulate synapse formation and function
The LPHN subfamily is composed of three members, LPHN1-3 [10]. Unlike LPHN2, LPHN1
and LPHN3 are highly enriched in the brains of zebrafish, rodents, and humans [6, 11, 12]. In
rodents, expression of Lphn1 and Lphn3 is high until the third postnatal week and then decreases
in older animals, suggesting a role during postnatal brain development [13]. Indeed, various
studies have demonstrated that LPHN1 and LPHN3 regulate synaptic development and function,
through their interactions with multiple partners.

LPHN1’s interaction with NRXs may regulate synapse function
Originally identified as the endogenous receptor of α-latrotoxin, a component of black widow
spider venom, LPHNs act as co-receptors for the neurotoxin together with the presynaptically
localized single-pass transmembrane neurexins (NRX-1α, -1β, -2β, and -3β) [11]. LPHNs bind to
α-latrotoxin in a calcium-independent manner, whereas NRXs bind it in a calcium-dependent
manner. Disruption of LPHN1 and/or NRX-1α in mice confirmed that the two receptors bind αlatrotoxin independently, but act cooperatively to regulate the effect of α-latrotoxin on
neurotransmitter release [14]. Furthermore, LPHN1 interacts at high affinity with NRX-1α and 1β, through its olfactomedin (Olf) domain, to form a trans-cellular adhesion complex in a
calcium-dependent manner (Figure 1). Together with the fact that LPHN1 co-enrich with
postsynaptic markers in biochemical preparations [14], this suggests that LPHN1/NRX1 could
produce a trans-synaptic contact between neurons [12].

LPHN1 interacts with TEN2 to stabilize synapses and induce neurotransmitter release
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Other endogenous binding partners for LPHNs are the teneurins (TENs), single-pass
transmembrane glycoproteins encoded by four different genes (Ten1-4). In the rat brain, TEN2
binds with high affinity to LPHN1 and low affinity to LPHN2, but has no affinity for LPHN3.
The interaction between LPHN1 and TEN2 was shown to mediate intercellular neuronal contact
in a calcium-independent manner [12, 15]. In addition, in an artificial synapse formation assay,
presynaptically enriched LPHN1 induced post-synaptic specialization in neurons, whereas the
postsynaptically enriched TEN2 influenced axon-target interaction (Figure 1) [15]. LPHN1 thus
seems to regulate synapse stability and function through its interaction with TEN2. Similarly,
TEN1 and TEN3 both interact with LPHN3 [16], although a specific role for these interactions in
synapses has not yet been demonstrated.

LPHN/FLRT trans-synaptic complexes regulate the strength and density of synapses
Another group of LPHN interacting partners are the fibronectin leucine-rich transmembrane
(FLRT) proteins, as shown by affinity-purifications from rat synaptosome extracts using the
LPHN3 or FLRT3 extracellular domain [16]. FLRT3 is a postsynaptic protein partially colocalizing with the postsynaptic scaffolding protein PSD95 at glutamatergic but not GABAergic
synapses. While LPHN3, like LPHN1, is sufficient to induce postsynaptic differentiation,
FLRT3 is not sufficient to induce presynaptic differentiation. However, Lphn3 or Flrt3
knockdown experiments in hippocampus, dentate gyrus, or cerebral cortex reveal a decrease in
the strength and number of synapses, as well as a decrease in glutamatergic transmission,
sometimes accompanied by a reduction in the number of dendritic spines [16, 17]. These results
suggest that the LPHN3-FLRT3 complex positively regulates synaptic development and
function.
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In vertebrates, while NRXs are expressed ubiquitously, FLRTs and TENs are expressed in a cellspecific manner that is complementary and non-overlapping [16]. Therefore, only certain
combinations of LPHNs and FLRTs or TENs seem to be present at any given synapse,
suggesting their role in the specific formation of different neuronal circuits. Indeed, lphn3knockdown zebrafish larvae are reported to have defects in dopaminergic neurons, which control
locomotor activity and impulsivity. This phenotype is reminiscent of Lphn3 mutant mice, which
are hyperactive and display increased sensitivity to a locomotor stimulant. In both species, the
defects can be reversed by ADHD medication [18].

Although LPHNs are conserved in invertebrates, their roles in synaptogenesis have not yet been
demonstrated in these models. However, the C. elegans homolog of LPHN1, LAT1, was shown
to be involved in the modulation of neurotransmitter release in the pharyngeal nervous system
[19], so some functions may be conserved. Interestingly, invertebrate LPHN homologs lack the
Olf domain, which is required for forming the LPHN-NRX complexes as well as the functions of
LPHN/FLRT and LPHN/TEN complexes in synapses [12, 17]. The Olf domain is absent in
LPHNs in invertebrates, and thus may confer a specific role for LPHNs in the vertebrate brain.
Additionally, in C. elegans, TEN1 and LAT1 are possibly engaged in cis interactions and thus
might have different modes of action than their vertebrate counterparts [3].

A.3.2 FMI/CELSRs regulate synaptogenesis and dendritogenesis
The aGPCR Flamingo (Fmi) is found in invertebrates and is evolutionary conserved, as
mammals have three Fmi homologs named Celsr1-3. In C. elegans, fmi-1 is expressed in neurons
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and localized in axons during development and adulthood [20]. In Drosophila, fmi is expressed
at the neuromuscular junction and in dorsal sensory neurons of the peripheral nervous system
(PNS) as well as in the central nervous system (CNS), where it is mostly present on dendritic and
axonal membranes [21, 22]. Similarly, in rodents, Celsrs1-3 are predominantly expressed in the
brain. While Celsr1 is mostly restricted to regions of neural stem cell proliferation, Celsr3 is
preferentially expressed in post-mitotic neurons, and Celsr2 is expressed in both proliferating
and post-mitotic neurons of the postnatal brain [23, 24].

Fmi regulates axon guidance and synaptogenesis in invertebrates
In the ventral nerve cord of C. elegans, pioneer axon growth allows the formation of a path that
will be followed by later growing follower axons. In fmi-1 mutants, the navigation of both
pioneer and follower axons is perturbed. The navigation of pioneer axons requires the CTF of
FMI-1, whereas the navigation of follower axons requires the NTF [20], suggesting that FMI-1
controls axon navigation through signal transduction for pioneer axons and through axon-axon
adhesion and/or trans signaling for follower axons.

At the larval neuromuscular junction of Drosophila fmi mutants, Fmi prevents the formation of
inappropriate ectopic synapses. fmi mutants also present defective synaptic responses in a subset
of muscles, as well as an age-dependent loss of muscle innervation due to drastic degeneration of
axons in the third larval stage. Importantly, Fmi restoration in neurons rescues these synaptic and
axonal defects. Fmi is thus required in neurons for the selection of synaptic targets, for
synaptogenesis, and for the maintenance of axons and synapses in adulthood (Figure 2) [21].
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In the sensory system of Drosophila, processes of dendritic avoidance or repulsion occur during
early development and are required to obtain a specific dendritic branching pattern for each of
the dorsal sensory neurons. fmi mutant embryos show dendritic overgrowth and overlap of dorsal
sensory neurons [22, 25]. These defects can be partially rescued by the specific expression of an
fmi construct containing only the extracellular hormone-binding domain (HBD) that impairs Fmi
homophilic binding (Figure 2). Intracellularly, genetic experiments suggest a signaling pathway
(Figure 2) involving the proteins Fmi, Esn, and Van Gogh [26] that could be localized in
dendrites and locally activate RhoA upon contact of two branches to redirect dendrites away
from each other. In addition, neuronal G protein Gaq may also function downstream of Fmi to
inhibit dendritic growth [27]. At the larval stage, fmi mutants show dendritic outgrowth from the
contralateral sides with overlapping of dendrites that can only be rescued by Fmi-containing
cadherin repeats (Figure 2). Thus, Fmi first restricts dendritic growth in embryos and then
controls neuron-neuron dendritic avoidance through homophilic binding at the larval stage.

CELSRs modulate dendritic growth in the mammalian brain
In rodents, CELSR2 is distributed in dendrites and axons of various embryonic and postnatal
neuronal cells [28]. Celsr2 loss-of-function manipulations, performed on organotypic brain slices
from rat, caused simplification of the dendritic arborization of hippocampal and cortical
pyramidal neurons and cerebellar Purkinje cells (PCs). This decrease in dendritic complexity is
likely due to dendrite retraction, indicating that CELSR2 is required for dendritic maintenance
[29]. Rescue experiments suggest a dual role of CELSR2: promotion of dendritic maintenance
through homophilic interactions mediated by the extracellular cadherin repeats and decreasing
dendritic complexity through the EGF-HBD region (Figure 2). This suggests that different
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ligands of CELSR2, binding to different domains, could exert opposite effects on dendrites. This
property of CELSR2 could be important for the control of dendritic complexity depending on
environmental molecular cues.

In contrast to CELSR2, CELSR3 suppresses dendritic growth [30]. This functional difference
may be determined by a single amino acid in the 7TM domain: Celsr1, Celsr3, and Fmi possess
a histidine in the first intracellular loop of the 7TM domain, whereas Celsr2 has an arginine. This
residue switch is correlated with an inversion of the roles of the corresponding proteins in
dendritogenesis, perhaps suggesting the presence of different second messengers initiating
different signaling pathways. The role of Celsr3 in dendritogenesis in vivo remains to be
confirmed since Celsr3 knockout mice lack a dendritic phenotype, in contrast with the reported
knockdown phenotype [30, 31].

A.3.3 BAIs regulate dendrite, spine, and synapse formation
Three different BAI receptors are encoded by Bai1-3, and are only present in vertebrates. Their
expression increases in the brain after birth, with a peak in rodents at postnatal day 1 for Bai3
and at postnatal day 10 for Bai 1 and Bai2. Bai1 and Bai3 are specifically expressed in the brain,
whereas Bai2 is also found in many other tissues [6, 32-35]. Although suggested by the antidepressant phenotype of the Bai2 knockout mice[36], the involvement of BAI2 in neuronal
circuit formation remains to be demonstrated. In contrast, roles for BAI1 and BAI3 in
dendritogenesis and synaptogenesis have been described by several studies.

BAI1 regulates synaptogenesis and synaptic plasticity
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BAI1 is enriched in the post-synaptic density (PSD) of excitatory synapses. Here, it co-localizes
with the AMPA receptor GluR1 [37, 38] and potentially interacts with a variety of PDZ proteins
such as PSD95, PSD93, the MAGUKs MAGI1-3, and the synapse-associated protein 97
(SAP97). BAI1 also binds to MDM2, an E3 ubiquitin ligase, and prevents PSD95 ubiquitination
and degradation (Figure 3). In Bai1-null animals, the synaptic ultrastructure is characterized by a
decreased PSD thickness associated with increased PSD95-associated MDM2 and PSD95
ubiquitination. This modification is associated with defects in hippocampal-dependent learning
and memory and in synaptic plasticity. The restoration of PSD95 to physiological levels in the
hippocampus of Bai1-null mice restores normal synaptic plasticity, showing that plasticity
defects are directly linked to the destabilization of PSD95 [39]. Knockdown experiments in
cultured neurons further revealed the role of BAI1 in spinogenesis and synaptogenesis and, to a
lesser extent, in synapse maintenance [38]. Rho GTPases and ERK have been previously shown
to regulate the morphogenesis of dendritic spines as well as synapse formation and plasticity [31,
40]. Interestingly, BAI1 activates Rho via Gα12/13 [38] and activates Rac1 by recruiting the
Par3/Tiam1 complex at the PSD [41, 42]. Finally, BAI1 promotes the phosphorylation of ERK in
a PDZ-motif-dependent manner. BAI1 seems thus required for the proper assembly of actin in
developing spines via Rho GTPases and ERK signaling.

BAI3 regulates dendritogenesis and synaptogenesis in early brain development
Dendrite morphogenesis relies on the stabilization of neurites and the regulation of the actin
cytoskeleton via the modulation of Rho GTPases [43, 44]. Bai3 knockdown during early
neuronal development leads to dendrite overgrowth in various types of neurons in vitro, as well
as in PCs in vivo [34]. No major dendritic defects are observed in adult mice with a specific
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disruption of Bai3 in PCs [45]. This discrepancy could be due to developmental timing
differences in the inactivation of BAI3 in these experiments. This would suggest a requirement
of BAI3 preferentially at an early stage of dendritogenesis and/or a subsequent recovery of the
major defects in the adult. Dendrite morphogenesis relies on the stabilization of neurites and the
regulation of the actin cytoskeleton via the modulation of Rho GTPases. BAI3 controls dendritic
growth by regulating the activity of the Rho GTPase Rac1, partially through binding to the
ELMO1/DOCK180 complex, a guanylate exchange factor of Rac1 (Figure 3) [34]. Thus, BAI3
might control the rearrangement of dendritic actin cytoskeleton via Rac1, a potential role
reinforced by the fact that BAI3 co-localizes with actin in growing dendrites.

Proteomic analysis of synaptic fractions revealed the localization of BAI3 at excitatory synapses
in the forebrain and in the cerebellum [46, 47]. Knockdown or cell-specific knockout
experiments in PCs show that BAI3 promotes the connectivity of its two types of excitatory
afferents, the parallel and the climbing fibers. Indeed, Bai3 loss-of-function leads to a decrease in
the number and size of parallel fiber presynaptic boutons [35], as well as a decrease in the
number, size, and extension territory of climbing fiber presynaptic boutons [35, 45]. During
synaptogenesis, each PC is first contacted by multiple climbing fibers around embryonic day 19
in mouse. Then, only one climbing fiber “wins” and supernumerary climbing fibers are
eliminated. In the PC-Bai3-null mice, many PCs remain multi-innervated in the adult [45]. This
defect in climbing fiber elimination could be a direct effect of BAI3 in determining the “winner”
climbing fiber, or an indirect effect consecutive to the defective establishment of parallel fiber
connections [35], since normal transmission at parallel fiber synapses is necessary for proper
climbing fiber elimination.
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The only extracellular partners of BAI3 reported so far are the secreted C1QL proteins from the
complement C1Q-related family (Figure 3) [48]. The four C1QLs, generated from four genes,
are expressed almost exclusively in the mammalian brain, each one with a specific and partially
overlapping expression pattern [35, 49]. C1QLs-BAI3 interaction was first reported to inhibit
synapse formation or maintenance in cultured hippocampal neurons [48]. Two subsequent
studies show that in the cerebellar cortex, C1QL1 needs to be secreted specifically at the
climbing fiber to allow proper formation of climbing fiber/PC synapses [35, 45]. In addition,
C1QL1 is transiently expressed in the cerebellum and promotes PC spinogenesis in a BAI3dependent manner. Thus, BAI3 could regulate the number of parallel fiber/PC synapses early
during development [35]. Both C1ql1 and Bai3 knockout mice exhibit defects in climbing fiber
elimination and motor learning defects, highlighting the importance of the signaling pathway
formed by C1QL1 and BAI3 for proper CF/PC synaptogenesis and cerebellar function [45].

A.4 ADHESION GPCRs IN MYELINATING GLIA
While synapses permit direct communication between neurons, the glial-derived myelin sheath
enables the rapid propagation of action potentials along axons; thus, myelinating glia are also
key players in information transfer in the nervous system. Myelin is made by Schwann cells
(SCs) in the PNS and oligodendrocytes (OLs) in the CNS. Myelination increases the conduction
velocity of action potentials; additionally, OLs and SCs provide trophic support to aid in the
proper functioning and survival of neurons [50, 51]. Relatively less is known about myelinating
glia compared to neurons. Similarly, little is known about the roles of aGPCRs in myelinating
glia compared to roles in synaptogenesis and dendritogenesis. Nevertheless, recent studies have
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established two aGPCRs, Gpr126 and Gpr56, as key regulators of both SC and OL development.

A.4.1 GPR126 is essential for Schwann cell myelination
Previous work has defined several steps in SC development, leading from neural crest
progenitors to mature myelinating SCs [50]. During embryogenesis, SC precursors migrate with
axons in the developing PNS and differentiate into immature SCs that remain associated with
many axons. In a process called radial sorting, immature SCs insert cytoplasmic projections into
the axon bundle and begin to envelop and separate individual axons away from the rest of the
bundle according to axon diameter. Some immature SCs will remain associated with many small
axons and become non-myelinating SCs. However, immature SCs that will eventually make
myelin will first become promyelinating SCs that associate in a 1:1 ratio with a single axonal
segment. Upon additional cues, myelinating SCs then iteratively wrap their plasma membrane
around the associated axonal segment, ultimately generating a mature myelin segment with a
thickness proportional to the diameter of the axon they wrap.

The first evidence of a role for aGPCRs in myelination was the discovery that Gpr126 is required
for the normal progression from a promyelinating SC to a fully mature myelinating SC in both
zebrafish and mice [52, 53]. In Gpr126 mutants, SCs express the transcription factor Sox10,
which is required for SC specification, maintaining SC identity, and proper progression of the
lineage [54-56]. However, Gpr126 mutant SCs fail to express later-stage transcription factors
Oct6 (Pou3f1) and Krox20 (Egr2). Oct6 and Krox20 are required to activate the expression of
many myelin-associated genes, including Myelin basic protein (Mbp), which encodes a structural
component of the myelin sheath. Ultrastructural analyses demonstrated that Gpr126 mutant SCs
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can associate with axons in the proper 1:1 ratio, but are arrested at the promyelinating stage of
development, and fail to ever elaborate a myelin sheath [52, 53].

In vitro, SCs co-cultured with neurons follow a similar developmental progression as described
above – they migrate and proliferate along nascent axons, perform radial sorting, and myelinate
axons [57]. However, in the absence of axons, SCs fail to differentiate. This requirement for
neurons can be overcome by the addition of axonal membrane fragments [58, 59] or by
increasing levels of cAMP. Elevation of cAMP induces SC maturation, as illustrated by their
upregulation of myelin-related gene expression and downregulation of immature SC markers
[60-62]. Thus, an in vivo role for cAMP elevation in SC myelination had long been
hypothesized, although the mechanism by which cAMP might be elevated has been elusive.
Interestingly, myelination defects in gpr126 mutant zebrafish can be suppressed by treating the
animals with forskolin, an adenylate cyclase activator that potently elevates cAMP. Specifically,
SCs of forskolin-treated gpr126 mutant zebrafish express oct6, krox20, mbp, and produce
ultrastructurally normal myelin [52]. Additionally, elevating cAMP levels and activating protein
kinase A (PKA) restored myelination in myelinating cultures from Gpr126-/- knockout mice [63],
and PKA activation also rescues myelination in zebrafish [64]. Moreover, cAMP is
downregulated in the sciatic nerves of mutant mice in which Gpr126 has been deleted
specifically in SCs [63]. Finally, GPR126 was shown to directly couple to the Gs-protein and Giprotein families [63], which are associated with modulating cAMP levels. All together, these
data suggest that Gpr126 is a major, if not the sole receptor, that elevates cAMP in SCs to initiate
myelin-gene expression and terminal differentiation.
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Gpr126 has cAMP-independent roles in Schwann cell development
Until quite recently, it was unclear if aGPCRs functioned as adhesion molecules by virtue of the
NTF, as traditional GPCRs signaling through heterotrimeric G proteins by virtue of the 7TM, or
if the same molecule could perform both functions. Notably, studies on Gpr126 have contributed
to answering this question, as Gpr126 SC myelination studies strongly suggested that aGPCRs
could behave as traditional GPCRs [63, 65]; later, the Gpr126-NTF was reported to have a CTFindependent role in heart development [66]. Together, this suggested that a given aGPCR can
have domain-specific roles, at least in different cellular contexts. Interestingly, recent structurefunction studies of Gpr126 have shown that an aGPCR can also have multiple independent
functions in modulating the development of a single cell [65].

Preliminary analyses of gpr126 zebrafish mutants suggested that Gpr126 functions specifically
in the final maturation of SCs. This function of Gpr126 is conserved in mammals; however, both
global and SC-specific Gpr126 mutant mice display additional defects that were not observed in
gpr126 zebrafish mutants, including severe delays in radial sorting, axon degeneration, and limb
contracture abnormalities [53, 63]. While species differences may certainly be at play, there are
key differences between the alleles in Gpr126 mutant mice and zebrafish. The targeted deletion
in Gpr126 null mice produces an early premature stop codon that results in the near absence of
Gpr126-NTF mRNA, and these mice have severely impaired radial sorting and completely lack
peripheral myelination as mentioned above [53, 63]. In contrast, two previously studied mutant
alleles in zebrafish were likely not null alleles; the gpr126st49 allele is a point mutation resulting
in a premature codon near the GPS [52], such that the NTF might be intact while the CTF
signaling domain is absent. Similarly, the gpr126st63 allele is a missense mutation that disrupts a
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highly conserved cysteine in the 7TM, thus the NTF and CTF both remain intact [52].
Importantly, neither gpr126st49 nor gpr126st63 display defective radial sorting. In contrast,
recently generated gpr126stl47 mutants represent a very early premature stop codon (amino acid
position 96), which is more similar to the targeted deletion in Gpr126 mutant mice [65].
Interestingly, SCs in gpr126stl47 mutants phenocopy the radial sorting defects observed in mouse
mutants. These defects could be rescued by genetically “adding back” the Gpr126-NTF but could
not be rescued by cAMP elevation, suggesting that Gpr126 has CTF-independent roles in SC
development. These findings are consistent with earlier studies highlighting NTF- and CTFspecific functions for aGPCRs in C. elegans axon migration, fertility, and viability [3, 20],
though future work is required to determine how the Gpr126-NTF might direct radial sorting in a
cAMP-independent fashion.

Control of Gpr126 signaling in Schwann cells
Given that aGPCRs have both CTF-dependent and independent roles, an important question
centers around binding partners that might modulate these functions. Notably, most aGPCRs are
orphaned [1, 67], meaning their ligands and activation methods are unknown. aGPCRs are
unique relative to other GPCRs in that they undergo an autoproteolysis event at the GPS motif
that separates the protein into an NTF and CTF, which then remain non-covalently associated
with one another at the cell membrane [2, 4]. Interestingly, a spate of recent studies have shown
that several aGPCRs, including GPR126, generate a tethered agonist ligand, termed the Stachel
sequence (German word for “stinger”), which potently activates the CTF of the receptor in vitro
[68-71]. Moreover, analysis of zebrafish mutants suggested that activation of Gpr126 by the
Stachel sequence is required for SC myelination [68], and it was recently suggested that Gpr126-
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interacting proteins in the extracellular matrix (ECM) might modulate availability of the Stachel
sequence.

The NTFs of several aGPCRs can bind to ECM molecules; Gpr126 is no exception, as the
Gpr126-NTF can bind to type IV collagen and Laminin-211 [65, 72], which are both components
of the SC basal lamina. In rodent SCs and GPR126-expressing heterologous cells, exogenous
application of type IV collagen induced cAMP elevation, which is required for SC
differentiation. Additionally, GPR126 derivatives lacking the NTF were constitutively active,
suggesting that the NTF is important for inhibiting Gpr126-CTF signaling [72]. Interestingly,
Laminin-211 also binds Gpr126 in a different region of the NTF than the collagen-IV binding
site. Overexpression of lama2 rescued myelination defects in hypomorphic gpr126st63 zebrafish
mutants in a cAMP-dependent manner [65]. Intriguingly, and in contrast to type-IV collagen,
addition of Laminin-211 to GPR126-expressing heterologous cells suppressed cAMP
accumulation under static conditions. However, under dynamic culture conditions, Laminin-211
activated GPR126. The in vivo relevance of this result was underscored by the observation that a
polymerization-defective mutant form of lama2 could no longer restore myelination in gpr126
zebrafish mutants. Taken together, these studies suggest that ECM molecules in the basal lamina
may modulate the NTF and impact Stachel sequence signaling. Moreover, the Laminin211/Gpr126 studies suggested that aGPCRs may be mechanically sensitive, consistent with
contemporaneous work in Drosophila melanogaster [73]. For an in depth discussion of the
emerging concept of aGPCRs as mechanosensors, the reader is referred to the mechanosensation
chapter of this textbook.
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Importantly, these data tie in with the model that Gpr126 has CTF-independent functions in SC
development. Low levels of cAMP promote SC proliferation and facilitate an immature state,
while elevated cAMP drives myelination [74]. Perhaps in early SC development, the Gpr126NTF remains tightly associated with the CTF such that cAMP elevation is suppressed. Changes
in ECM proteins in the SC basal lamina, including Laminin-211 polymerization, may modulate
the NTF such that the Stachel sequence can bind the 7TM and induce Gpr126 signaling cascades
through Gs, which elevate cAMP, activate myelin-related gene expression, and allow terminal
maturation of myelinating SCs (Figure 4).

A.4.2 GPR56 regulates oligodendrocyte development
OLs are the myelinating glia of the CNS that, as mentioned above, share many characteristic
features with their PNS counterparts, the SCs. Like SCs, OLs generate myelin by iteratively
wrapping their plasma membranes around axon segments [75], although OLs can myelinate
many axonal segments, in contrast to the single axon segment myelinated by a SC. Accordingly,
OLs and SCs perform similar functions using an overlapping, but not identical, set of genes[76].
Moreover, while SCs are derived from neural crest, the OL lineage is derived from neural stem
cells, which ultimately give rise to all resident cells in the CNS except for microglia [77]. OL
precursor cells (OPCs) migrate in waves from their germinal zones and become immature OLs as
they begin extending cytoplasmic processes and associating with axons [75]. Finally, upon
incompletely understood cues, immature OLs terminally differentiate into mature myelinating
OLs that spiral and compact their plasma membrane around as many as 40 different axon
segments [78].
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Although Gpr126 is essential for SC development and myelination, it has no known function in
OLs, suggesting that there might be another aGPCR that is similarly important for OL
maturation and myelination. Previously published data sets indicate that Gpr56, an aGPCR in the
same subfamily as GPR126, is highly expressed in OPCs in the developing mouse CNS [79, 80].
In humans, mutations in GPR56 cause bilateral frontoparietal polymicrogyria (BFPP) [7], a
cortical brain malformation associated with a variety of devastating neurological impairments
such as epilepsy and mental retardation. Interestingly, brains of BFPP patients also exhibit
reduced white matter volume by MRI and signal changes in T2 weighted images [8, 74, 81],
which are indicative of myelin defects. Two complementary studies have recently defined key
functions for GPR56 in OL development [82, 83].

In these studies, the authors analyzed both zebrafish and mouse Gpr56 mutants. gpr56stl13 mutant
zebrafish harbor a 6 bp deletion that removes a completely conserved tryptophan residue in the
GPS motif that is essential for autoproteolysis [83]. Since previous reports show that disruption
of autoproteolytic cleavage of GPR56 prevents the protein from being trafficked to the
membrane and thus severely impairs GPR56 signaling [84], stl13 is likely a strong loss-offunction allele. Although loss of Gpr56 function in stl13 mutants did not result in abnormal OPC
specification or initial OPC numbers, both Gpr56 knockout mice and gpr56stl13 zebrafish
displayed significantly fewer OL lineage cells over time [82, 83]. GPR56 is expressed in many
CNS cell types including oligodendrocyte precursor cells (OPCs) and immature
oligodendrocytes [82], which could impact some of the OL phenotypes observed in Gpr56
mutants. Giera et al. also used OL-specific deletion of Gpr56 to demonstrate that this aGPCR
functions cell autonomously in OLs to regulate their development. Ultrastructural analyses show
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that zebrafish and mouse Gpr56 mutants possess fewer myelinated axons as compared to
controls in the spinal cord and corpus callosum, respectively. However, axons that are
myelinated appear to be myelinated normally, suggesting that GPR56 regulates the number of
OL lineage cells, but is not required for myelination per se. Marker analyses in both species
demonstrated that the reduction in OL number is not due to increased OPC cell death, but instead
a lack of OPC proliferation [82, 83]. Additionally, overexpression of gpr56 in wild-type
zebrafish larvae induced increased OPC proliferation, while the ventral spinal cord was
precociously myelinated in gpr56stl13 zebrafish mutants at early developmental stages [83].
Together, these studies support the notion that loss of GPR56 results in OPCs prematurely
exiting the cell cycle in favor of differentiation.

Gpr56 regulates oligodendrocyte development via Gα12/13 and RhoA
Previous studies established that GPR56 couples to Gα12/13 and activates RhoA to control
migration of neural precursor cells in vitro [85, 86]. RhoA is highly expressed in mammalian
OPCs, but is downregulated at later stages to facilitate terminal differentiation of OLs[87],
paralleling the early function of GPR56 in these cells. In zebrafish, knockdown of the genes
encoding Gα12/13 proteins or overexpression of a dominant-negative RhoA phenocopied OL
lineage defects in gpr56stl13 mutants, while overexpression of constitutively active RhoA rescued
the defects [83]. In mouse, levels of active RhoA were significantly reduced in Gpr56 knockout
optic nerves while there were no observable changes in PKCα, the only other effector reported to
be downstream of GPR56 [82]. Taken together, these experiments strongly support a model in
which GPR56 couples to Gα12/13 and signals through RhoA to promote OPC proliferation and
inhibit terminal differentiation to ultimately regulate appropriate levels of CNS myelination
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(Figure 5). In the future, it will be interesting to determine if this activation is dependent on the
Stachel sequence as well as what ligand(s) might influence GPR56-dependent OL development.

A.4.3 Other aGPCRs in myelinating glia
Beyond GPR126 and GPR56, VIGR/GPR98 (ADGRV1) is expressed in OLs, and modulation of
this aGPCR can affect levels of a key myelin protein, MAG (Myelin-associated glycoprotein). In
vitro, VIGR knockdown reduces, while overexpression increases, MAG expression [88].
Additionally, expression studies suggest that there may be yet undiscovered aGPCR players in
glial cell development and myelination as RNAseq analyses in the mouse CNS indicates that
Gpr125 (Adgra3), BAI1-3, Lphn1, Lphn3, and Celsr2 are all expressed (FPKM > 5) in OL
lineage cells [89]. Future studies can elucidate the roles of additional aGPCRs in myelinating
glia.

A.5 DISCUSSION
Thus far, three groups of aGPCRs, latrophilins, Flamingo/CELSRs, and BAIs, have been
implicated in morphogenesis of various neurons and/or their connectivity. Similarly, two
aGPCRs from the group VIII (ADGRG) subfamily, GPR126 and GPR56, have proven to be
critical regulators of myelination. These molecules are thus crucial for the establishment of a
properly functioning nervous system.

The importance of understanding the molecular basis underlying dendrite and synapse formation
is highlighted by the fact that any modification in neuronal microcircuits can lead to
neurodevelopmental defects and brain pathologies. This is underscored by the fact that some
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aGPCRs regulating dendritogenesis and synaptogenesis are also associated with
neurodevelopmental pathologies. In humans, deletion of LPHN1 is associated with various
symptoms including mental retardation, psychomotor and language delay, and hearing
impairment [90]. SNPs in LPHN3 increase the risk for attention deficit/hyperactivity disorder
(ADHD) and substance addiction [91, 92]. In addition, human BAI1 is present in a “hot spot” for
de novo germline mutations in autism patients [93], and the BAI1-associated protein BAIAP2 is
also linked to autism [94]. Finally, genetic association studies reveal that BAI proteins could
contribute to behavioral defects in psychiatric disorders. Indeed, SNPs and CNVs in the BAI3
gene have been associated with schizophrenia [95, 96],bipolar disorder [97], and addiction[98].

Similarly, the importance of understanding the molecular mechanisms that govern proper
myelination is emphasized by the fact that damage to or loss of this insulation leads to
debilitating symptoms in many neurological disorders. For example, in multiple sclerosis, OL
myelin is attacked and destroyed by the body’s immune system [99]. As noted above, BFPP
patients present with white matter abnormalities; perhaps GPR56 represents a new candidate
target to modulate OL differentiation in the CNS. Similarly, GPR126 may represent a viable
target for patients with peripheral nerve disease as this aGPCR is required for proper myelin
gene expression in humans [100]. Furthermore, mutations in LAMA2, which encodes the α2
chain of Laminin-211, cause merosin-deficient congenital muscular dystrophy (MDC1A) in
humans [101]. Given that GPR126 binds to Laminin-211, activation of GPR126 could be
pursued in MDC1A patients. GPCRs are the most widely studied targets for the development of
pharmacological drugs. Therefore, studying aGPCRs is highly pertinent to increase our
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understanding of these receptors in the context of human neurodevelopmental and myelin
diseases and to find efficient treatments for human disorders.
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A.6 FIGURES

Figure A1. Structure and functions of LPHN1 at the synapse.
The extracellular N-terminal fragment (NTF) of latrophilins contains a rhamnose-binding lectin
domain (RBL) [102], a central olfactomedin-like domain (Olf), a serine/threonine-rich region
(STRR), and a hormone-binding domain (HBD), in addition to the characteristic GAIN domain
containing the autoproteolytic GPS motif. The 7TM domain is followed by a long cytoplasmic
tail where most of the alternative splicing occurs. One splicing site, referred as SSA, is also
present between the lectin and olfactomedin domains in the N-terminal region. LPHN1 interacts
extracellularly with neurexin1α and 1β (NRX1α/1β) [12], Teneurin 2 (TEN2) [15], and FLRT3
[16], and intracellularly with Gαq/αo [103] and the postsynaptic scaffolding proteins SHANK1/2
[13, 14].
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Figure A2. Structure, partners, and functions of FMI and CELSR2 in neurons.
In the NTF, Fmi/CELSR proteins contain nine cadherin repeats (CR), six EGF-like domains
(EGF), two laminin globular-like domains (Lam), a hormone-binding domain (HBD), and the
GPS-containing GAIN domain. The three CELSR proteins share 50% sequence identity in their
N-terminal and 7TM regions but have different C-terminal regions: 300 residues-long for
CELSR1-2 and 590 residues-long for CELSR3. The C-terminal intracellular domain does not
contain any conserved motif between invertebrates and vertebrates, except for a proline-rich
region (PRR). In addition, CELSR2 has two splice variants, one long and one short, which differ
based on splicing of exon 31, affecting 20 residues in the cytoplasmic tail. Fmi interacts with
Espinas (Esn) [26] and Gαq [27]. CELSR2 and CELSR3 are localized both pre- and
postsynaptically and are engaged in homophilic interactions[25].

216

Figure A3. Structure, partners, and functions of BAI1 and BAI3 in neurons.
In the NTF, BAI proteins contain thrombospondin type 1 repeats (TSR1; five TSRs in BAI1 and
four TSRs in BAI2 and BAI3), a HBD, and a GAIN domain containing the GPS site for autoproteolysis. At the N-terminal extremity, BAI3 also possesses a CUB (complement C1r/C1s,
Uegf, Bmp1) domain, and BAI1 has an integrin-binding RGD motif. The N-terminal region of
the BAIs is followed by the 7TM domain and a cytoplasmic domain containing an α-helical
RKR motif and a terminal PDZ-binding motif (QTEV residues). BAI1 also presents a C-terminal
proline-rich region (PRR). BAI1 interacts intracellularly with PAR3/TIAM1 [37], BAIAP2
[104], and Gα12/13, as well as PSD95 [38] and MDM2 [39], possibly through the QTEV domain.
BAI3 interacts with the complement C1Q-related molecule C1QL1 [48] extracellularly and with
ELMO1/DOCK180 [34] intracellularly.
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Figure A4. Interactions with the ECM modulate Gpr126 throughout Schwann cell
development. In addition to the canonical aGPCR domains (GAIN, GPS, and 7TM), GPR126
also possesses CUB and Pentraxin (PTX) domains in the NTF. Recent data showing that
Gpr126-NTF interacts with Laminin-211 (α2, β1, γ1) [65] supports the addition of a novel
Laminin-binding domain (LBD) in the NTF. Altogether, current data support a model in which
molecules in the SC basal lamina (Laminin-211 in black, collagens in gray) interact with
GPR126-NTF to stabilize the receptor in an inactive state during early development. This
prevents cAMP accumulation by suppressing GPR126 Gs signaling to prevent SC differentiation.
Following basal lamina maturation and Laminin-211 polymerization, an active conformation of
GPR126-CTF is facilitated to induce Gs signaling and cAMP elevation, possibly through
mechanical modulation of the receptor. This results in PKA activation, which promotes myelinrelated gene expression and terminal SC differentiation.
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Figure A5. Gpr56 regulates oligodendrocyte development by promoting precursor
proliferation and inhibiting premature differentiation. Although GPR56 contains all of the
classic aGPCR domains (GAIN, GPS, and 7TM), other protein domains in either the NTF or the
intracellular tail region have not been described. Recent data from zebrafish and mouse models
suggest that GPR56 couples to Gα12/13 [82, 83] and activates RhoA to prevent terminal
differentiation of OLs. In doing so, GPR56 indirectly promotes OPC proliferation (dashed arrow)
by maintaining the OPC in an immature, proliferative state.
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Appendix B
Gpr126/Adgrg6 has Schwann cell autonomous
and non-autonomous functions in peripheral
nerve injury and repair
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B.1 ABSTRACT
Schwann cells (SCs) are essential for proper peripheral nerve development and repair,
although the mechanisms regulating these processes are incompletely understood. We
previously showed that the adhesion G protein-coupled receptor (aGPCR)
Gpr126/Adgrg6 is essential for SC development and myelination. Interestingly, the
expression of Gpr126 is maintained in adult SCs, suggestive of a function in the mature
nerve. We therefore investigated the role of Gpr126 in nerve repair by studying an
inducible SC-specific Gpr126 knockout mouse model. Here, we show that remyelination
is severely delayed after nerve crush injury. Moreover, we also observe non-cell
autonomous defects in macrophage recruitment and axon regeneration in injured nerves
following loss of Gpr126 in SCs. This work demonstrates that Gpr126 has critical SC
autonomous and non-autonomous functions in remyelination and peripheral nerve repair.
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B.2 SIGNIFICANCE STATEMENT
Lack of robust remyelination represents one of the major barriers to recovery of
neurological functions in disease or following injury in many disorders of the nervous
system. Here we show that the adhesion class G protein-coupled receptor (GPCR)
Gpr126/Adgrg6 is required for remyelination, macrophage recruitment, and axon
regeneration following nerve injury. At least 30% of all approved drugs target GPCRs;
thus, Gpr126 represents an attractive potential target to stimulate repair in myelin disease
or following nerve injury.

232

B.3 INTRODUCTION
In the peripheral nervous system (PNS), specialized glia known as Schwann cells (SCs)
are best known for their role in generating the myelin sheath during development, which
enables rapid action potential propagation. Yet, following nerve injury, SCs are also vital
players in repair. Axons distal to an injury site undergo Wallerian degeneration, a
programmed cellular response that drives axon fragmentation. SCs associated with these
degenerating axons also respond in a stereotyped fashion, becoming “Büngner” or repair
SCs, which are essential mediators of nerve repair. Repair SCs downregulate the
expression of genes associated with myelination and upregulate genes associated with
immature SC stages. Further, repair SCs also upregulate neurotrophic factors and
cytokines, which promote neuronal survival and macrophage recruitment, respectively
(Arthur-Farraj et al., 2012). The macrophages recruited by SCs phagocytose axon and
myelin debris, and SCs themselves also efficiently clear debris by a specialized form of
autophagy (Gomez-Sanchez et al., 2015). Following nerve injury, axons regrow through
Büngner bands – repair SC-containing basal lamina tubes – back to their targets. Once
SC-axon contact is reestablished, repair SCs differentiate and remyelinate the regenerated
axons, which is necessary to restore optimal nerve function following repair.

Although there are some differences between developmental myelination and
remyelination following injury, many of the same molecular programs are reinitiated
during repair. For example, the transcription factors Oct-6 (Pou3f1) and Krox-20 (Egr2)
are similarly expressed in both contexts, with transient Oct-6 expression following axon
contact that in turn regulates Krox-20 and subsequent myelin gene expression (Scherer et
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al., 1994; Zorrick et al., 1996; Chen et al., 2007). During development, Oct-6, Krox-20,
and myelin gene expression as well as myelination are all downstream of Gpr126
(Adgrg6) activation in SCs (Monk et al., 2009; Monk et al., 2011; Mogha et al., 2013).
Gpr126 is a member of the adhesion G protein-coupled receptor (aGPCR) class; aGPCRs
possess a 7-transmembrane domain that couples to heterotrimeric G-proteins as well as a
long N-terminal region rich in functional motifs often involved in cell-cell or cell-matrix
adhesion. Most aGPCRs undergo an autocleavage event that splits the receptor into two
fragments, and recent studies demonstrate that this autocleavage can generate a tethered
agonist ligand in many aGPCRs (Leibscher et al., 2014; Stoveken et al., 2015; Demberg
et al., 2015). In the case of Gpr126, activation by the tethered agonist is required for SC
myelination (Leibscher et al., 2014; Petersen et al., 2015), and we recently determined
that laminin-211 binds the N-terminus of Gpr126 and modulates the availability of the
tethered agonist (Petersen et al., 2015).

Despite the essential function of Gpr126 in SC development, it is unknown if this aGPCR
is similarly required for remyelination following injury. Moreover, Gpr126 is robustly
expressed in mature SCs (Mogha et al., 2013), but its function in adult nerve is not
known. In the present study, we investigate the role of Gpr126 in SCs following nerve
injury by employing tamoxifen-inducible conditional mouse models. We show that while
Gpr126 is dispensable for myelin maintenance up to four months, this aGPCR has key
SC-autonomous and non-autonomous functions during injury and repair. Mirroring its
role in development, we show that Gpr126 is required in SCs for remyelination.
Unexpectedly, we also find that Gpr126 is required in SCs for increased macrophage
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numbers in the distal stump as well as efficient axon regeneration following injury.
Importantly, mutations in LAMA2, which encodes the α2 chain of the Gpr126 binding
partner laminin-211, cause merosin-deficient congenital muscular dystrophy (MDC1A)
in humans, and 80% of these patients present with a dysmyelinating neuropathy (Shorer
et al., 1995; Mercuri et al., 1996; Quijano-Roy et al., 2004). Therefore, this work has
important implications for repair in MDC1A patients and potentially for other peripheral
nerve diseases as well.
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B.4 MATERIALS AND METHODS
B.4.1 Mice
All animal experiments were performed in compliance with Washington
University’s institutional animal protocols. Gpr126fl/fl mice, PLPCre-ERT2 mice, DhhCre
mice, RosaLacZ mice, and genotyping assays were previously described (Mogha et al.,
2013; Leone et al., 2003; Jaegle et al., 2003; Soriano et al., 1999). For all experiments,
mice of both sexes were analyzed and we always compared littermate sibling controls.

B.4.2 Tamoxifen Injections
For all experiments involving “icKO mice”, PLPCre-ERT2;Gpr126fl/fl;Rosa+ animals were
injected daily with either tamoxifen (in 9:1 sunflower oil:ethanol) to induce the Cre
recombinase activity or with solvent only (control, 9:1 sunflower oil:ethanol). We
injected animals beginning at eight weeks of age once per day at 2 mg/mL for five
consecutive days. For myelin maintenance experiments, we analyzed N = 3 control- and
tamoxifen-injected animals 4 weeks following the final injections and N = 3 control- and
tamoxifen-injected animals 4 months following the final injections.

B.4.3 Nerve Crush
Sciatic nerves of right hind limbs were crushed four weeks following the final control or
tamoxifen injection according to standard protocols (Akassoglu et al., 2002; Bauder et
al., 2012). Briefly, mice were anesthetized by isofluorane before and during surgery. Fur
was removed with an electric trimmer and the sciatic nerve of the right hind limb was
exposed by making a small cut in the skin. The exposed sciatic nerve was carefully
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crushed with number 5 forceps as described (Bauder et al., 2012), and the crush site was
marked with powdered carbon. After crush, surgical wounds were sutured with nylon
thread, sealed with metal clips, and mice were administered pain reducing chow (Bio
Serv) during recovery until they were sacrificed. We used a minimum of N = 3 mice for
control and tamoxifen-injected groups at each time point.

B.4.4 Nerve and Muscle Harvest
Following the nerve injury, sciatic nerves were harvested at 3 days post injury (dpi), 7
dpi, 21 dpi, or 35 dpi. For myelin maintenance experiments, sciatic nerves were harvested
at 4 weeks or 4 months after the last tamoxifen injection. We isolated a 1 cm long
segment from each sciatic nerve distal to the crush site, which was marked with
powdered carbon. This 1 cm long segment was cut in half; the more proximal 0.5 cm
segment was always used for TEM while the more distal 0.5 cm segment was always
used for IHC. These two halves of the nerve segment were drop fixed in appropriate
fixatives. The tissues were embedded such that the midpoint of the original 1 cm segment
faced the front of the block face for sectioning so that TEM and IHC images derive from
approximately the same distance (0.5 cm) from the crush site. For neuromuscular
junction (NMJ) innervation experiments, extensor digitorum longus (EDL) muscles were
isolated at 12 dpi from the legs of mice whose sciatic nerves had been crushed as
described above. EDL muscles from the uncrushed contralateral sides were used as
controls.

B.4.5 Immunohistochemical Staining
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Sciatic nerves were isolated as described above, drop fixed in 4% paraformaldehyde
(PFA) overnight at 4° C, and processed as described (Mogha et al., 2013) for all stains
except for Gpr126 and SCG10. For Gpr126 staining, nerves were drop fixed in 4% PFA
for 30 minutes at room temperature and then processed as described (Giera et al., 2015).
For EDL muscle, tissue was drop fixed overnight at 4o C after sticking on a piece of a
toothpick to avoid curling. After washing with PBS, muscle was kept in 30% sucrose
solution and then cryosectioned longitudinally at 20 µm thickness. The following primary
antibodies were used: Rabbit anti-Gpr126CTF (1:10) (Petersen et al., 2015), rat anti-MBP
(1:10; AbD Serotec), chicken anti-lacZ (1:400; Abcam), rabbit anti-cJun (1:400; Cell
Signaling), rabbit anti-s100 (1:400; Dako Cytomation), rat anti-CD68 (1:50; Abcam), and
rabbit anti-Ki67 (1:400; Abcam), rabbit anti-SCG10 (1:2000) (Shin et al., 2014), goat
anti-Iba1 (1:200; Abcam), rabbit anti-NF-200 (1:500; Sigma). For NMJ stains, αBungarotoxin (BTX)-Alexa Fluor 555 (Molecular Probes/Invitrogen) was used. After
three washes in PBS, sections were incubated with the appropriate fluorescently labeled
secondary antibodies (1:1000; Invitrogen) suspended in blocking buffer for 1 hour at
room temperature. After further washing in PBS, slides were mounted using Vectashield
with DAPI (Vector Labs) to label nuclei. Fluorescent images were obtained with a Zeiss
AxioImager M2 microscope.

B.4.6 Western Blotting
Sciatic nerves were isolated from mice at 3 dpi. Segments of uninjured and distal injured
sciatic nerve measuring 1 cm in length were homogenized in lysis buffer (Cell Signaling)
with protease and phosphatase inhibitors (Roche). 15 mg of protein was loaded and
238

analyzed by SDS-PAGE and western blot with the following antibodies: rabbit anti-cJun
(1:1000; Cell Signaling), rabbit anti-alpha tubulin (1:20000; Abcam), goat anti-rabbit IgG
HRP (1:10000; Life Technologies). Membranes were developed with SuperSignal West
Pico (Thermo Scientific), imaged on a ChemiDoc MP imaging system (Bio-Rad
Laboratories) and quantified with Image Lab 5.2.1 software (Bio-Rad Laboratories).

B.4.7 Transmission Electron Microscopy
Sciatic nerves were isolated as described above, drop fixed in modified Karnovsky’s
fixative (4% PFA and 2% glutaraldehyde in 0.1 M sodium cacodylate, pH 7.4) at 4° C
overnight, and processed as described (Monk et al., 2011). Semithin sections (200-300
nm) were stained with toluidine blue, viewed on a light microscope (Zeiss AxioImager
M2), and images were recorded with an AxioCam MRm. Thin sections (70 nm) were
stained with uranyl acetate and Sato’s lead stain and then viewed on a Jeol (JEM-1400)
electron microscope. Images were recorded with an Advanced Microscopy Techniques
V601 digital camera.

B.4.8 Bluo–gal Staining
Mouse sciatic nerves were harvested as described above and were postfixed in 2% PFA
and 0.1% glutaraldehyde in 0.1 M sodium cacodylate for 1 hour at 4o C. Nerves were
processed with the bluo-gal solution as described (Aoyama et al., 2004). Briefly, nerve
segments were incubated in bluo-gal solution (5 mM potassium ferricyanide + 5mM
potassium ferrocyanide + 2 mM MgCl2 + 0.1% 5-bromo-3 indoyl-β-D-galactoside) at 37o
C for 20 hours. Following this, nerves were postfixed in 2% PFA and 2% glutaraldehyde
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in 0.1 M sodium cacodylate overnight at 4o C. After this step, nerves were processed for
transmission electron microscopy as described (Monk et al., 2011)

B.4.9 Morphometric Quantifications
To calculate g-ratios, we manually measured axon diameter and axon + myelin diameter
in Image J. We measured 100 axons from ~2200 µm2 regions of nerve selected at random
from N = 3 for control- or tamoxifen-injected animals at each time point. The
measurements were taken with the observer blind to treatment.

To calculate axon regrowth index, longitudinal sciatic nerves sections were made (7 µm
thick) at 3 dpi. These nerve sections were stained with anti-SCG10 as described (Shin et
al., 2012). We measured distance of the longest SCG10+ axons from the crush site,
measuring at least 5 axons within a 0.2 mm distance. The lengths were normalized to the
lengths of the corresponding sibling controls. We also counted the number of SCG10+
regenerated axons at standard distances from the crush site. Axons were counted at 0.5
mm intervals starting at 1.5 mm from the crush site. The number of axons at each given
distance was normalized to 1 mm. Averages were taken at each spot and were compared
between control and tamoxifen groups for corresponding sites from the crush sites. At
least 3 animals per group were examined, and measurements were taken with the
observer blind to treatment or genotype.

To quantify myelin debris, we used Image J to define contours around myelin debris in
~2200 µm2 regions of TEM micrographs, and contour area was normalized to the total
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area. At least 10 randomly selected areas were quantified from N = 3 animals per group,
and measurements were taken with the observer blind to treatment. For axon numbers,
we similarly quantified total axon number from ~2200 µm2 regions of TEM micrographs.
At least 10 randomly selected areas were quantified from N = 3 animals per group, and
measurements were taken with the observer blind to treatment.

To quantify molecular markers of SCs, proliferation, and macrophages, we manually
counted the number of Ki67+ or cJun+ nuclei, which were also positive for DAPI. The
number of these nuclei was normalized to the total number of nuclei in the field of view.
Macrophages were counted as CD68+ or IBA1+ cells and the numbers were normalized
to the corresponding sibling control for each experiment. For LacZ+ cells, we counted the
LacZ+ cells manually and normalized to the total number of SCs positive for S100. We
used 3 animals for each group in each experiment, and quantifications were performed
with the observer blind to treatment.

B.4.10 RNA extraction and reverse transcription
Total RNA was extracted from single sciatic nerves that had been flash frozen in liquid
nitrogen using traditional 3-phase separation with TRIzol (Life Technologies). Briefly,
TRIzol was added to the frozen tissue samples, which were then homogenized using the
following steps: the nerves were first cut into smaller pieces with dissection scissors, then
disrupted with a plastic-tipped electric homogenizer, and finally passaged through a
syringe and successively smaller needles (22.5 g and 27 g) ten times each.
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Total RNA (200ng) was then reverse transcribed in 20 µl using Superscript III First
Strand Synthesis with random hexamers (Invitrogen). The reaction mixture was
incubated for 5 min at 65° C, 50 min at 50° C, and for 5 min at 85° C, as per the
instructions from the manufacturer. To control for genomic DNA contamination, a no
reverse transcriptase reaction (RT-) was also performed for each RNA sample.

B.4.11 Quantitative reverse-transcription PCR
All assays were performed on a ViiA7 (Applied Biosystems) qPCR machine with 2X
SsoFast Evagreen Supermix (Applied Biosystems). Cycling parameters were 95° C (10
min) followed by 40 cycles of 95° C (15 s), then 60° C (1 min) with a ramp speed of 1°
C/s. Melting curve analysis was completed as follows: 95° C (15 s), 60° C (1 min), and a
progressive increase up to 95° C (0.5° C/min).

Myelin gene expression was assayed using the following previously published primers:
Sox10: 5′-CAGGTGTGGCTCTGCCCACG-3′ and 5′-GTGTAGAGGGGCCGCTGGGA3′; Mbp: 5′-CCAAGTTCACCCCTACTCCA-3′ and 5′-TAAGTCCCCGTTTCCTGTTG3′ (Sox10 and Mbp; Finzsch et al., 2010); Oct6: 5’-TCGAGGTGGGTGTCAAAGG-3’
and 5’-GGCGCATAAACGTCGTCCA-3’ (Zhu et al., 2014). Chemokine expression of
84 genes was evaluated using the 96-well format of the RT2 Profiler PCR Array:
Chemokines and Receptors (mouse) (Qiagen) for the ViiA7 machine. All qPCR data was
analyzed using Microsoft Excel. Relative expression was calculated using the ΔΔCt
method (Livak et al., 2001). All samples were normalized to the average expression of
several stably expressed housekeeping control genes: ActB, B2m, GapDH, GusB, and
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Hsp90. Relative expression (RQ), or fold change (2-ΔΔCt), is shown in figures. Error bars
depict RQmax and RQmin, which are the maximum and minimum limits of possible RQ
values based on the standard deviation of the ΔCt values. Three biological replicates for
all genotypes and sibling controls were performed.

B.4.12 Statistical Analyses
All data are presented as the mean + or ± s.d. Significance is represented as *, P < 0.05;
**, P < 0.01; ***, P < 0.001. Sample sizes are similar to previously published works. A
minimum of three animals per genotype was used unless otherwise noted. Statistical
analyses were performed using an unpaired Student’s t-test with two tails or using
ANOVA as indicated and in accordance with previously published works. Unequal
variance and data sets analyzed by a Student’s t-test met the appropriate assumptions,
including normality.
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B.5 RESULTS
B.5.1 Inducible deletion of Gpr126 from mature Schwann cells
Gpr126 is essential for SC development (Monk et al., 2009; Monk et al., 2011; Mogha et
al., 2013; Petersen et al., 2015), yet we previously noted that Gpr126 is also highly
expressed in mature SCs (Mogha et al., 2013), indicating additional possible roles of this
aGPCR in adult nerve. To investigate the role of Gpr126 in the mature PNS, we
generated SC-specific, tamoxifen-inducible conditional knockout mice by crossing
previously described Gpr126fl/fl mice (Mogha et al., 2013) with mice expressing
tamoxifen-inducible Cre recombinase under control of the PLP promoter (Leone et al.,
2003). We also used the Rosa-LacZ locus as a reporter for Cre activity, and
Gpr126fl/fl;PLPCre-ERT2;Rosa+ mice are hereafter referred to as “icKO mice.” icKO mice
were injected once per day with 2 mg of tamoxifen or vehicle control (nine parts
sunflower oil + one part ethanol) at eight weeks of age for five consecutive days.
Immunohistochemical (IHC) analyses of sciatic nerve cross sections four weeks post
injection using anti-Gpr126 and LacZ antibodies revealed that the majority of SCs in
tamoxifen-injected animals are Gpr126(-) and LacZ(+) (Fig. 1A, Number of animals (N)
= 3). Some SCs are Gpr126(+) following tamoxifen administration, but all Gpr126(+)
SCs are LacZ(-) (Fig. 1B, N = 3), indicating that Cre was not activated in these cells.

B.5.2 Gpr126 deletion does not affect myelin maintenance up to 4 months
Having established that tamoxifen administration effectively deletes Gpr126 from mature
SCs, we next sought to use this model to determine if Gpr126 is required remyelination
after injury. Given that we have recently determined that loss of Gpr126 in SCs leads to
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axon-glial interaction defects after ~one year of age (Küffer et al., 2016), we wanted to
test whether Gpr126 is required for myelin maintenance in the short-term (e.g., at time
points to be examined in nerve injury studies). To this end, we examined sciatic nerves of
tamoxifen- and control-injected icKO mice at four weeks post injection. We did not
observe differences between the two groups in the levels of Myelin basic protein (MBP)
by IHC (Fig. 2A,B; N = 3 for each group), and LacZ staining again demonstrated robust
Cre activity in tamoxifen-injected animals (Fig. 2A,B). Consistent with this observation,
toluidine blue staining of semithin (200 - 300 nm) sections showed no obvious
differences in morphology between tamoxifen- and control-injected icKO animals at 4
weeks (Fig. 2C-D; N = 3 for each group). We next counted the number of SC nuclei at 4
weeks post injections to determine if SC number is impacted by the loss of Gpr126 and
did not observe any significant difference in the number of SC nuclei (Fig. 2G; N = 3 for
each group). Quantitative reverse-transcription PCR (qPCR) analysis on the sciatic
nerves for mature SC markers (Sox10, Oct6, and Mbp) revealed no significant change in
the expression levels of these genes at 4 weeks post-injection (Fig. 2H). Finally,
ultrastructural analyses by transmission electron microscopy (TEM) further demonstrated
that there are no differences in myelin ultrastructure or thickness in tamoxifen-injected
vs. control-injected icKO mice four weeks following the final injection (Fig. 3A,C,E,G; N
= 3 for each group, P = 0.19, ANOVA). These data support the notion that Gpr126 is not
required for myelin maintenance up to one month, consistent with previous observations
in zebrafish (Glenn et al., 2013).
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In order to determine if deletion of Gpr126 from SCs affects longer-term myelin
maintenance, we expanded our analysis to four months post-tamoxifen injections. Similar
to four weeks post injection, MBP levels and nerve morphology are not affected in icKO
Gpr126 mutants compared to controls as assessed by IHC (not shown) and toluidine blue
stained semithin sections, respectively (Fig. 2E,F; N = 3 for each group). Moreover, TEM
analyses again revealed no obvious differences in myelin ultrastructure or thickness in
tamoxifen-injected vs. control-injected icKO mice (Fig. 3B,D,F,H; N = 3 for each group,
P = 0.13, ANOVA). Together, these data suggest that Gpr126 is dispensable for myelin
maintenance up to four months; thus, we were able to perform nerve injury studies
without confounding effects on Gpr126-dependent PNS maintenance.

B.5.3 Remyelination is impaired in inducible Gpr126 mutants
To further dissect the function of Gpr126 in mature nerve, we next investigated its
necessity in remyelination following nerve injury. To this end, we crushed the sciatic
nerves of tamoxifen- or control-injected icKO mice at 4 weeks after the last injection and
analyzed the nerves at 21 days post injury (dpi; N = 3 for each group). By this time point
in control nerves, myelin debris has been largely cleared, axons have regrown, and
redifferentiated SCs are robustly remyelinating regenerated axons (Akassoglu et al.,
2002). To ensure valid comparisons between the experimental groups, we marked the
crush site at the time of injury with powdered carbon, and we analyzed distal sciatic
nerve segments at the same distance from the crush site (5 mm).
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Toluidine blue-stained semithin sections and TEM analyses show that nerves from
control-injected icKO mice are robustly remyelinated with little myelin debris persisting
(Fig. 4A,C,E). In contrast, remyelination is significantly impaired in sciatic nerves from
tamoxifen-injected icKO mice as assessed by toluidine-blue stained semithin sections
(Fig. 4B). TEM analyses further revealed many defects at the ultrastructural level in
tamoxifen-injected icKO mice at 21 dpi (Fig. 4D) including significantly more myelin
debris (Fig. 4D, black arrows; Fig. 4E; P = 5.7 X 10-13, Student’s t-test), large caliber
axons (>1 µm) in bundles (Fig. 4D, asterisks), aberrant SC cytoplasmic protrusions (Fig.
4D, white arrows), and fewer myelinated axons (Fig. 4F, P = 2.3 X 10-8, Student’s t-test).
G-ratio analyses revealed that the remyelinated axons observed in the tamoxifen-injected
icKO animals have thinner myelin (i.e., higher g-ratios) compared to control-injected
animals (Fig. 4G,H; P = 0.00006, ANOVA). Importantly, IHC staining with MBP and
LacZ showed that myelin debris-like figures were associated with LacZ(+) SCs (Fig. 5B,
arrowheads), while myelin rings with normal morphology were not associated with
LacZ(+) SCs (Fig. 5B, asterisks). This indicates that Gpr126(+) SCs are capable of
remyelination, while Gpr126(-) SCs are not, supporting the model that Gpr126 is required
SC-autonomously for remyelination. To more conclusively demonstrate that the LacZ(+)
cells we observed in tamoxifen-injected animals are incapable of remyelination, we
performed bluo-gal staining on the sciatic nerves at 21 dpi prior to TEM analysis. This
causes bluo-gal crystals to form in LacZ(+) cells, which can be visualized by TEM
(Aoyama et al., 2004). This approach showed that bluo-gal(+) SCs (Fig. 5D,E; black
arrows) are filled with myelin debris and have not remyelinated, whereas we never
observed bluo-gal crystals in SCs that have remyelinated (Fig. 5D,E; asterisks).
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To determine if remyelination impairments in tamoxifen-injected icKO animals are
transient, we analyzed the sciatic nerves from control- and tamoxifen-injected icKO mice
at 35 dpi (Fig. 6). We again performed bluo-gal staining prior to TEM analysis to identify
SCs with or without Cre activity. We observed that even at 35 dpi, remyelination was
impaired in tamoxifen-injected animals (Fig. 6B). There were some myelinated axons
present (Fig. 6B; red asterisks), but these were always associated with bluo-gal(-) SCs. In
contrast, axons that were associated with bluo-gal(+) SCs were unmyelinated, often with
myelin debris still present (Fig. 6B; black arrows). Together, these data indicate that
Gpr126 is required autonomously in SCs for remyelination.

B.5.4 Gpr126 is not required for demyelination or c-Jun elevation in repair SCs
following injury
Consistent with the essential role of Gpr126 in SC developmental myelination, we
propose that this aGPCR is similarly required for remyelination following injury. Beyond
this role, however, we note that cellular responses to nerve injury and subsequent
regeneration are complex and highly controlled. Thus, the impaired remyelination we
observe in inducible Gpr126 mutants could also in part be attributable to several, nonmutually exclusive causes. Following nerve injury, SCs transform into dedicated repair
cells that degrade myelin by a selective form of autophagy termed “myelinophagy”
(Gomez-Sanchez et al., 2015), macrophages are recruited to aid in myelin debris
clearance, and axons must regrow through SC/basal lamina tubes found distal to the
injury (Chen et al., 2007). Therefore, we sought to further investigate each stage of injury
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and repair in order to define the function(s) of Gpr126 in peripheral regeneration. First,
we analyzed nerves at 3 dpi by TEM and IHC staining. At this early time point postinjury, robust demyelination, repair SC generation, and myelin/axonal debris clearance
should be evident (Arthur-Farraj et al., 2012; Jessen and Mirsky, 2008; Jessen et al.,
2015). Neither toluidine blue-stained semithin sections nor TEM micrographs revealed
overt differences between tamoxifen- or control-injected icKO mice (Fig. 7A–D), and
both groups had similar amounts of myelin debris (Fig. 7E; N = 3, P = 0.91, Student’s ttest). These data suggest that Gpr126 is not required in SCs for demyelination following
injury.

Next, we examined the ability of SCs lacking Gpr126 to elevate c-Jun. After injury, this
transcription factor is required in SCs for downregulation of mature SC genes, for
transformation into repair SCs, and c-Jun can be used as a molecular marker of repair
SCs (Arthur-Farraj et al., 2012; Jessen et al., 2015). We observed no differences in cJun(+) nuclei by IHC in control- vs. tamoxifen-injected animals at 3 dpi (Fig. 8A–C; N =
3, P = 0.85, Student’s t-test). Additionally, Ki67 staining revealed that proliferation was
not affected in control- vs. tamoxifen-injected icKO mice at 3 dpi (data not shown).
Western blot analysis demonstrated that cJun was indeed elevated in tamoxifen-injected
icKO nerves at 3 dpi, although levels were slightly lower than control-injected nerves
(Fig. 8D,E; N = 4, P = 0.02). Tamoxifen-injected icKO animals possess both mutant and
unrecombined wild-type SCs, which could impact quantitative analysis of protein levels.
Therefore, we next examined c-Jun levels in SC-specific conditional knockout
Gpr126fl/fl;DhhCre+ mice in which Gpr126 is deleted at ~E12.5 (Mogha et al., 2013). The
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Gpr126fl/fl;DhhCre+ mice are hereafter referred to as “cKO” animals. qPCR for the
transcription factor Sox10, which marks all SCs, revealed no significant differences
between control and cKO animals 3 dpi (Fig. 8H). Western blot analyses showed that,
without injury, cJun levels in some cKO mice were slightly higher than in wild-type
siblings (Fig. 8F,G; N = 6, P = 0.003; see also Chemokine section below). Importantly,
however, upregulation of total c-Jun is not affected negatively in cKO animals at 3 dpi,
and indeed levels were higher in these mutants compared to wild-type siblings (Fig.
8F,G; N = 6, P = 0.001, Student’s t-test). Together, these data support the notion that
Gpr126 is dispensable for acquisition of some characteristics of the repair SC, namely
demyelination, proliferation, and c-Jun activation.

B.5.5 Gpr126 is required in SCs for macrophage recruitment to peripheral nerve
following injury
Although SCs themselves can clear significant myelin debris in the distal stump of
injured peripheral nerves (Perry et al., 1995; Niemi et al., 2013; Gomez-Sanchez et al.,
2015), blood-derived macrophages, which are in part recruited by SCs, are also key
players in myelin debris clearance (Martini et al., 2008). To test if loss of Gpr126 in SCs
impairs macrophage numbers, we performed IHC with macrophage markers (CD68 and
Iba-1) on distal sciatic nerves of control- and tamoxifen-injected iCKO mice at different
time points after injury (3, 7, and 21 dpi) (Fig. 9). We counted the number of CD68(+) or
Iba-1(+) cells at all time points in control vs. tamoxifen-injected nerves. Quantification
revealed a significant decrease in the number of CD68(+) macrophages in tamoxifen- vs.
control-injected icKO animals at 3 dpi (Fig. 9C, P = 8.33 X 10-05, Student’s t-test) and 7
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dpi (Fig. 9F, P = 1.99 X 10-08, Student’s t-test), but not at 21 dpi (Fig. 9I, P = 0.82,
Student’s t-test ). Similarly, the number of Iba1(+) cells is significantly higher in control
nerves at 3 dpi (Fig. 9L, P = 0.0004, Student’s t-test) and 7 dpi (Fig. 9O, P = 0.0015,
Student’s t-test), but not at 21 dpi (Fig. 9R, P = 0.59, Student’s t-test). To further dissect
the role of SC-derived Gpr126 in macrophage recruitment, we again employed cKO mice
in which Gpr126 is deleted in SCs from E12.5 (Mogha et al., 2013). IHC analysis of cKO
nerves at 3 dpi revealed that, similar to icKO nerves, macrophage numbers are
significantly reduced compared to the WT nerves (Fig. 10A-F; for C, P = 0.01, Student’s
t-test; for F, P = 0.00054, Student’s t-test). These data reveal an unexpected role for SCderived Gpr126 in proper recruitment of macrophages following nerve injury.

Previous work has shown that after peripheral nerve injury, repair SCs secrete a variety
of chemokines in order to recruit macrophages to the injury site (Martini et al., 2008;
Lutz et al., 2014). Therefore, we hypothesized that Gpr126 is required for chemokine
expression after injury, and that the reduced infiltration of macrophages in Gpr126
mutants might be due to decreased chemokine expression by SCs. To begin to test this
hypothesis, we compared the expression of a wide range of chemokines and their
receptors between control and cKO nerves (N = 3) at 3 dpi by qRT-PCR. Of the 84 genes
tested, 4 chemokines were significantly downregulated in cKO nerves: Ccl2, Ccl3,
Cxcl10, and Tnf (Fig. 9G). Importantly, Ccl2 (Toews et al., 1998; Taskinen et al., 2000)
and Tnf (Chernov et al., 2015) are both normally upregulated after peripheral nerve
injury. Additionally, Tnf is important for the immunological activation of SCs (Qin et al.,
2008; Mao et al., 2010), and Ccl2 is required for macrophage recruitment after peripheral
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nerve injury (Toews et al., 1998). Interestingly, of the 4 significant hits, Tnf is the most
downregulated in Gpr126 mutant nerves, and previous studies have shown that Tnf is
required for inducing the expression of Ccl2 (Chen et al., 2004; Lin et al., 2007; Ho et
al., 2008; Xia et al., 2011), Ccl3 (Wang et al., 2013), and Cxcl10 (Hardaker et al., 2004;
Qi et al., 2009) in other contexts. To ensure that chemokine gene expression is not altered
in cKO SCs without injury, we repeated the chemokine array analysis to compare
uninjured cKO sciatic nerves compared to wild-type controls at eight weeks of age. Of
the 84 tested genes, only MapK1 was slightly (1.5-fold) upregulated in uninjured cKO
nerves compared to controls (N = 3, P = 0.04, Student’s t-test). Together, these data
suggest that Gpr126 is required for inducing expression of Tnf to activate the expression
of chemokines by repair SCs in order to recruit peripheral macrophages after nerve
injury.

B.5.6 Gpr126 is required in SCs for proper axon regeneration following injury
Following myelin and axonal debris clearance in the distal portion of an injured nerve,
regenerating axons grow through tracts called Büngner bands, which contain SCs and
their original basal laminae (Chen et al., 2007; Jessen et al., 2015). Given that Gpr126
has two known basal lamina binding partners – collagen IV (Paavola et al., 2014) and
laminin-211 (Petersen et al., 2015) – and that aGPCRs have adhesive functions as well as
signaling functions (Langenhan et al., 2013), we reasoned that Büngner bands, and
subsequently axon regeneration, might be impaired following loss of Gpr126 in SCs. To
test this, we performed IHC on longitudinal sections at 3 dpi with an anti-superior
cervical ganglion 10 (SCG10) antibody to selectively label regenerating axons (Cho et
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al., 2013; Shin et al., 2014). SCG10 levels rapidly decline in distal axons following
injury, accumulate in proximal axons within an hour following injury, and are maintained
during axon regeneration (Shin et al., 2014). We observed that axon regeneration is
significantly impaired in tamoxifen-injected icKO mice compared to control-injected
mice (Fig. 11A–D) by measuring the lengths of the longest SCG10(+) axons (Fig. 11C; N
= 3, P = 2.2 X 10-13, Student’s t-test) as well as SCG10(+) axon numbers at standard
intervals from the crush site (Fig. 11D, N = 3, P values given in figure legend). This
analysis suggested that Gpr126 in SCs is required for axon regeneration. However,
myelin debris clearance is impaired in icKO mice (Fig. 4E), which could potentially
impact axon regeneration. To control for this, we next injured sciatic nerves of cKO
mice. As cKO SCs never form myelin (Mogha et al., 2013), no myelin debris can be
present following injury. Similar to icKO mice, we observed significantly impaired axon
regeneration by anti-SCG10 staining 3 dpi in cKO mice compared to littermate
Gpr126fl/fl;DhhCre- controls (Fig. 11E–H; N = 3 for cKO, N = 4 for controls, P = 0.002 for
length of the longest axon, Student’s t-test; P values for axon numbers at standard
distances from the crush site given in figure legend).

Next, we wanted to determine whether the observed axon regeneration defects were
transient; however, SCG-10 staining is only effective for regenerating axons up to ~3 dpi
(Shin et al., 2014). Therefore, we instead examined neuromuscular junction (NMJ)
innervation of the extensor digitorum longus (EDL) muscle, which is innervated by the
sciatic nerve, at 12 dpi. We stained NMJ end plates with α-Bungarotoxin (BTX) and
counterstained axons with NF-200 (Cho et al., 2013, Cho et al., 2015). This analysis
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revealed that even at 12 dpi, the number of NMJs occupied by NF-200(+) axons was
significantly lower in tamoxifen-injected animals compared to control-injected animals
(Fig. 12A–C; N = 3, P = 0.05, Student’s t-test), although contralateral uninjured NMJ
innervation was unaffected (data not shown). We observed a similar phenotype in cKO
EDL muscle compared to wild-type siblings (Fig. 12D–F; N = 3, P = 0.003, Student’s ttest), again, with contralateral NMJs unaffected (data not shown). Together, these results
suggest that Gpr126 is non-autonomously required in SCs for peripheral axon
regeneration following nerve injury.
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B.6 DISCUSSION
In regeneration as in development, the peripheral nerve is a complex organ that requires
interactions and communication between many cell types for proper function. SCs
“sense” axon injury by an unknown mechanism, and as Wallerian degeneration and
subsequent axon regeneration proceed, SCs respond with remarkable plasticity. Mature
phenotypes are lost and the cells are transformed into dedicated repair SCs that play
many roles in nerve repair and functional recovery. Repair SCs clear debris and recruit
macrophages to the distal stump. Repair SC morphology drastically flattens and elongates
(Arthur-Farraj et al., 2012), but the basal lamina that once encompassed the mature SC
persists. Repair SCs form longitudinal columns within the basal lamina tubes, and these
units are collectively referred to as Büngner bands. Regenerating axons grow through
Büngner bands and require extracellular matrix cues and trophic support from repair SCs
for their migration and survival (Chen et al., 2007; Lutz et al., 2014). Finally, SCs further
demonstrate their capacity for dramatic change by once more acquiring mature
phenotypes, and in the case of myelinating SCs, by remyelinating the regenerated axons.
Although the signals that regulate remyelination are not completely understood, many
developmental pathways are reinitiated (Chen et al., 2007). The aGPCR Gpr126 is
essential for developmental myelination (Monk et al., 2009; Monk et al., 2011; Mogha et
al., 2013) and intriguingly, Gpr126 mRNA and protein are maintained in mature SCs
(Mogha et al., 2013) (Fig. 1). Although prolonged loss of Gpr126 in SCs is associated
with abnormal axon-glial interactions after ~one year (Küffer et al., 2016), our data
suggests that Gpr126 is dispensable for myelin maintenance up to four months after
deletion (Fig. 2,3). The lack of a myelin maintenance phenotype up to four months
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following loss of Gpr126 permitted us to perform nerve injury studies without
confounding homeostatic impairments. We noted a significant reduction in the number of
remyelinated axons and persistence of myelin debris at 21 dpi (Fig. 4B,D,E,F), and our
marker and TEM analyses suggested that Gpr126(+) SCs were capable of proper
remyelination while Gpr126(-) SCs were not (Fig. 5,6). In addition to this SCautonomous function in remyelination, we also observed interesting non SC-autonomous
phenotypes in icKO and cKO mutants following injury, namely, reduced macrophage
recruitment and impaired axon regeneration (Figs. 9–12).

Following nerve injury, repair SCs upregulate several chemokines including interleukins,
TNF-α, LIF, and MCP-1, which serve to recruit macrophages to the distal nerve (Martini
et al., 2008; Lutz et al., 2014). These macrophages phagocytose myelin and axonal
debris, thereby facilitating eventual nerve repair (Martini et al., 2008; Bruck et al., 1997).
Interestingly, here we show that Gpr126 is required in SCs to upregulate chemokine
expression following nerve injury, particularly Tnf and some of its downstream targets –
Ccl2, Ccl3, and Cxcl10 (Fig. 10G). Dissecting the molecular relationships between
Gpr126 and these chemokines in macrophage recruitment will be an important next step.
Despite their importance, however, macrophages are not completely essential for debris
clearance in the distal stump, as repair SCs are also highly proficient at this task. Indeed,
for the first five days following injury (Perry et al., 1995; Liu et al., 1995), SCs are
primarily responsible for debris clearance and in mouse mutants that lack macrophage
recruitment to distal nerve due to loss of the chemokine receptor Ccr2, SCs are capable of
clearing myelin debris alone (Niemi et al., 2013). It was recently shown that repair SCs
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clear myelin debris by a specialized form of autophagy termed “myelinophagy” (GomezSanchez et al., 2015). Therefore, our observation that myelin debris persists up to 21 dpi
(Fig. 4E) suggests that Gpr126 is also required in SCs for efficient myelinophagy, and
future work is required to directly test this hypothesis.

We also observed impaired axon regeneration and NMJ reinerrvation in SC-specific
Gpr126 mutants that was not the consequence of increased myelin debris, as both icKO
(myelin debris present) and cKO mutants (no myelin debris present) displayed the same
phenotype (Fig. 11,12). Given that the ECM proteins laminin-211 and collagen IV are
binding partners for Gpr126 (Petersen et al., 2015; Paavola et al., 2014), it is possible that
the Büngner band basal lamina tubes are disrupted without Gpr126 in such a way that
axon regeneration is negatively impacted. Although we did not observe obvious loss of
the basal lamina by TEM, abnormal basal lamina loops and outfoldings were evident in
Gpr126 icKO mutants up to 21 dpi (Fig. 4D), suggesting that the stability of this structure
was in some way compromised. We note that laminin proteins are known modulators of
axon regeneration following nerve injury. Antibody-mediated perturbation of the α2laminin chain reduces axon regeneration on nerve sections, while genetic loss of the γ1laminin chain impairs axon regeneration in vivo (Agius et al., 1998; Chen et al., 2003).
Thus, perhaps Gpr126 and laminin-211 interactions are required in regeneration in
addition to development. Interestingly, loss of c-Jun in SCs also impairs axon
regeneration in addition to neuronal survival (Arthur-Farraj et al., 2012). c-Jun is a
transcription factor that functions as a key mediator of repair SC transformation
following injury, although c-Jun levels are upregulated in Gpr126 mutant SCs after nerve
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crush (Fig. 8). In the future, it will be important to investigate whether c-Junindependent/Gpr126-dependent pathways in SCs are required for nerve repair.

In SC development, a major pathway downstream of Gpr126 activation is the elevation of
cAMP to initiate terminal differentiation (Monk et al., 2009; Monk et al., 2011; Mogha et
al., 2013). Whereas a driving role for cAMP in SC differentiation has been known for
decades (Scherer et al., 1994; Morgan et al., 1991; Mokuno et al., 1988; Monuki et al.,
1989; Mirsky et al., 1990), the function of this second messenger in the injury response is
less clear, as previous studies draw different conclusions regarding levels of cAMP in
distal nerve stumps following injury. cAMP levels were reported to be increased 1 – 6
hours post nerve crush injury in rabbit (Appenzeller et al., 1972) and decreased 2 – 35
days post cut or crush injury in rat (Podulso et al., 1995). There are also conflicting
reports regarding the effect of exogenous cAMP elevation on nerve repair (McQuarrie et
al., 1977; Gershenbaum et al., 1980), and cAMP certainly functions in peripheral axons
in addition to SCs (Kilmer et al., 1984; Kilmer et al., 1987). Given that Gpr126 can
couple to Gi-family proteins in addition to Gs (Mogha et al., 2013; Leibscher et al.,
2014) and that Gpr126 has G protein signaling-independent functions in SCs (Petersen et
al., 2015), we cannot conclude that a lack of cAMP elevation underlies any of the
phenotypes we observe in the SC-specific Gpr126 mutants following injury. Indeed, it is
perhaps counterintuitive that such a strong differentiation signal would be required in SCs
while they are maintaining a repair, non-differentiated phenotype, although we predict
that cAMP elevation is required for remyelination following re-establishment of axon-SC
interactions in repair as in development. As the sensitivity and in vivo applications for
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cAMP sensors improve (Langenhan et al., 2015), it will be very interesting to monitor
cAMP levels in individual SCs following nerve injury and during repair responses and
remyelination.

In neurobiology, aGPCRs have traditionally been studied in the context of development
(e.g., Langenhan et al. 2016), but here we demonstrate key functions for Gpr126 in nerve
regeneration in the adult animal. We show that Gpr126 is required in SCs for axon
remyelination, mirroring its essential developmental role. We also show that SC-derived
Gpr126 is needed for proper macrophage recruitment, myelin debris clearance, and axon
regeneration, uncovering new and unexpected roles for this aGPCR in peripheral nerve
repair. As a GPCR, Gpr126 represents an attractive therapeutic target in PNS disease and
injury, and given the link between Gpr126 and laminin 211, this work has important
clinical implications for MDC1A patients.
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B.7 FIGURES

Figure B1: PLPCre-ERT2 drives recombination of Gpr126 in mature Schwann Cells (SCs).
(A,B) Immunohistochemistry (IHC) shows Gpr126 protein levels in inducible conditional PLPCreERT2
;Gpr126fl/fl ;Rosa+ knockout (icKO) mice 4 weeks after control (A) or tamoxifen (B)
injections. (A-A”) Gpr126 (red) is observed in SCs from control-injected sciatic nerve (arrows),
but LacZ (green) is not, indicating a lack of Cre activity. (B-B”) Gpr126 (red) is not observed in
recombined LacZ(+) (green) SCs (red arrows), demonstrating that PLPCre-ERT2 can effectively
delete Gpr126 from mature SCs. Some Gpr126(+) cells are observed (white arrows), but do not
costain for LacZ, indicating that Cre was not active. DAPI (blue) labels nuclei. (A,B) scale bar =
50 µm. (C) Schematic representation of experimental approach in icKO mice.
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Figure B2: Gpr126 is dispensable for maintenance of MBP protein levels and gross myelin
morphology up to four months. (A,B) IHC of sciatic nerve cross-sections stained with MBP
(red), LacZ (green), and DAPI (blue) 4 weeks following final control (A) or tamoxifen (B)
injections. Scale bar = 50 µm. (C-F) Toluidine blue stained semithin sections of control- (C,E)
and tamoxifen- (D,F) injected animals reveal no gross differences 4 weeks (C,D) or 4 months
(E,F) following the final injections. Scale bar = 20 µm. (G) Number of SC nuclei is not
significantly different in tamoxifen-injected animals compared to controls at 4 weeks post
injection. (H) qPCR at 4 weeks post tamoxifen injection reveals that expression of key SC
differentiation genes (Sox10, Oct6, Mbp) is not significantly altered between the two groups.
Error bars are shown as + s.d.
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Figure B3: Gpr126 is dispensable for myelin maintenance up to four months. (A-D)
Transmission electron microscopy (TEM) micrographs of sciatic nerves from control-injected
(A,B) and tamoxifen-injected (C,D) icKO animals 4 weeks (A,C) and 4 months (B,D) following
the final injection. No gross differences were observed in either treatment or time point. Scale bar
= 2 µm. (E-H) Quantification of G-ratio in control-injected (black) and tamoxifen-injected (gray)
icKO animals at 4 weeks (E,G) and 4 months (F,H) following the final injection. G-ratio
quantification reveals no significant difference between the two groups at 4 weeks post injections
(P = 0.19, ANOVA) or at 4 months post injections (P = 0.13, ANOVA). Error bars are shown as
+ s.d.
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Figure B4: Remyelination is impaired in inducible Gpr126 mutants. (A,B) Toluidine blue
stained semithin sciatic nerve sections reveal impaired remyelination in tamoxifen-injected icKO
animals (B) compared to control animals (A) 21 days post injury (dpi). Scale bar = 20 µm (C,D)
TEM micrographs of control-injected (C) or tamoxifen-injected (D) icKO sciatic nerves 21 dpi.
Axons in control nerves are well-myelinated. In tamoxifen-injected icKO sciatic nerves, myelin
debris is evident (black arrows in D), few axons are myelinated, large caliber axons are observed
in bundles (asterisks in D), and SC cytoplasmic protrusions are observed (white arrows in D).
Scale bar = 2 µm (C,D). (E-F) Quantification of nerve abnormalities in control-injected (black)
vs. tamoxifen-injected (gray) icKO animals 21 dpi. (E) More area is covered by myelin debris in
tamoxifen-injected icKO mice compared to controls (P = 5.8 x 10-13, Student’s t-test). (F) Fewer
axons are myelinated in tamoxifen-injected compared to control-injected icKO animals P = 2.3 x
10-08, Student’s t-test. (G,H) G-ratio analyses show that when remyelination occurs in tamoxifeninjected animals, the myelin sheaths are thinner than in control-injected animals (P = 0.003,
ANOVA). Error bars are shown as + s.d.
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Figure B5: Gpr126 in Schwann cells is required for remyelination at 21 dpi. (A-B) IHC of
sciatic nerve cross-sections at 21 dpi in control-injected (A) and tamoxifen-injected (B) animals
stained with MBP (red), LacZ (green), and DAPI (blue). Robust MBP stain in control animals
reveals that most myelin rings have normal morphology. In tamoxifen-injected animals, MBP
stain with abnormal morphology is associated with LacZ(+) SCs (arrowheads), while MBP stain
with normal morphology is associated with LacZ(-) SCs (asterisks). (C-D) Bluo-gal EM staining
of nerves at 21 dpi reveals that the myelinated axons observed in tamoxifen treated nerves are
associated with bluo-gal(-) SCs that therefore lack Cre activity (asterisks D). In contrast, bluogal(+) SCs (identified by deposition of electron dense bluo-gal reaction residue, arrowheads) have
persistent myelin debris. Scale bar = 50 µm (A-B”), 2 µm (C,D).
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Figure B6: Gpr126 in Schwann cells is required for remyelination at 35 dpi. (A-B) TEM
images at 35 dpi of sciatic nerve cross sections from control- (A) or tamoxifen-injected (B).
Myelin debris persists and is associated only with SCs possessing bluo-gal crystals (B, arrows).
In contrast, SCs lacking bluo-gal crystals are associated with myelin (B, asterisk). (C-E)
Quantifications show the % LacZ(+) (gray bars) or LacZ(-) (black bars) SCs with the indicated
characteristics. (C) More LacZ(+) SCs are associated with myelin debris compared to LacZ(-)
SCs (P = 0.001 Student’s t-test). (D) More LacZ(+) SCs are observed at the promyelinating stage
than LacZ(-) SCs (P = 0.007, Student’s t-test). (E) Only LacZ(-), and never LacZ(+) SCs, are
observed at the myelinating stage. N = 4.
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Figure B7: Demyelination is not impaired in inducible Gpr126 mutants following injury.
(A,B) Toluidine blue stained semithin sciatic nerve sections reveal grossly equal demyelination in
tamoxifen-injected icKO animals (B) compared to control animals (A) at 3 dpi. Scale bar = 50
µm (C,D) TEM micrographs of control-injected (C) or tamoxifen-injected (D) icKO sciatic
nerves at 3 dpi. Scale bar = 2 µm. (E) Quantification reveals no significant differences in the area
covered by myelin debris in control- (black bar) vs. tamoxifen-injected (gray bar) icKO animals
(P = 0.914, Student’s t-test). Error bars are shown as + s.d.
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Figure B8: Gpr126 is not required for c-Jun induction in Schwann cells following injury.
(A,B) IHC of sciatic nerve cross-sections at 3 dpi in control-injected (A) and tamoxifen-injected
(B) animals stained with LacZ (green), c-Jun (red), and DAPI (blue). Both LacZ(+) (white
arrows) and LacZ(-) (red arrows) SCs are c-Jun(+) indicating that SCs upregulate c-Jun normally
in the presence or absence of Gpr126. Scale bar = 20 µm. (C) Quantification reveals no
difference in the number of c-Jun(+) nuclei in control- (black bar) vs. tamoxifen-injected (gray
bar) icKO animals (P = 0.85, Student’s t-test). (D) Western blot analysis of sciatic nerve without
(-) and with (+) nerve injury shows that tamoxifen-injected icKO animals upregulate c-Jun at 3
dpi, although to a variably lesser extent than control-injected animals. Results from N = 2 control
and N = 2 tamoxifen-injected animals are shown. (E) Quantification of c-Jun levels in control(black bars) vs. tamoxifen-injected (gray bars) icKO nerves 3 dpi (+/- nerve crush). Results are
quantified from N = 4 control and N = 4 tamoxifen-injected animals (P = 0.02 control-injected (+)
nerve crush vs. tamoxifen-injected (+) nerve crush, Student’s t-test). (F) qPCR analysis shows
that Sox10 expression is not significantly different in WT (black bar) vs. SC-specific conditional
knockout Gpr126fl/fl;DhhCre+ mice (cKO animals, gray bar) (P= 0.93, Student’s t-test). (G)
Western blot analysis of cKO nerves compared with wild-type sibling (WT) nerves at 3 dpi
reveals that cJun is upregulated in both groups after injury. Results from N = 3 WT and N = 3
cKO animals are shown. (H) Quantification of c-Jun levels in WT (black bars) vs. cKO (gray
bars) nerves 3 dpi (+/- nerve crush). Results are quantified from N = 6 WT and N = 6 cKO
animals (P = 0.001, WT (+) nerve crush vs. cKO (+) nerve crush, Student’s t-test). Error bars are
shown as + s.d.
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Figure B9: Macrophage recruitment is delayed in inducible Gpr126 mutants following
injury. IHC of sciatic nerve cross-sections in control-injected (A, A’, D, D’, G, G’) and
tamoxifen-injected (B, B’, E, E’, H, H’) icKO animals stained with CD68, s100 (green), and
DAPI (blue), and (J-Q’) IHC staining with Iba1 (red), S100 (green) and DAPI (blue) at 3 dpi (AB’, J-K’), 7 dpi (D-E’, M-N’) and 21 dpi (G-H’, P-Q’), respectively. Scale bar = 50 µm. (C, F,
I,) Quantification reveals a significant decrease in the number of CD68(+) macrophages in
tamoxifen- (gray bar) vs. control-injected (black bar) icKO animals at 3 dpi (C, P = 8.33 X 10-05,
Student’s t-test) and 7 dpi (F, P = 1.99 X 10-08, Student’s t-test), but not at 21 dpi (I, P = 0.82,
Student’s t-test). (L, O, R) Similarly, the number of Iba1(+) cells is significantly higher in control
nerves at 3 dpi (L, P = 0.0004, Student’s t-test) and 7 dpi (O, P = 0.0015, Student’s t-test), but
not at 21 dpi (R, P = 0.59, Student’s t-test). Error bars are + s.d.

268

Figure B10: Macrophage recruitment and chemokine expression are impaired in
conditional Gpr126 mutants following injury. IHC for CD68 (A-B’) and Iba1 (D-E’) show
macrophages (red) in WT (A,D) and cKO (B,E) nerves at 3 dpi. Scale bar = 50 µm. (C,F)
Quantification of CD68(+) cells (C) and Iba1(+) cells (F) reveals that macrophage number is
significantly decreased in cKO (gray bars) compared to WT (black bars). For C, P = 0.01,
Student’s t-test; for F, P = 0.00054, Student’s t-test. (G) Chemokine expression is significantly
reduced in Gpr126 cKO nerves at 3 dpi relative to controls (Ccl2, P = 0.0442; Ccl3, P = 0.0375,
Cxcl10, P = 0.0244, Tnf, P = 0.0144, Student’s t-test). Error bars are ± s.d.
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Figure B11: Axon regeneration is impaired when Gpr126 is absent in SCs. (A,B) IHC of
longitudinal sections of crushed sciatic nerves stained with SCG10 at 3 dpi revealed that
SCG10(+) axons extend farther in control-injected (A) compared to tamoxifen-injected (B) icKO
animals (white arrows). Crush sites are marked with white vertical lines. Scale bar = 500 µm.
(C,D) Quantifications reveal that axon regeneration is significantly impaired in tamoxifeninjected compared to control-injected icKO animals. (C) Lengths of longest axons are shorter in
tamoxifen-injected (gray bar) icKO animals compared to control-injected (black bar) icKO
animals (P = 2.207 x 10-11, Student’s t-test). (D) Numbers of regenerated SCG10+ axons at
defined distances from the crush site are significantly lower in tamoxifen-injected icKO animals
(gray bars) compared to control animals (black bars) (P = 0.003 at 1.5 mm; 0.003 at 2 mm; 0.01
at 2.5 mm; 0.01 at 3 mm; 0.02 at 3.5 mm; 0.002 at 4 mm; 0.03 at 4.5 mm; 0.01 at 5 mm from the
crush site. Student’s t-test for each point). (E,F) IHC of longitudinal sections of crushed sciatic
nerves stained with SCG10 at 3 dpi revealed that SCG10(+) axons extend farther in wild-type (E)
compared to cKO mutants (F) (white arrows). Crush sites are marked with white vertical lines.
Scale bar = 500 µm. (G,H) Quantifications reveal that axon regeneration is significantly impaired
in cKO Gpr126 mutants compared to WT littermates. (G) Lengths of longest axons are shorter in
cKO (gray bar) animals compared to WT (black bar) animals (P = 0.002, Student’s t-test). (H)
Numbers of regenerated SCG10+ axons at 3 dpi is significantly lower in cKO mice (gray bars)
compared to WT controls (black bars) (P= 0.02 at 1.5 mm; 0.01 at 2 mm; 0.006 at 2.5 mm; 0.002
at 3 mm; 0.0005 at 3.5 mm; 0.0004 at 4 mm; 0.01 at 4.5 mm; 0.01 at 5 mm from the crush site.
Students t-test for each point). Error bars are shown as + s.d.
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Figure B12: Neuromuscular junction reinnervation is impaired when Gpr126 is absent in
SCs. (A-C) Neuromuscular junction (NMJ) staining with Alexa-555 conjugated Bungarotoxin
(BTX, red) and NF-200 (green) reveals that significantly fewer NMJs are reinnervated at 12 dpi
(white arrows) in tamoxifen-injected animals (B-B’’) compared to control-injected animals (AA’’) (N = 3 P= 0.05, Student’s t-test). (D-F) Significantly fewer NMJs are reinnervated at 12 dpi
in cKO mice (F-F’’) compared to wild-type siblings (D-D’’) (N = 3 P= 0.003, Student’s t-test).
Scale bar= 50 µm. Error bars are shown as + s.d.
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Appendix C
Progress on identifying other adhesion GPCRs
with functions in myelinating glia
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PREFACE
I performed all qPCR and RT-PCR included in this appendix. I generated and injected the
gpr97 TALEN and isolated both mutant alleles. mbp ISH analysis of the stl211 allele was
performed by a high school summer student, Amber Watson, and myself. A visiting
Master’s student, Nicole Bartsch, and I generated and injected the gpr64a TALEN. I
isolated the stl86 and stl87 alleles. The gpr133 TALEN was generated and injected by
Nina Auerbach, another visiting Master’s student, with the help of Sarah C. Petersen. NA
and SCP isolated the gpr133 mutant alleles. Nicholas E. Sanchez provided the mouse
sciatic nerve cDNA and the mouse Bai2 and Ipo8 RT-PCR primers.
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C.1 EXPRESSION OF OTHER aGPCRS IN THE CNS AND PNS
I profiled the expression of all zebrafish aGPCRs in the adult optic nerve (OLs) and pLLn
(SCs) (Figure C1). I then chose four aGPCRs with varying expression levels in zebrafish
glia-rich tissues and tested for expression in the mouse sciatic nerve. Interestingly,
Gpr97, Gpr133, Eltd1, and Bai2 are all expressed in both the zebrafish and mouse PNS
(Figure C2 A,B). This suggests that the expression profiles of zebrafish aGPCRs may be
good indicators of whether or not an aGPCR is likely to have a conserved role in
myelinating glial development.

C.2 GPR97 AND GPR133 TALEN MUTANTS
To determine if any of these other aGPCRs are important in myelinating glial
development, we generated targeted mutations in gpr97 and gpr133 using TALENs
(Figure C2 C,D). ISH analysis of mbp expression in gpr97stl211 mutants showed that loss
of gpr97 may result in a mild reduction in mbp mRNA at 3 dpf in both the CNS and PNS,
but that these differences are no longer evident by 5 dpf (Figure C3 A-E). However, TEM
analyses and additional marker analyses should be done to determine if the early
reduction in mbp expression has any lasting consequences on myelin ultrastructure or
later stages such as myelin maintenance. Additionally, the myelination status of gpr133
mutants should be characterized.

C.3 TALENs TARGETING GPR64a DISRUPTED CONSERVED CYSTEINE
RESIDUES IN THE GPS
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gpr64a is another zebrafish aGPCR that showed some expression in tissues enriched for
myelinating glia. We used TALENs to target the GPS domain of gpr64a, similarly to the
strategy used in gpr56stl13 mutants, and were able to isolate two alleles, stl86 and stl87,
which result in 14 bp and 15 bp deletions, respectively. I performed ISH on both stl86
and stl87 and observed no differences in mbp expression in either allele in the CNS or
PNS at either 3 dpf or 5 dpf (data not shown). Here again, TEM should be performed to
confirm that the myelin is ultrastructurally normal in gpr64a mutants. gpr64 is also
duplicated in zebrafish, so it is possible that both copies will have to be mutant to see any
effect on myelination.
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C.4 FIGURES

Figure C1. Zebrafish aGPCR expression profiles in tissues enriched for myelinating
glia. (A) Expression of aGPCRs in the optic nerve (CNS) of adult zebrafish. (B)
Expression of aGPCRs in the adult zebrafish pLLN (PNS). Fold change, or RQ, is
depicted. Error bars represent RQmin and RQmax. Expression of each aGPCR was
compared to the average expression of three housekeeping genes – ipo8, gapdh, and tbp.
Fold change was calculated relative to the expression in whole juvenile zebrafish at 21
dpf.
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Figure C2: Using TALENs to disrupt aGPCRs expressed in myelinating glia. (A)
Protein domain architecture of a selection of zebrafish aGPCRs that are expressed in
tissues enriched for myelinating glia – zfGpr97, zfGpr133, zfEltd1, zfBai2. (B) These
four aGPCRs are expressed at varying levels in the pLLn or optic nerve of adult
zebrafish. RT-PCR in mouse sciatic nerves at P42 confirms that the expression of these
aGPCRs in the PNS is conserved. (C,D) TALEN-induced lesions in gpr97 and gpr133
and their genotyping assays.
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Figure C3: gpr97 have mild impacts on mbp expression at early stages. (A) Images
showing examples of how mbp expression was scored by ISH. At 3 dpf, gpr97stl211 hets
and mutants appear to have less mbp expression than wild-type siblings in both the CNS
(B) and PNS (D). However, these experiments should be repeated with larger sample
sizes to enable statistical analyses. Also, by 5 dpf, there is no difference in mbp
expression between gpr97 mutants and controls in either the CNS (C) or PNS (E).
284

Figure C4: TALEN induced lesions in zebrafish gpr64a disrupt conserved cysteine
residues in the GPS. (A) Protein domain and exon architecture of zebrafish gpr64a,
showing that the TALEN targets the GPS domain. (B) Sequences of specific deletions
generated in gpr64astl86 and gpr64astl87. (C) Protein sequence alignment of the GPS motif
from human, mouse, and zebrafish Gpr64 showing the disruption of conserved cysteine
residues in stl86 and stl87 mutants.
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C.5 MATERIALS AND METHODS
C.5.1 Zebrafish qPCR
Zebrafish brain and 21 dpf cDNA samples were the same as those used in Chapter 2 of
this thesis. The pLLn and optic nerves were isolated in a similar manner from the same
adults as those used in Chapter 2. All of the qPCR shown in this appendix was performed
in conjuction with, and therefore identically to that described in Chapter 2. See sections
2.5.2-2.5.6.

C.5.2 Mouse RT-PCR
cDNA from wild-type mouse sciatic nerves at P42 was kindly provided by Nicholas E.
Sanchez (Monk lab).
The following primer pairs were used: Gpr97: 5’-CCACTTGACCTTCTTCGCCT-3’ and
5’-AGATCATGGAGACGGCACTG-3’; Gpr133: 5’-CCGCTTGCCCAATAAATCCC-3’ and
5’-GTCATGGCGTTGTCCTCTGA-3’; Eltd1: 5’-AGACTCCTCCCGCTTCTAGT-3’ and 5’AAGCAGGCTTCCACACCATT-3’; Bai2: 5’-TACCTGTCACTTCGGGAACAC -3’ and

5’-AGCACCTCCTTGGGTAGAAAG-3’; Ipo8: 5’-TCAGAGAGACGGAGAATGACG3’ and 5’-CTTTGGATTTGACAGCAGAGC-3’

C.5.3 TALENs in zebrafish
TALENs were generated as previously described [1]. We targeted exon 2 of zebrafish
gpr97 and gpr133 with the aim of generating null alleles. We targeted the GPS domain of
gpr64a to disrupt signaling. The sequences of the targeted lesions are shown in Figure C2
and Figure C4.
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C.5.4

In situ hybridization (ISH)

mbp ISH was performed as described in section 4.5.3. Progeny from gpr97stl211 het
intercrosses were fixed at 72 hpf or 5 dpf and subjected to ISH. I then scored each larva
on a scale of 0-2; 0 = no mbp expression apparent; 1 = weak expression apparent but not
normal levels; 2 = more mbp expression than a 1, but still not as strong as a 3; 3 =
strong/normal mbp expression.

C.6 REFERENCES
1. Dahlem TJ, Hoshijima K, Jurynec MJ, Gunther D, Starker CG, Locke AS, et al.
Simple Methods for Generating and Detecting Locus-Specific Mutations Induced
with TALENs in the Zebrafish Genome. PLoS genetics. 2012;8(8):e1002861.
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Appendix D
Gpr126 genetically interacts with Nf1
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PREFACE

This experiment was designed, performed, and analyzed by Breanne L. Harty, with input
from Kelly R. Monk and Amit Mogha.

We thank Nancy Ratner for kindly providing sciatic nerve cDNA samples from the Nf1
cKO animals. We also thank Cristina de Guzman Strong and her lab for use of and
assistance with their ViiA7 qPCR machine.
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D.1 GPR126 MUTANT SCHWANN CELLS ARE HYPERPROLIFERATIVE
SC-specific loss of Gpr126 results in an increased number of Ki67-positive nuclei in the
sciatic nerve at P4 and P21 [1], suggesting that these mutant SCs may be
hyperproliferative. Gpr126 mutant nerves also resemble preneoplastic nerves. Thus, we
hypothesized that Gpr126 may be involved in tumorigenesis in peripheral nerves. To
begin addressing this question, we first needed to assess the expression of Gpr126 in
nerve tumors.

D.2 LOSS OF NF1 RESULTS IN PNS TUMORS
It is well documented that mutations in neurofibromin-1 (NF1) result in
Neurofibromatosis-1, a genetic disorder currently affecting approximately 100,000
Americans, that is characterized by small tumors throughout the nervous system [2-6].
These tumors, known as neurofibromas, are typically benign at first, but over the life of
the patient can often transform into MPNSTs. These tumors can be modeled and studied
using SC-specific Nf1 cKO mice, which spontaneously develop neurofibromas very
similar to those found in human patients [7].

D.3 GPR126 GENETICALLY INTERACTS WITH NF1
Therefore, we obtained cDNA from wild-type sciatic nerves, Nf1 cKO nerves without
tumors, as well as NF1 cKO nerves that had developed neuromas. qPCR showed that
Gpr126 expression is markedly reduced when Nf1 is deleted regardless of tumor status.
Additionally, Gpr126 expression increased in the Nf1 mutants that had developed
neurofibromas, although it was still significantly reduced relative to wild-type levels.
Together, these data suggest that Gpr126 genetically interacts with Nf1, and that Gpr126
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expression level may be associated with tumor status. However, additional work is
required to understand the nature of the Gpr126/Nf1 interaction and the possible link
between Gpr126 and neurofibroma formation, especially because the qPCR data and the
Ki67 IHC data don’t necessarily agree. The hyperproliferation (excess Ki67-positive
nuclei) observed in Gpr126 mutants suggests that loss of Gpr126 expression might be
associated with tumorigenesis, however qPCR shows that Gpr126 expression increases,
rather than decreases in Nf1 cKO tumors when compared to Nf1 cKO nerves that had not
yet developed tumors.
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D.4 FIGURE

Figure D1: Gpr126 expression is reduced in Nf1 cKO sciatic nerves. Fold change in
expression of Gpr126 relative to the housekeeping gene, Gapdh, as measured by qPCR.
Left: wild-type sciatic nerves (N =2); Middle: sciatic nerves from Nf1 cKO animals that
had not developed tumors (N = 2); Right: Nf1 cKO sciatic nerves positive for
neurofibromas (N = 3). Student’s t-test.

292

D.5 MATERIALS AND METHODS
D.5.1 Sample procurement
We obtained all cDNAs used in this experiment as a kind gift from Nancy Ratner.
D.5.2 Quantitative reverse-transcription PCR
All assays were performed on a ViiA7 (Applied Biosystems) qPCR machine with 2X
SsoFast Evagreen Supermix (Applied Biosystems). Cycling parameters were 95° C (10
min) followed by 40 cycles of 95° C (15 s), then 60° C (1 min) with a ramp speed of 1°
C/s. Melting curve analysis was completed as follows: 95° C (15 s), 60° C (1 min), and a
progressive increase up to 95° C (0.5° C/min). All qPCR data was analyzed using
Microsoft Excel. Relative expression was calculated using the ΔΔCt method [8]. All
samples were normalized to the average expression of the housekeeping gene, GAPDH.
Relative expression (RQ), or fold change (2-ΔΔCt), is shown in the graph. Error bars depict
RQmax and RQmin, which are the maximum and minimum limits of possible RQ values
based on the standard deviation of the ΔCt values. We had two biological replicates for
the wild-type and “no tumor” samples, and three biological replicates for the
“neurofibroma” samples. Two technical replicates were performed for all samples.

The following primers were used: Gpr126: 5’-GTAGCAGAATGGCTCAATTCAACCT-3’
and 5’-TGACTTTCATCCTGTCCTCTCC-3’; GAPDH: 5’-GTGTGAACGGATTTGGCCGT3’ and 5’-GCCGTGAGTGGAGTCATACTGGA-3’.
D.5.3 Statistical Analyses
Statistical analyses were performed using an unpaired Student’s t-test with two tails,
actual p-values are shown in the graph.
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Appendix E
More on mapping mutations in zebrafish using
whole genome sequencing
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PREFACE
Breanne L. Harty (Monk Lab) wrote this guide with significant input from Sarah D.
Ackerman in October 2014. Additional notes have been added over the years as we have
sequenced and mapped more mutants, and many of the notes are simply anecdotal pieces
of advice as Sarah and I have participated in the sequencing and mapping of over 12
mutants using this protocol.
This appendix consists of two key parts: 1) a protocol for isolated genomic DNA from
zebrafish to submit for sequencing, and 2) a detailed “how-to” guide on using the
terminal and PERL scripts to analyze WGS data. This mapping protocol is ever-evolving
and being added to. The exact details will be slightly different for every mutant, however
the core tools will be constant and the concepts should be broadly applicable. Also,
please note that some of the information in this guide is specific to Mac users. The
terminal interface for PC users will appear slightly different but the commands should
work the same.
PERL scripts written by Tom O’Reilly-Pol, PhD (Stephen L. Johnson Lab) and Ryan S.
Gray, PhD (Liliana Solnica-Krezel lab) and modified/commented by BLH and SDA
Script troubleshooting and post-chromosomal analyses protocols written by BLH, with
significant input from SDA
All of the scripts and files mentioned herein can be obtained upon request from the Monk
lab. Email Kelly R. Monk (monkk@wustl.edu) Breanne L. Harty (blharty@wustl.edu) or
Nicholas E. Sanchez (sanchez@wustl.edu). We are currently working on getting all of
these files hosted on a common website through the Washington University Zebrafish
Facility, but as of February 2017, they are not yet available.

Some parts of this appendix may be reproduced or adapted at a later date in the following
manuscript that is currently in preparation:
Nicholas E. Sanchez, Breanne L. Harty, Sarah D. Ackerman, Thomas O’ReillyPol, Ryan S. Gray, Lilianna Solnica-Krezel, Stephen L. Johnson, Kelly R. Monk.
Whole genome sequencing-based mapping and candidate identification of
mutations from fixed or fresh zebrafish tissue from forward genetic screens. 2017.
In preparation.
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E.1 PREPARING ZEBRAFISH GENOMIC DNA FOR WHOLE
GENOME SEQUENCING

E.1.1 Introduction
This protocol describes the steps necessary to obtain genomic DNA from zebrafish larvae
of sufficient quantity and quality to be used for WGS library preparation. This protocol
was established during the Tg(lhx1a:eGFP)/Tg(mbp:mCherry-CAAX) (LM) screen
conducted jointly by the Lila Solnica-Krezel and Kelly Monk Labs, as well as the
Johnson Lab. Thus far, these protocols have been used on fresh whole larvae at 5 days
post fertilization (dpf) (Monk), and from whole larvae at 5 dpf that had undergone in situ
hybridization (ISH) with the mbp probe (Monk).

The Genome Technology Access Center (GTAC) at Washington University in St Louis
does all of our library prep and WGS. To get good-quality libraries for Illumina
sequencing, GTAC requires at least 1ug of gDNA in a volume up to 130 ul. I have
obtained good data from libraries that had to be prepped with only 800 ng gDNA, but if
possible provide the full 1 ug.
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E.1.2 Genomic DNA isolation from fresh tissue/living larvae
1. Obtain pools of at least 20-30 zebrafish larvae (**sedated in tricaine) and
transfer to a 1.5 ml tube. Remove as much egg water (or embryo medium) as
possible. **The tricaine does not interfere with any of the downstream steps,
therefore it is most humane to use it.
2. Add 500µl of fish lysis buffer (see The Zebrafish Book for recipe). Place tubes
in heat block at 98°C for 10 min. This step is absolutely critical for getting
good DNA yield at the end. If you forget this step, you will NOT be able to see a
pellet at step 4.
3. Add 5 µl of 20 mg/ml of Proteinase K. Let sample digest overnight (at least 12
hours) at 55°C in a heat block or an air incubator.
4. Centrifuge the sample for 1 min at 17900 x g. Transfer the supernatant into a
new 1.5 ml tube.
5. Add 500µl 100% isopropanol. Mix the sample by inversion, and let sit at RT for
at least 5+ minutes or overnight at -20°C. Some protocols insist that yield is
better if the isopropanol is cold when added, but I have always added RT
isopropanol and then left at -20°C o/n and that has always given good yield.
Others have done the quicker way with a 5 min RT precipitation, but we have
never compared side-by-side.
6. Centrifuge the sample for 15 min at 17900 x g at RT, and pour off the
supernatant.
7. Add 500 µl of 70% ethanol, and let sit for 5+ min at RT.
8. Remove the ethanol with a pipette, briefly spin the sample, remove the residual
ethanol with a smaller tip, and let the sample air dry before resuspending the
pellet in 100 ul of TE. This volume can and should be adjusted based on pellet
size. For smaller pellets, start with less volume, you can always add more TE if
the pellet is not resuspending. Very large pellets may require more TE.
9. Incubate the sample at 60°C and vortex intermittently to resuspend the pellet
10. Store DNA at 4°C overnight to submit for sequencing the following day, or at 20°C for long-term storage.
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E.1.3 Genomic DNA isolation from PFA-fixed/ISH larvae
(** indicates steps with major modifications from original protocol)

1. During fixation and ISH be sure to use fresh PFA (thawed for less than 3 days)
at every step
2. Screen larvae for relevant phenotype while they are still in developer or
AP/NTMT buffer if possible to avoid all of the glycerol steps
3. Separate into mutant and sibling pools
a. Each pool should contain 20-30 larvae
b. Larvae should ONLY be included in the mutant pool if you are very
confident in the phenotypic scoring. Mistakes here can confound the data
analysis later!
4. Remove developer/AP and replace with 4% PFA for 20 min at RT with shaking
NOTES: If you are using in situ fish that have been in 70% glycerol for a long
time, back them out of glycerol by replacing with 50% glycerol -> 30%
glycerol -> PBSTw, then proceed to STEP 6.
Also, larvae do not have to be postfixed in 4% PFA, they can be left in AP
Buffer at 4°C if you intend to extract the gDNA within a week -> proceed
directly to STEP 7.
5. Replace PFA with 100% MeOH and store at -20°C until ready to isolate DNA
6. 2 quick washes in PBSTw to remove MeOH
7. Remove as much liquid as possible
8. Proceed with gDNA extraction using the Qiagen DNeasy Kit (cat# 69506)
NOTE: This protocol has been modified from the original protocol that comes
with the kit!!
a. Add 180 ul ATL Buffer -> let sit at RT for 10 min
b. Add 20 ul of ProtK solution (included in kit), vortex
c. **Put samples in shaker at 56°C, ~200rpm, for 3 hours
i. Note: when we have done this on ISH fish just following the
~30min recommended in the protocol, the yield was ~10-20X
lower
d. Vortex thoroughly to ensure that the tissue is completely homogenized
e. Add 200 ul AL Buffer, vortex. A white precipitate will form in most tubes.
f. Incubate at 56°C for 10 min.
g. Add 200 ul 100% EtOH (not included in kit), vortex. The white precipitate
should disappear.
h. Apply the sample to a spin column, and spin for 1 min at 8000rpm
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i.
j.
k.
l.
m.
n.
o.
p.
q.

Discard collection tube. Place column in a new collection tube.
Add 500 ul AW1 Buffer, spin 1 min at 8000 rpm
Discard collection tube. Transfer column to new collection tube.
Add 500 ul AW2 Buffer, spin 3 min at 14000 rpm
Discard collection tube.
Transfer column to a clean, labeled 1.5 mL microcentrifuge tube (eppi)
**Add 100 ul AE buffer and incubate at RT for 1-1.5 hours
Spin at 8000 rpm for 2 min
Add the eluate from previous step back to the same column. Incubate
another ~20-30 min
r. Spin at 8000 rpm for 2 min
s. Quantify the DNA yield by nanodrop. You need 1 ug DNA in less than
130 ul volume
t. SUBMIT FOR SEQUENCING!!!
NOTES: 98°C for 10min prior to ProtK addition actually decreased yield with
the kit, so the ATL buffer might not like getting that hot.
We have attempted several times to use the fresh tissue protocol with ISH larvae,
but have never been able to successfully get good DNA. We have not been able to
determine the essential kit component that makes up for that difference, but
anecdotally we would NOT recommend using anything other than the kit for ISH
fish at this point.
Be aware of your kit’s expiration date! If the kit is old, the DNA yield will be very
poor.
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E.2 A BEGINNER’S GUIDE FOR MAPPING ENU-INDUCED MUTATIONS IN
ZEBRAFISH USING WHOLE GENOME SEQUENCING
E.2.1 Introduction
This protocol describes the background information and the steps necessary to analyze
whole genome sequencing data for the purpose of mapping a causal mutation isolated in a
three-generation forward genetic ENU screen in zebrafish. This protocol was established
during the Tg(lhx1a:eGFP)/Tg(mbp:mCherry-CAAX) (LM) screen conducted jointly by
the Solnica-Krezel and Monk Labs, as well as the Johnson Lab. Notes included are
specific to the sequencing center at Washington University in St Louis, but should be
generally applicable with slight modifications. The steps described herein and all of the
notes that go along with them are written from the perspective of a terminal and PERL
novice with the intent of providing very detailed information and advice for those that are
unfamiliar with using the terminal and/or PERL and/or perhaps do not have extensive
genetics/genomics background. These analyses have been used successfully with adult
tissue (LSK), fresh whole larvae at 5 days post fertilization (dpf) (Monk), and from whole
larvae at 5 dpf that had undergone in situ hybridization (ISH) with the mbp probe
(Monk). Note: expect coverage to be slightly reduced with ISH samples.

E.2.2 Sample Submission
1. See “Preparing Zebrafish Genomic DNA for Whole Genome Sequencing”
Protocol for information on extracting high-quality genomic DNA from zebrafish
larvae (fresh tissue or ISH)
2. Submit 1 µg of genomic DNA (in less than 130 µl TE) to the Genome
Technology Access Center (GTAC) for library prep and whole genome
sequencing (WGS). NOTE: If cost is a concern, it is cheaper to do your own
quality control and make your own libraries. There are kits available for making
libraries, but know that GTAC will not take responsibility for poor quality data if
you make your own.
•

The first mutant sequenced (LSK lab) was done on 2 lanes of single-end
sequencing (Hi-seq, 1 x 50 bp reads) with the mutant and sibling pools
each getting separate lanes.

•

Thus far, the Monk lab has sequenced both the sibling and mutant pools
for one allele on a single lane of paired-end sequencing (Hi-seq, 2 x 101bp
reads). We have not experienced any major differences in coverage, and a
single paired-end lane is ~$200 less expensive than 2 single-end lanes.
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o The long-term goal is to build a WT SNP database for our screen
background so that we will no longer have to sequence the
siblings and instead will be able to sequence 2 or more mutants
per lane
•

See “GTAC_sequencing_submission_form.xlsx” for the form required to
submit WGS samples.

Monk Lab GTAC Contacts (good as of February 2017)
Sample QC and Library Prep: Toni Sinnwell (tsinnwell@path.wustl.edu)
Whole Genome Sequencing: Paul Cliften (pcliften@path.wustl.edu)

E.2.3 File handling and organization
1. Sequencing results should be returned to you 4-6 weeks after sample submission.
GTAC will send you a link to your data that contains a variety of different files.
Download all files ASAP and back them up! This data will only be maintained by
GTAC for 30 days.
•

The link GTAC sends you will contain two folders that are named with the
barcode sequences (6-7 nucleotides) as well as the
“summary_of_services.html” file. One of the barcodes represents the data
from your mutant pool and the other from your sibling pool. The
summary_of_services.html is a webpage that will show you which
barcode belongs to which pool. Keep track of this and name your files
appropriately!!

•

SAVE ORIGINAL FILES AS TEXT FILES (.txt)!!!!! Do not save
them as Excel spreadsheets. You can view them/save copies in Excel for
your own viewing pleasure, but Excel adds weird characters at the end of
lines that are not interpretable by the PERL scripts you will use for the
analysis later!

•

When saving ALL files, it will make your life much easier if you use a
CONSISTENT and LOGICAL naming scheme. (e.g. stl64_MUT for all
mutant files and stl64_SIB for all sibling files)
o It will also be easier if you keep track of the original files by
keeping the core name they were assigned by GTAC and simply
adding your prefix at the beginning
o Don’t hesitate to use long file names! Make sure you can still
identify what each file contains in five years.
302

•

The analysis process will generate A LOT of different files with very
similar names. The folder names are more amenable to customization than
the file names with the way the PERL scripts are written. So take
advantage of folder within folder structures to keep all of your files
organized.

•

Always use underscores instead of spaces in file names. In general,
space characters can be tricky, as a space can be interpreted by programs
like PERL as a delimiter similar to a “tab” or a comma.

2. The initial folders of files that GTAC sends you will not include one file type that
you will need, so you need to request these files specifically. You will need the
snpInGenome.bed files for both mutant and sibling pools. Regardless of where
you obtain your whole genome sequencing services, the .bed file is going to be
the most important for these analyses. GTAC will just add them to the appropriate
folders in the link they sent you previously. Again, download, name appropriately
and back up file ASAP.
3. The Integrative Genomics Viewer (IGV) is a user-friendly way to visualize large
sequencing datasets with any desktop/laptop (doesn’t require large server). The
software is free from the Broad Institute and can be downloaded here:
http://www.broadinstitute.org/igv/. IGV will allow you to view all of the SNPs
and the individual reads at each position. For IGV you will need the BAM (.bam)
and BAMindex (.bam.bai) files for both siblings and mutants.
•

BAM files should still be saved as .bam and BAMindex files should still
be saved as .bam.bai NOTE: When you save the original files, the prefix
of the file names should be IDENTICAL for the .bam and the .bam.bai
files because the identical prefix tells IGV which index file goes with
which BAM file. Example: stl64_mut_all_sorted_rmdup_sorted.bam
(BAM) and stl64_mut_all_sorted_rmdup_sorted.bam.bai
(BAMindex)…the sibling files were named identically to the mutant files
except with stl64_sib in place of stl64_mut

E.2.4 Introduction to the Terminal
This introduction is only intended to give you the very basic information you need to be
able to navigate through different directories in the terminal in order to ultimately execute
the necessary PERL scripts to analyze the WGS data. I find online blogs and discussion
forums to be useful tools for further information on using the terminal, and of course
trusty Google!
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•

PERL scripts are executed/run through your computer’s terminal
o For Macs this is easily accessed through the X11 application in your
Finder
§ For the sake of consistency, all further information will be shown
using a Mac, but everything should work the same using a terminal
emulator on a PC
o PC users have to download a terminal emulator such as PuTTY

•

When you first open your terminal (Mac), it should look something like this…
Figure E1: Screenshot of
the terminal window on a
Mac. The command line is
considered everything after
the $. Use the return key
(ENTER) to execute
commands, not to carry text
over to the next line.
You are in your home directory at this point (your home directory is the account
you log into when you first log in to your computer). When executing commands
in the terminal it is important to always know what directory you are in (aka your
working directory). For these purposes you can imagine a directory as a folder.
When you log in to your computer, you are essentially accessing a very large
folder, then you have your Desktop, Documents, Pictures, etc which are all
separate folders (i.e. directories), and then you have all of the different files and
folders within those larger folders.

•

Three very useful commands for moving around between directories and
navigating through the terminal are “pwd”, “cd”, and “ls”
o pwd = print working directory
§ This will show you the complete pathname of your current
directory
§ Directories are separated by slashes
§ The leading slash represents the topmost directory with which
everything else is referenced to, so when designating a pathname,
always start with a leading slash.
o cd = change directory
§ cd <name of the directory you wish to move into> (e.g. cd
stl64_SEQUENCE_ANALYSIS) will move you forward a
directory (e.g. take you from the larger Desktop folder to the
stl64_SEQUENCE_ANALYSIS subfolder that sits on your
desktop)
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§

cd .. (note the space between the cd and the two periods!) will back
you out one directory (e.g. take you back out of the
stl64_SEQUENCE_ANALYSIS subfolder into your Desktop
directory)

§

NOTE: cd and cd .. do not actually show you anything in the
terminal. The changing of directories just happens. If the command
failed (most likely you forgot the space before the dots!) it will
show an error message. If no error, assume it worked. To make
sure it worked, use the ls command and check the contents of your
new directory!

o ls = list
§ The ls command will list all of the contents within a particular
directory in alphabetical order
§ This is particularly useful if you are not sure where a file is located

Figure 2: Examples of various commands within a Mac terminal. Use pwd (red
arrows), ls (blue arrows), cd (black arrow) and cd .. (gray arrow) to determine the
working directory and its contents and navigate into and back out of the Desktop
directory.
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E.2.5 Introduction to PERL
Again, this introduction is meant to provide the basic information needed to execute the
necessary scripts for analyzing your WGS data. All of the scripts used for the analysis are
written in PERL. The scripts themselves have been commented to try and aid in
understanding exactly what the different steps of the scripts are accomplishing, but this
protocol will not go into deep detail about programming in PERL. There are some very
good book resources around if you find you would like more detailed information on this
aspect. Discussion forums also make very good resources here. As always, Google is
your friend!

•

PERL scripts can be opened and edited in any text editor. The file extension for a
PERL script is “.pl”, but the default for text editors is “.txt” so you have to make
sure you include the “.pl” in the file name when saving scripts.

•

Since these scripts will require the user to change pieces of information (mostly
filenames), I recommend simply copying the original files and making your
changes in the copied version because once you change the original, it will be
hard to go back and troubleshoot if something goes wrong.

•

Files used by the PERL scripts are not actually changed themselves, they are
simply “read” by the script and then the information is used to create a new output
file or tell you something about your input file

•

In general, the command to execute a PERL script from the terminal is…

perl <script_file_name.pl> <file_1_being_used_by_the_script>
<file_n_being_used_by_script>

o If you are executing the script in the same directory where the script file
and file(s) reside, then you do not have to specify the pathname for those
files, you can just give the file names. I prefer to keep the script files and
the files they will be working with in the same folder, it makes life much
easier!
o The carrots mean to insert the appropriate file name, do not put carrots
around your file names in the command line
o However, let’s say you are in your Desktop directory at the moment and
your script file is in a folder called “PERL_scripts” and the file that your
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script needs is in a separate folder called “WGS_files”, your command
line (from the Desktop directory) would look like this…
perl
/Users/lab_monk/Desktop/PERL_scripts/script_file.pl/Users/lab_monk/Desktop/WGS_files/snps_file_1.txt

You can see how long and easy-to-mess-up this could get,
particularly if your script requires multiple different input files (as
is sometimes the case!)
o Often times a script will be executed on multiple files or folders of files
and it is easier to specify the path to these files within the script rather than
on the command line. In these cases the files being manipulated are left off
the command line because the information needed is already embedded in
the script. In these cases the command line looks like this…
perl script_file_name.pl (Much simpler!)
o To determine what the command line should look like (called the “usage”)
for a particular script, one should refer either to the comments within the
script OR the README file associated with that script.
§ In programming, a “comment” is a line or part of a line in a code
that is not interpreted as part of the script, but is rather for the
user’s benefit only
o In PERL, comments are denoted by the pound sign (#)
o Anything following # or multiple ### is not part of the
actual script
o Often programmers use commenting as a way of
troubleshooting their code so you may see lines of code
preceded by # (especially print commands). This is because
one can easily turn “on” or “off” a piece of code simply by
adding or removing a #.
o Comments are also a very useful way of adding notes,
clarification, instructions, etc that are solely for the user to
be able to understand and effectively use the code.
§ It is also common practice in programming to generate what is
called a README file with every script. This file is a very simple
text file (.txt) that accompanies the script that provides useful
information about that script, whether it be the usage, special
requirements for the input file(s), details about the output, etc.
o README files are almost always named exactly like the
script file followed by “_readme.txt” (e.g. for the script
called split_for_filtering.pl, the README file would be
called split_for_filtering_readme.txt)
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o README files are typically kept in the same location as
their corresponding script file
•

Specific information about the purpose of different parts of the codes and the
meaning of different commands can be found within the comments of the scripts,
but here is a general overview of some basic PERL commands/syntax…
o All counting in PERL begins at 0. So if you have 10 columns in your input
file, this will be referred to as [0]-[9] rather than [1]-[10] (where the
brackets indicate it is a column/position)
o Each complete line of code is followed by a semicolon (;) to denote the
end of the command
o Variables = ways of storing values so they can be referred to or
manipulated by the script
§ Variables can be many things…numbers, words, letters, or strings
of any of these
§ Scalar variables – denoted by a $ in front of the variable name store a single value
§ Array variables – denoted by @ in front of the variable name store lists of values
• Each value in the list is assigned a position/column and this
location is denoted by [ ] (see note about counting above)
o

“my” command
§ my is a command used to define a variable name and assign it a
value
§ Variables are often defined as “empty” at the beginning of a script
so that the value can be manipulated as the script goes on
(especially true for arrays)
§ To define a scalar variable…
• my $number = 0;
o If you want your variable to be text, then the text
after the equals sign must go in quotation marks as
such
§ my $name = “Breanne”;
§ To define an array variable…
• my @list_of_words = ( “red”, “arrow”, “sequence” );
• This creates 3 columns, each containing one word
o @list_of_words [0] is the first column in the array
and contains the word red
o @list_of_words [1] is the second column in the
array and contains the word arrow
o @list_of_words [2] is the third column and contains
the word sequence
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•

As mentioned above, arrays are often defined as empty
variables at the very beginning of the script because they
will be manipulated throughout the script. To define an
array as empty, use empty parentheses after the =
o my @emptyarray = ( );

o Naming Variables
§ If possible, name variables in a very straightforward and logical
way that is related to the purpose of that variable
§ Variable names can be whatever you’d like, and as long as you’d
like, as long as they are formatted as one word without spaces
• So if you want to define an empty variable as “stl64 mutant
SNPs” it would be…
o my $stl64mutantSNPs = “ “; for a scalar
o my @stl64mutantSNPs = ( ); for an array
§ As you will see in the scripts later, one script often requires many
different variables and if they are not named in a logical manner it
can be very difficult to keep track of which variables are being
manipulated
o Loops
§ I will not go into great detail here as the reasons for using different
types of loops in different circumstances can get complicated, but
suffice it to say that loops are a very useful tool in programming
that do exactly what the name implies – they cause a particular
chunk of code contained within the loop to be repeated multiple
times
§ Types of loops you will see in these scripts
• while
o repeats the code within as long as a given condition
(that the programmer provides) is true. A while loop
tests this condition at the beginning of every
iteration of the loop. The loop ends when the
condition is no longer true.
• for
o for loops are similar to while loops except in the
way in which conditions are provided for
instructing the loop on how long to continue. for
loops allow finer control as more conditions can be
evaluated.
§ Loop syntax
• Loops are easily recognized in codes by the following
general syntax:
loop type (condition statements) {
Code to be executed;
Code to be executed;
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•
•

•

}
Note that the beginning and end of a loop is designated by
curly brackets { }
The code to be executed within a loop can be one or many
different commands, including other loops
o Often, any lines of code that are within loops are
indented further than the lines that open and close
the loop as an easy way of highlighting the presence
of a loop.
Programmers often put the curly bracket that closes a loop
on its own line indented in line with the original line of
code that opened the loop (as shown in the syntax example
above)
o Loops within loops (nested loops) can get quite
complex so using indentation and separate lines can
help keep a code organized and easy to follow

o Conditional (if/else/elsif) statements provide instructions on what to do
when a certain condition (or set of conditions) is true or false. They look
something like this…
if (condition 1) {
do this;
}
elsif (condition 2) {
do this if condition 1 is false, but condition 2 is true;
}
else {
do this if neither condition 1 or condition 2 are true;
}

§

elsif statements act as extensions to the original if
statement as they allow you to test multiple different
conditions
o elsif statements follow if statements and precede
else statements
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§

Note that else statements do not provide conditions.
They always follow an if statement and the else
statement applies to anything that did not meet the
conditions of the if and elsif statements.
o The default is to do nothing. So if an else
statement is not provided after the if statement,
nothing will be done with the variables that do
not meet the condition of the else statement.

E.2.6 Using PERL to analyze WGS data to identify a causal mutation
The following scripts and data analyses take advantage of the concepts of
recombination and linkage to reveal a region of homozygosity that should contain the
mutation that causes the phenotype you initially sorted your pools of larvae based on. The
descriptions herein assume that your phenotype is recessive and that the mutant pool has
been correctly sorted from siblings (all individuals with the mutant phenotype will be
homozygous at the causal mutation). This protocol also assumes that you have sequenced
the sibling pool for that mutant. If not, then you should have a database of SNPs that have
been previously identified in your sibling pools from other mutants and this database can
act as your sibling pool. The SNPs surrounding your SNP of interest for some distance
should be linked to the causal SNP, meaning they will also be homozygous in the mutant
pool (thus the “region” of homozygosity). The initial analyses for obtaining the region of
homozygosity should be the same for all mutants, but the downstream steps for
determining which candidate SNP in the region is your causal SNP will likely vary for
each mutant.

Mapping your mutation to a region of homozygosity
By now you should have obtained, downloaded, and saved (as .txt) the
snpInGenome.bed files for both the sibling and mutant pools and renamed them in a
logical fashion according to which pool they belong to. You may have noticed another
file included in the link GTAC sent you called the snpInExon.snpEff file. The snpInExon
files will be useful later for helping assess which SNP is likely causative, but they are not
useful for mapping purposes because, as the name implies, these files only provide
information about SNPs known to be in exons. Since only ~2% of the genome is actually
coding, this does not provide sufficient information about the surrounding SNPs, which –
if linked to your mutation of interest – should be homozygous as well, even if they are
intronic/intergenic or do not have an interesting consequence for the protein. The
snpInGenome.bed files, again as their name implies, provide information about ALL
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SNPs called as different from the reference throughout the genome, and therefore are the
files you will be working with to map to a region of homozygosity.
1. Create a folder on your Desktop that will house all of the files you will work with
and generate during this analysis
2. Copy the scripts (.pl files), and the WGS_homozygosity_data_template.xlsx file
from the server into this folder. The readme files can be placed in a subfolder, the
scripts and Excel template should be left out in the main folder.
a. DO NOT simply move these files!!! They are a shared resource and
therefore the original files should NOT be edited. If you wish to mess with
the code or change file names etc, copy them into your own folder and edit
the copy.
3. Open a terminal and change directories (cd) until you find this main folder
4. Change directories into your main folder
5. To check that you are in the right place, use the ls command to list the contents of
your main folder
a. Should see the script files, the excel template, and the readme files (or
folder). If not, you are in the wrong directory -> back out (cd ..) and find
the right folder
b. If you are in the right folder, proceed to step 6
6. Run the split_for_filtering_BH.pl script to split the sibling snpInGenome.txt file
into separate files by chromosome (chr).
a. Background: As it stands, the snpInGenome file contains all of the SNPs
on all of the chromosomes. Downstream analyses will be comparing SNPs
based on their position. Since the position of a SNP is in reference to its
position on a particular chromosome, the actual numbers for position may
be redundant as there is a position 203 in all 25 chromosomes! To make
sure we are only comparing a SNP at position 203 between mutant chr1
and sibling chr1, and NOT position 203 on chr1 to position 203 on chr9
we have to split the original snpInGenome files by chromosome.
i. Script used: split_for_filtering_BH.pl
ii. Input file: The snpInGenome.txt file for the sibling pool
iii. Usage from the directory where the script lives:
perl split_for_filtering_BH.pl <input file.txt> <prefix>
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1. The prefix can be anything you want that will make sense
to you, but I recommend using something simple like…
allele#_SIB
2. Again, do not actually put carrots around anything in the
command line, just a single space between each item
iv. Output: 25 files that will have the prefix you provided in the
command line followed by “_filter_chr_#.txt”
1. The output files will be generated in the folder that the
script resides in, so in this case, the main folder on the
desktop (not in a subfolder)
b. Notes: The way the script is currently written, any SNPs that do not map
to a specific chromosome will be ignored. This includes SNPs in the
mitochondrial genome (chrMT) and SNPs that are still on scaffold
chromosomes (chrZv9).
i. The mitochondrial genome does not matter for these analyses as
the mutations were generated in males
ii. The causal mutation could very well be on a scaffold chromosome,
so we are working on modifying the script so that these will not be
ignored, but even if the causative SNP were on one of these
scaffolds, you should still see linkage to a region of homozygosity
on a chromosome. This is because those scaffolds actually do
belong to a real chromosome, we just don’t know which one and in
what orientation yet. More on looking into chrZv9 SNPs later.
1. 01/25/15, Sarah Ackerman and I generated a script capable
of NOT ignoring these SNPs and separating each scaffold
“chromosome” into separate files. This is really only
necessary if you suspect that your causative SNP is on one
of these scaffolds, but the script is now available if needed.
Still working on comments in the script and follow-up
analyses, so please just contact Breanne L. Harty or Kelly
R. Monk if you want the script.
7. Save all of the new sibling chromosome files into a folder that is logically named
a. Again, use UNDERSCORES instead of spaces in all file and folder names
8. Rerun the split_for_filtering.pl script from step 1 to split the mutant snpInGenome
file into separate chromosomes
a. The only thing that changes is what you enter in the command line. Put
your mutant file name as the input file and change the prefix to reflect that
they are now the mutant chromosomes (e.g. allele#_MUT)
b. The output file names will look exactly the same except for the prefix that
you provide in the command line so it is IMPERATIVE that you use a
consistent naming scheme that keeps track of which files come from the
sibling pool and which come from the mutant pool.
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9. Save all of the new mutant chromosome files into a folder that is named like the
sibling folder you made in step 2
a. By the end of step 9 you should have a main folder on your Desktop, and
inside this folder are…
all of your scripts
3 subfolders called something like:
1. allele#_SIB_chromosomes
2. allele#_MUT_chromosomes
10. Open the bp_homozygosity_mutant_and_wt_one_file_BHedits.pl script in a
text editor such as TextWrangler. I like TextWrangler in particular because it
adds line numbers in the left margin so you can easily identify/refer to a line of
code, and it color codes PERL scripts so that it is obvious which lines are
commands and which are comments, etc but your favorite text editor will work
just as well if you are comfortable enough with the scripts to identify the lines of
code that have to be edited.
a. Unlike the split_for_filtering.pl script which got all the information it
needed from the command line, the
bp_homozygosity_mutant_and_wt_one_file_BHedits.pl script needs to be
edited each time it is run because the information that tells the script
which files to manipulate and what to call the output file is contained
within the script itself
i. This is because it is going to be manipulating all 50 of the
chromosome files that you generated in steps 6-9
11. Edit the bp_homozygosity_…script appropriately to reflect the folder and
filenames you are using for your mutant
a. There are 4 variables that need to be edited each time this script is run for
a new mutant or new files (NOTE: DO NOT change the variable names
themselves, only things after the equal sign!!! And don’t forget the
quotation marks or the semicolon at the end!):
i. my $genomedir = “ “;
1. This is the folder where your mutant chromosome files live
2. You must provide the entire pathname for this folder
a. Use the pwd command in the terminal to show you
the pathname for your main folder and then add the
name of the mutant chromosomes subfolder to the
end of the string so it looks something like this…
my $genomedir =
“/Users/lab_monk/Desktop/stl64_SEQ_ANALYSIS/stl64_MUT_chromosomes”

ii. my $wildtypedir = “ “;
1. This is the folder where your sibling chromosome files live
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2. The only difference between my $genomedir and my
$wildtypedir should be the last part of the pathname that
specifies that it is the folder of sibling chromosomes
instead!
my $wildtypedir =
“/Users/lab_monk/Desktop/stl64_SEQ_ANALYSIS/stl64_SIB_chromosomes”

iii. my $mutant = “ “;
1. This is whatever comes before the number and the .txt in
the file names for your mutant chromosome files
a. Example: for the stl64 mutant, my mutant
chromosome files were called….
stl64_MUT_filter_chr_1.txt,
stl64_MUT_filter_chr_2.txt,
stl64_MUT_filter_chr_3.txt, etc so I would put
stl64_MUT_filter_chr_ between the quotation
marks after the equal sign like this…
my $mutant = “stl64_MUT_filter_chr_”;

iv. my $wt = “ “;
1. This is the equivalent of my $mutant except for the sibling
chromosome files, so it should look something like this…
my $wt = “stl64_SIB_filter_chr_”;
12. Save the edited version of the script in your main folder. Again I recommend
editing a copy and not the original because if you mess up it will be harder to find
out where if you don’t have the original to compare to.
13. Run the newly edited bp_homozygosity_mutant_and_wt_one_file_BHedits.pl
script
a. Background: This script will essentially split each chromosome into
“bins” (a set number of base pairs assigned by the user) and calculate the
percent homozygosity of the major allele for all SNPs in the bin for both
mutants and siblings, as well as the ratio of mutants to siblings for that bin.
See the readme file and comments within the script for more detail on the
programming or functionality of the script. NOTE: A major disadvantage
of this script is that it is NOT a sliding window. This means the genome is
being arbitrarily chopped at whatever the bin size is without regard to the
number of SNPs in the bin. This means that you will likely need to
ultimately run the script several times with different bin sizes to ensure
that your region of highest linkage is not being somehow cut in half by the
bin size.
315

i. Script used:
bp_homozygosity_mutant_and_wt_one_file_BHedits.pl
ii. Input files: the mutant chromosome files and the sibling
chromosome files
iii. Usage from the directory where the script lives:
perl bp_homozygosity_mutant_and_wt_one_file_BHedits.pl
1. Note that there does not need to be anything after the script
name
2. If you changed the name of the script after editing, put the
name of your edited script after the perl command
iv. Output: one text file containing the following 6 columns of
information for all chromosomes
1. Chromosome
2. The position of the last base pair in the bin
3. Number of SNPs included in the bin
4. Mutant pool homozygosity of the major allele
5. Sibling pool homozygosity of the major allele
6. The ratio of mutant/sibling (column 4/column 5)
a. The output file will be generated in the folder that
the script resides in, so in this case, the main folder
on the desktop (not in a subfolder)
b. NOTES: If a mutation is responsible for the phenotype you sorted your
mutants by, you would expect the percent homozygosity at that SNP to
approach 100% (or 1.0) in the mutant pool and be closer to 50% (0.5) in
the sibling pool. Since SNPs nearby will be linked you should see a high
percentage of homozygosity for the entire bin in mutants and a lower
percentage in siblings. By taking the ratio of mutants/siblings you can
eliminate regions of high homozygosity in mutants that are also highly
homozygous in siblings. This is to some degree going to be affected by the
chosen bin size. See comments in the script for more information, but if
you are not getting good peaks in step 18, try adjusting your bin size (my
$binsize in the script – by default set to 200kb, but can easily edit to a new
value).
14. Open the WGS_homozygosity_data_template.xlsx spreadsheet
a. This is quite a large file so don’t be surprised if it takes a minute or two to
open
b. The first 5 sheets in the workbook are various charts that will be generated
when you enter your data
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c. The final sheet is the template which contains all of the formulas that will
generate the charts in the first 5 sheets
i. Do NOT mess with any of the formula-containing columns!!!
15. Once the script has finished running, open the output file from step 13 -> Edit ->
Select All -> Copy
a. You know the script is done running when the bash-$ returns to the
command line in your terminal window. Be patient, it is analyzing 50
different files, it takes a few minutes!
16. Select cell A1 in Sheet1 of the WGS_homozygosity_data_template.xlsx
spreadsheet
17. Paste the values from the output file (should fill out the first 6 columns of sheet 1
and the formulas in the columns further to the right should do their thing and
numbers will appear!)
a. The first 5 sheets will generate charts from the data that you input in the
last sheet (currently called sheet 1)
18. Explore your data! You are looking for high peaks in the Normalized mut/wt data
series (chart 2)
a. There may be peaks on multiple chromosomes, but upon closer inspection
most of these will be because they contain very few SNPs.
b. You are looking for a single cluster of many bins that have an allele ratio
of 2 or higher.
i. Currently the chromosome # is not labeled on the charts, but the
chromosome boundary points are marked on the horizontal axis
ii. Your most likely region of interest is going to be in a cluster of
consecutive bins with relatively high allele ratios (even if not all
the way to 2)
NOTE: In order to compare to the SNP positions in your snpInExon file, you need to first
translate from the genomic position in the bp_homozygosity output file back to
chromosomal position. Once you know the chromosome, just re-run the
bp_homozygosity script for that chromosome only and this will give you chromosomal
position. We are still working on a way to streamline the script so that this step is not
necessary, but for now this approach works like a charm.

Quick ways to narrow/confirm your region:
1. Play with the bin size
a. The default bin size in the original script is 200kb. This has proven in all
cases to be a good bin size to get the initial chromosome linkage, and in
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some cases has been enough to get the more precise region of
homozygosity.
b. However, for some mutants, after getting to the chromosome, narrowing
the bin size can help more specifically identify the region with the highest
linkage (you will have multiple regions!! Each mutant is different and it
seems to vary largely on how many times it was outcrossed, and how
obvious the phenotype was).
c. Messing with bin size can also sometimes reveal peaks that were not
previously showing as highly linked with other bin sizes. This is in part
because of what I mentioned above in that the bin is not sliding along the
chromosome, it is simply chopping it up. So say your region of highest
linkage is from 100kb to 250kb…a bin size of 200kb will chop off a good
chunk of that region and could cause it to be swamped or look less linked
than it actually is. Therefore, whether you are expanding your bin or
narrowing it, I recommend changing the size such that the “cut sites” will
not land in the same places. So with our 200kb default, a 100kb bin may
not actually buy you that much more information since it is “cutting” the
chromosome in many of the same places. So maybe try 80kb or 150kb or
500kb, etc.
d. To edit the bin size, simply go into the bp_homozygosity…script and
change the my $binsize variable to whatever size you want.
i. Make sure you keep the “=” between the my $binsize part and the
number, and be sure you don’t delete the “;” at the end!!! Losing
either of these will cause the code to throw an error.
2. Analyze the specific chromosome more closely
a. Once you have narrowed down the entire genome to a specific
chromosome, it is VERY useful to run the bp_homozygosity…script
specifically on that chromosome. This will give you an idea of WHERE
your region of homozygosity is on that chromosome.
b. You can’t easily do this with the data from the whole genome simply
because the x-axis is giving GENOMIC position, which is hard to translate
exactly to chromosomal position
c. To run the bp_homozygosity… script on one specific chromosome:
i. Go to line #72 in the original script file
ii. It should read: for ($j=1; $j<26; $j++){
iii. $j in this case indicates chromosome number; $j++ tells it to count
up by 1
iv. In your COPY of the script, change the first part to
$j=chromosome of interest
v. Change the second part to $j<chromosome of interest +1
1. EXAMPLE: Let’s say I want to analyze chromosome 9
more carefully. My new line of code should look like this:
for ($j=9; $j<10; $j++){
2. The output will be only bins on chromosome 9
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vi. Put the data for your single chromosome into the Excel data
template
vii. Change the x-axes on the different charts (will be in the millions),
you should now be able to see regions of linkage along the
chromosome.
viii. These bin sizes now reflect approximate chromosome position.
NOTE: The number and size of the region(s) of homozygosity (number of bins with large
peaks) will vary depending on several things:
1. Position along the chromosome affects frequency of recombination
a. Telomeres are known to have higher rates of recombination, but
depending on how close your gene of interest is to the telomere,
there may not be sufficient room on the other side of the gene to
get recombination, so your region might be larger
b. Centromeres are known to have lower rates of recombination so if
your gene is close to a centromere, the region of homozygosity
may be larger
2. The number of meiosis events included in the pool
a. The more larvae used, the more opportunities there were for
recombination to occur, and more recombination increases
heterozygosity thereby giving a smaller region of homozygosity
3. The number of times the mutation has been outcrossed
a. Outcrossing inherently increases heterozygosity throughout the
genome, it also provides additional opportunities for recombination
events. Therefore, more outcrosses should narrow the region of
homozygosity, while more intercrosses will make it larger.

Narrowing down your list of candidate SNPs to identify the causal mutation
1. Identify the chromosome of interest
2. Identify all bins that have an allele ratio greater than or equal to 2 on that
chromosome AND have a reasonable number of SNPs in the bin (seen in output
file from step 15 above)
a. If there are only 5 SNPs in the whole bin, its real easy to get an allele ratio
of 2 or higher
3. Isolate the SNPs on that chromosome from the snpInExon.snpeff files for both
SIBs and MUTs (these files were included in the original link from GTAC and
you should already have downloaded and saved them appropriately)
a. Open them with Excel
b. Sort the data by chromosome (column A), then by position (column B)
c. Copy all of the SNPs from the sibling chromosome and paste into a new
workbook
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i. Change the color of the text for the sibling SNPs so that you will
be able to distinguish between the mutant and sibling SNPs
d. Copy all of the SNPs from the mutant chromosome into the new
workbook that you just placed the sibling SNPs into. If you would rather
have the mutant SNPs be a different color that’s obviously fine. The point
is to have some way of distinguishing mutant from sibling once you have
combined them into one file.
e. Save this new workbook. Again, please for your own sanity later, name it
in a way that you can tell exactly what it is just by looking at the filename!
If you have to go back and look at this months later you don’t want to have
to open every file in the folder to find it!! Example:
stl64_chr1_snpInExon_sibs_and_muts.xlsx
4. Sort the workbook by position
a. You should see an alternating pattern between your colored text and the
black text where there are SNPs at the same position in siblings and
mutants. If you care which one is on top, then just add another condition
to your sorting and tell it which text color to put on top!
5. Locate SNPs within the bins from step 2 based on position and highlight these
rows
6. Scan these regions for obvious candidates such as SNPs that are heterozygous (or
not present) in sibs but create STOP_GAINED, STOP_LOST, FRAMESHIFTS,
START_LOST, etc in the mutants
a. Basically doing a quick look for SNPs that stand out as obviously going to
have a major impact on the protein product
b. DO NOT eliminate a SNP just because it is not seen in the sibling pool.
This could be due simply to low coverage, or if there is a het phenotype
then it is possible you put 100% wildtype siblings in the pool (as was the
case with stl64)
7. While doing this, eliminate any regions/bins that only contain SNPs that lead to
SYNONYMOUS changes. SNPs that are homozygous in the sibs as well or that
are only heterozygous in the mutants can also be safely eliminated.
8. If there are no obvious candidates that stand out, literature searching is your
friend!! Look up the gene names containing NON_SYNONYMOUS SNPs and
see if anything pops out that way.
9. If you are down to only NON_SYNONYMOUS SNPs, then you should look at
the amino acid changes. While it is certainly not fool-proof, some amino acid
changes, while technically non-synonymous will not likely have a major affect on
the protein structure or properties. These could at least be moved to the bottom of
the candidate list.
10. Get the sequences surrounding the SNPs of interest and use a program like
Sequencher or APE to determine if the SNP disrupts a restriction site or creates a
new one. Any SNPs that do affect restriction sites can then be used to genotype a
panel of siblings and mutants. If any of your siblings are homozygous mutant, or
your mutants are homozygous wildtype, these would be strong evidence that this
SNP is not causative. These markers can then be used to try to narrow down the
region and may be able to help eliminate other SNPs!
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Appendix F
Additional insights on the function of Fbxw7 in
myelinating glia
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PREFACE
Unless otherwise noted below, I performed all experiments and analyses mentioned in
this appendix.

Adam Clemens collected the data in section F.3. Adam is a graduate student in the
developmental, regenerative and stem cell biology (DRSCB) program at Washington
University. I mentored Adam during his rotation period in the Monk lab.

Melanie Holmgren collected the data in sections F.4 and F.6. Melanie was an
undergraduate student that worked with me on the fbxw7stl64 project for about 2.5 years.
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F.1 METHODS
F.1.1 Transmission electron microscopy
TEM was performed as described in Chapter 4, section 4.5.7.

F.1.2 Rapamycin treatment
Embryos from stl64/+ intercrosses were raised together until 6 dpf and then divided into
two groups. One group was treated with 500 nM rapamycin in egg water while the
control group was bathed in the equivalent concentration of DMSO (0.05%) in egg water.
Larvae were incubated in drug for a total of 48 hours, and fixed in Karnovsky’s at 8 dpf
in preparation for TEM analysis. All treatment was randomized and totally blind to
treatment.

F.1.3 Whole mount in situ hybridization
ISH was performed as outlined in Chapter 4, section 4.5.3. The sox10, oct6, and olig2
probes have been previously described [1-3].

F.1.4 Acridine orange assay for cell death
Acridine orange staining was performed according to previously published protocols [4].
In brief, embryos were placed in a 2 mg/L solution of acridine orange in E3 embryo
medium for 30 minutes. Embryos were washed 3 times in E3 medium and then
immediately scored under a fluorescent dissecting microscope.

F.1.5 Quantitative reverse transcription PCR
qPCR was performed as described in Chapter 4, section 4.5.13.
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represent disintegration of the dystroglycan complex (Losasso et
al., 2000; Yamada et al., 2001; Matsumura et al., 2003; Singh et al.,
2004; Agrawal et al., 2006; Zhao et al., 2010). In contrast, we show
that, in Schwann cells, although increased !-DG cleavage is detrimental, regulated !-DG is physiological and !-DG31 may function as a truncated receptor. We find !-DG31, utrophin, and
Dp116 in Cajal bands without "-DG linkage to extracellular ligands, and previous data showed that utrophin persists in lysates
of nerves lacking Schwann cell dystroglycan (Saito et al., 2003).
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Loss!of!Fbxw7!in!Schwann!cells!disrupts!proper!membrane!organiza6on.!(A)!Electromyogram!(EMG)!analyses!were!performed!
on!control!and!cKO!mice!at!5>6!months!of!age.!Analyses!performed!by!the!McEwan!lab.!(B)!Fbxw7!cKO!mice!travel!less!
distance!in!the!open!ﬁeld!test!when!compared!to!control!siblings.!Total!distance!traveled!is!an!approxima6on!of!the!6>minute!
walking!test!performed!in!diagnosing!pa6ents!with!peripheral!neuropathies!(Grounds!et!al.,!2008;!Kobayashi!et!al.,!2012).!(C)!
Fbxw7!cKO!mice!do!not!perform!diﬀerently!on!the!rotarod!when!compared!to!controls,!sugges6ng!their!balance!and!motor!
coordina6on!are!intact.!Behavioral!assessments!and!analyses!performed!by!J.!Golden.!
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F.3 RAPAMYCIN RESTORES MYELIN THICKNESS IN fbxw7stl64 MUTANTS

Figure F2: Rapamycin inhibition of mTOR partially suppresses the PNS
hypermyelination phenotype in fbxw7stl64 mutants. stl64 mutants were treated with
either 0.05% DMSO (A) or 500 nM rapamycin (B) in egg water from 6 dpf to 8 dpf.
TEM was performed at 8 dpf, and the number of wraps/axon were counted as in Chapter
4 (C). stl64 mutants exposed to rapamycin had fewer wraps of myelin/axon than their
DMSO treated siblings, although they were not quite restored to WT levels. * = p<0.01,
** = p<0.001, *** = p<0.0001, NS = not significant. Importantly, this dosage of
rapamycin did not affect normal myelination in wild-type animals, and instead only
affected fbxw7 mutants. This suggests that Fbxw7 functions to control mTOR levels and
modulate proper thickness. Notably, a stronger dose of rapamycin, and/or longer
treatment period would likely alter myelination in wild-type animals as expected for
mTOR function in myelination.
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F.4 AGED fbxw7stl64/+ NERVES

Figure F3: Aged fbxw7stl64/+ nerves display enhanced SC number and nerve
fasciculation. Although I have not yet analyzed sufficient animals to carefully quantify
these phenotypes (N = 2 WT, N = 3 fbxw7stl64/+), preliminarily it appears as though
nerves from old heterozygous animals continue to display enhanced SC number: ~12
nuclei/nerve on average in controls, while the average is approximately 21 nuclei/nerve
in the heterozygous animals (A-B; SC nuclei pseudocolored in red). The fixation of
myelin in zebrafish makes it very difficult to properly quantify myelin thickness, and at
these older stages the myelin has compacted too much to enable counting individual
wraps/axon as I did during developmental stages. However, anecdotally, the myelin
appears to still be thicker in the heterozygous mutant nerves. Furthermore, we observed a
very interesting nerve fasciculation defect in 2/3 fbxw7stl64/+ animals analyzed. Nerve
fasciculation occurs when perineurial fibroblasts invade the nerve and the axons appear to
be clustered into discrete bundles (panel C’; fibroblasts pseudocolored in cyan).
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F.5 EXPRESSION OF OPC MARKERS IS ELEVATED IN fbxw7stl64 MUTANTS

Figure F4: fbxw7stl64 mutants display an increase in olig2+ cells in the CNS. ISH on
stl64/+ intercrosses at 3 dpf using a riboprobe against the OPC marker, olig2 (A, black
arrowheads). As previously described by Snyder et al. [6], fbxw7vu56 mutants display an
increase in olig2+ cells in the spinal cord. fbxw7stl64/+ (B) and fbxw7stl64/stl64 (C) animals
also display a similar excess of olig2 expression in the CNS (D). This provides further
evidence that stl64 mutants phenocopy the CNS defects observed in vu56 mutants, and
thus further support that fbxw7 is the causative gene in both cases.
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Figure F5: fbxw7stl64 mutants display a global increase in the number of sox10+ cells.
Snyder et al [6] also described an increase in sox10 expression in fbxw7vu56 mutants. ISH
using a riboprobe against sox10 (A; purple) on larvae from stl64/+ intercrosses at 30 hpf.
Homozygous stl64 (B) mutants consistently displayed general upregulation of sox10 in
both the CNS and PNS. This data is again consistent with the CNS observations in vu56
mutants, and supports our findings of increased SC number by TEM in both zebrafish
and mouse Fbxw7 mutants.
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F.6 CELL DEATH IS NOT AFFECTED IN THE PNS OF fbxw7stl64 MUTANTS

Figure F6: Cell death is not changed in stl64 mutants. Acridine orange (A.O.) staining
of dying cells (white arrows) in embryos from stl64/+ intercrosses at 40 hpf.
Representative images of a wild-type (WT) embryo (A), and a stl64/stl64 embryo (B).
A.O. positive cells (white arrows) were counted along the pLLn, but there was very little
cell death in general, and thus there were no significant differences between genotypes
(C) (N.S. = not significant). Error bars depict s.d. Student’s t-test.
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F.7 OCT6 EXPRESSION IS REDUCED IN fbxw7stl64 MUTANTS

Figure F7: oct6 expression is decreased in both the CNS and PNS of stl64 mutants.
ISH analyses using a riboprobe against the transcription factor, oct6. Shown are
representative images of wild-type (A), fbxw7stl64/+ (B), and fbxw7stl64/stl64 (C). fbxw7stl64
mutants display reduced oct6 expression in both the PNS (D) and CNS (E).
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F.8 FBXW7 AND c-MYC ARE OVEREXPRESSED IN fbxw7stl64 MUTANTS

Figure F8: mRNA expression of fbxw7 and its target c-myc in stl64 mutants. Fold
change in expression level of fbxw7, mbp, and the two gene duplicates of c-myc (myca
and mycb) in WT (white bars), fbxw7stl64/+ (grey bars), and fbxw7stl64/stl64 (black bars)
zebrafish larvae at 7 dpf as measured by qPCR. fbxw7, mbp, and mycb are all elevated in
fbxw7 mutants. myca is also slightly elevated, especially in homozygous mutants, but
these comparisons did not reach statistical significance. N=3 per genotype. ANOVA. * =
p<0.05, *** = p<0.001. If no asterisk (*) is present, the comparison was not statistically
significant. In all cases, expression in heterozygotes was not significantly different from
mutant expression.
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